CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><title>Cannabis Earnings News - Benzinga</title><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "Article", "publisher": {"@type":"Organization","logo":{"@type":"ImageObject","url":"/next-assets/images/schema-publisher-logo-benzinga.png"},"name":"Benzinga","url":"https://www.benzinga.com"}, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.benzinga.com/cannabis/earnings" }, "mainEntity": "WebPage", "headline": "Cannabis Earnings News", "url": "https://www.benzinga.com/cannabis/earnings", "dateCreated": "2019-04-18T13:04:28.000-04:00", "datePublished": "2019-04-18T13:04:28.000-04:00", "dateModified": "2023-02-22T13:02:15.000-05:00", "creator": { "@type": "Person", "name": "Benzinga" }, "author": { "@type": "Person", "name": "Benzinga" }, "description": "", "keywords": [], "mentions": [], "image": "/next-assets/images/schema-image-default.png" }</script><script type="application/ld+json">{ "@context": "http://schema.org", "@type": "NewsMediaOrganization", "name": "Benzinga", "email": "info@benzinga.com", "legalName": "Benzinga", "telephone": "877-440-9464", "url": "https://www.benzinga.com/", "logo": "/next-assets/images/schema-publisher-logo-benzinga.png", "image": "/next-assets/images/schema-image-default.png", "address": { "@type": "PostalAddress", "addressLocality": "Detroit", "addressRegion": "MI", "postalCode": "48226", "streetAddress": "1 Campus Martius Suite 200", "addressCountry": "USA" }, "sameAs": [ "https://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109", "https://twitter.com/benzinga", "https://www.linkedin.com/company/benzinga", "https://plus.google.com/108838891574408087738/posts", "https://www.youtube.com/user/BenzingaTV" ], "brand": [ { "@type": "Brand", "name": "Benzinga PreMarket Prep", "url": "https://www.benzinga.com/premarket" }, { "@type": "Brand", "name": "Benzinga Markets", "url": "https://www.benzinga.com/markets/" }, { "@type": "Brand", "name": "Benzinga Pro", "url": "https://pro.benzinga.com/" }, { "@type": "Brand", "name": "Benzinga Cloud: Data & APIs", "url": "https://www.benzinga.com/apis" }, { "@type": "Brand", "name": "Benzinga Events", "url": "https://www.benzinga.com/events" }, { "@type": "Brand", "name": "Benzinga Money", "url": "https://www.benzinga.com/money/" }, { "@type": "Brand", "name": "Benzinga Marketfy", "url": "https://marketfy.com/" } ] }</script><meta content="Copyright Benzinga. All rights reserved." name="copyright"/><link href="https://www.benzinga.com/cannabis/earnings" rel="canonical"/><meta content="Benzinga" name="author"/><link color="#1177BA" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><link href="/next-assets/images/apple-touch-icon.png" rel="apple-touch-icon" sizes="180x180"/><link href="/next-assets/images/favicon-32x32.png" rel="icon" sizes="32x32" type="image/png"/><link href="/next-assets/images/favicon-16x16.png" rel="icon" sizes="16x16" type="image/png"/><link href="/next-assets/site.webmanifest" rel="manifest"/><link color="#5bbad5" href="/next-assets/images/safari-pinned-tab.svg" rel="mask-icon"/><meta content="#2d89ef" name="msapplication-TileColor"/><meta content="#ffffff" name="theme-color"/><meta content="159483118580" property="fb:app_id"/><link href="http://feeds.benzinga.com/benzinga" rel="alternate" title="Benzinga" type="application/rss+xml"/><meta content="https://www.benzinga.com/cannabis/earnings" name="syndication-source"/><meta content="summary" name="twitter:card"/><meta content="@benzinga" name="twitter:site"/><meta content="Cannabis Earnings News" name="twitter:title"/><meta content="" name="twitter:description"/><meta content="Benzinga" property="og:site_name"/><meta content="https://www.benzinga.com/cannabis/earnings" property="og:url"/><meta content="Cannabis Earnings News" property="og:title"/><meta content="article" property="og:type"/><meta content="" property="og:description"/><meta content="/next-assets/images/schema-image-default.png" property="og:image"/><meta content="image/jpeg" property="og:image:type"/><meta content="1200" property="og:image:width"/><meta content="630" property="og:image:height"/><meta content="app-id=688949481, app-argument=https://itunes.apple.com/us/app/id688949481" name="apple-itunes-app" property="Benzinga for iOS"/><meta content="yes" name="apple-mobile-web-app-capable"/><meta content="black" name="apple-mobile-web-app-status-bar-style"/><meta content="max-image-preview:large" name="robots"/><link href="/manifest.json" rel="manifest"/><meta content="648186192" property="fb:admins"/><meta content="B01B3489A33F83DDA4083E88C260097C" name="msvalidate.01"/><meta content="84f3b1552db5dfbe" name="y_key"/><meta content="101a0095-334d-4935-b87e-0e8fc771214e" name="fo-verify"/><meta content="English" name="language"/><script id="voice-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebPage","name":"Benzinga","speakable":{"@type":"SpeakableSpecification","xpath":["/html/head/title","/html/head/meta[@name='description']/@content"]},"url":"https://www.benzinga.com/"}</script><script id="sitelink-search-schema" type="application/ld+json">{"@context":"https://schema.org/","@type":"WebSite","name":"Benzinga","potentialAction":{"@type":"SearchAction","query-input":"required name=search_term_string","target":"https://www.benzinga.com/search/fast?cx={search_term_string}"},"url":"https://www.benzinga.com/","hasPart":{"@type":"WebPageElement","cssSelector":".paywall-content","isAccessibleForFree":false},"isAccessibleForFree":false}</script><script id="navigation-header-schema" type="application/ld+json">{"@context":"https://schema.org","@type":"SiteNavigationElement","Name":["Our Services","News","Markets","Options","Ratings","Ideas","Money","Crypto","Cannabis"],"Url":["https://www.benzinga.com/services","https://www.benzinga.com/news","https://www.benzinga.com/markets","https://www.benzinga.com/markets/options","https://www.benzinga.com/analyst-stock-ratings","https://www.benzinga.com/trading-ideas","https://www.benzinga.com/money","https://www.benzinga.com/crypto","https://www.benzinga.com/cannabis"]}</script><meta name="next-head-count" content="45"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-300.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-regular.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-500.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-600.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-700.woff2" rel="preload" type="font/woff2"/><link as="font" crossorigin="anonymous" href="/next-assets/fonts/manrope-v15-latin/manrope-v15-latin-800.woff2" rel="preload" type="font/woff2"/><link href="https://cdn.benzinga.com" rel="dns-prefetch"/><link href="https://cdn.segment.com" rel="preconnect"/><link href="https://www.googletagservices.com" rel="preconnect"/><link as="script" href="https://cdn.parsely.com/keys/benzinga.com/p.js" rel="preload"/><link as="script" href="https://www.google-analytics.com/analytics.js" rel="preload"/><style>:root, :host { --fa-font-solid: normal 900 1em/1 "Font Awesome 6 Solid"; --fa-font-regular: normal 400 1em/1 "Font Awesome 6 Regular"; --fa-font-light: normal 300 1em/1 "Font Awesome 6 Light"; --fa-font-thin: normal 100 1em/1 "Font Awesome 6 Thin"; --fa-font-duotone: normal 900 1em/1 "Font Awesome 6 Duotone"; --fa-font-sharp-solid: normal 900 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-regular: normal 400 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-light: normal 300 1em/1 "Font Awesome 6 Sharp"; --fa-font-sharp-thin: normal 100 1em/1 "Font Awesome 6 Sharp"; --fa-font-brands: normal 400 1em/1 "Font Awesome 6 Brands"; } svg:not(:root).svg-inline--fa, svg:not(:host).svg-inline--fa { overflow: visible; box-sizing: content-box; } .svg-inline--fa { display: var(--fa-display, inline-block); height: 1em; overflow: visible; vertical-align: -0.125em; } .svg-inline--fa.fa-2xs { vertical-align: 0.1em; } .svg-inline--fa.fa-xs { vertical-align: 0em; } .svg-inline--fa.fa-sm { vertical-align: -0.0714285705em; } .svg-inline--fa.fa-lg { vertical-align: -0.2em; } .svg-inline--fa.fa-xl { vertical-align: -0.25em; } .svg-inline--fa.fa-2xl { vertical-align: -0.3125em; } .svg-inline--fa.fa-pull-left { margin-right: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-pull-right { margin-left: var(--fa-pull-margin, 0.3em); width: auto; } .svg-inline--fa.fa-li { width: var(--fa-li-width, 2em); top: 0.25em; } .svg-inline--fa.fa-fw { width: var(--fa-fw-width, 1.25em); } .fa-layers svg.svg-inline--fa { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; } .fa-layers-counter, .fa-layers-text { display: inline-block; position: absolute; text-align: center; } .fa-layers { display: inline-block; height: 1em; position: relative; text-align: center; vertical-align: -0.125em; width: 1em; } .fa-layers svg.svg-inline--fa { -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-text { left: 50%; top: 50%; -webkit-transform: translate(-50%, -50%); transform: translate(-50%, -50%); -webkit-transform-origin: center center; transform-origin: center center; } .fa-layers-counter { background-color: var(--fa-counter-background-color, #ff253a); border-radius: var(--fa-counter-border-radius, 1em); box-sizing: border-box; color: var(--fa-inverse, #fff); line-height: var(--fa-counter-line-height, 1); max-width: var(--fa-counter-max-width, 5em); min-width: var(--fa-counter-min-width, 1.5em); overflow: hidden; padding: var(--fa-counter-padding, 0.25em 0.5em); right: var(--fa-right, 0); text-overflow: ellipsis; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-counter-scale, 0.25)); transform: scale(var(--fa-counter-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-bottom-right { bottom: var(--fa-bottom, 0); right: var(--fa-right, 0); top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom right; transform-origin: bottom right; } .fa-layers-bottom-left { bottom: var(--fa-bottom, 0); left: var(--fa-left, 0); right: auto; top: auto; -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: bottom left; transform-origin: bottom left; } .fa-layers-top-right { top: var(--fa-top, 0); right: var(--fa-right, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top right; transform-origin: top right; } .fa-layers-top-left { left: var(--fa-left, 0); right: auto; top: var(--fa-top, 0); -webkit-transform: scale(var(--fa-layers-scale, 0.25)); transform: scale(var(--fa-layers-scale, 0.25)); -webkit-transform-origin: top left; transform-origin: top left; } .fa-1x { font-size: 1em; } .fa-2x { font-size: 2em; } .fa-3x { font-size: 3em; } .fa-4x { font-size: 4em; } .fa-5x { font-size: 5em; } .fa-6x { font-size: 6em; } .fa-7x { font-size: 7em; } .fa-8x { font-size: 8em; } .fa-9x { font-size: 9em; } .fa-10x { font-size: 10em; } .fa-2xs { font-size: 0.625em; line-height: 0.1em; vertical-align: 0.225em; } .fa-xs { font-size: 0.75em; line-height: 0.0833333337em; vertical-align: 0.125em; } .fa-sm { font-size: 0.875em; line-height: 0.0714285718em; vertical-align: 0.0535714295em; } .fa-lg { font-size: 1.25em; line-height: 0.05em; vertical-align: -0.075em; } .fa-xl { font-size: 1.5em; line-height: 0.0416666682em; vertical-align: -0.125em; } .fa-2xl { font-size: 2em; line-height: 0.03125em; vertical-align: -0.1875em; } .fa-fw { text-align: center; width: 1.25em; } .fa-ul { list-style-type: none; margin-left: var(--fa-li-margin, 2.5em); padding-left: 0; } .fa-ul > li { position: relative; } .fa-li { left: calc(var(--fa-li-width, 2em) * -1); position: absolute; text-align: center; width: var(--fa-li-width, 2em); line-height: inherit; } .fa-border { border-color: var(--fa-border-color, #eee); border-radius: var(--fa-border-radius, 0.1em); border-style: var(--fa-border-style, solid); border-width: var(--fa-border-width, 0.08em); padding: var(--fa-border-padding, 0.2em 0.25em 0.15em); } .fa-pull-left { float: left; margin-right: var(--fa-pull-margin, 0.3em); } .fa-pull-right { float: right; margin-left: var(--fa-pull-margin, 0.3em); } .fa-beat { -webkit-animation-name: fa-beat; animation-name: fa-beat; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-bounce { -webkit-animation-name: fa-bounce; animation-name: fa-bounce; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.28, 0.84, 0.42, 1)); } .fa-fade { -webkit-animation-name: fa-fade; animation-name: fa-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-beat-fade { -webkit-animation-name: fa-beat-fade; animation-name: fa-beat-fade; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); animation-timing-function: var(--fa-animation-timing, cubic-bezier(0.4, 0, 0.6, 1)); } .fa-flip { -webkit-animation-name: fa-flip; animation-name: fa-flip; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, ease-in-out); animation-timing-function: var(--fa-animation-timing, ease-in-out); } .fa-shake { -webkit-animation-name: fa-shake; animation-name: fa-shake; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-delay: var(--fa-animation-delay, 0s); animation-delay: var(--fa-animation-delay, 0s); -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 2s); animation-duration: var(--fa-animation-duration, 2s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, linear); animation-timing-function: var(--fa-animation-timing, linear); } .fa-spin-reverse { --fa-animation-direction: reverse; } .fa-pulse, .fa-spin-pulse { -webkit-animation-name: fa-spin; animation-name: fa-spin; -webkit-animation-direction: var(--fa-animation-direction, normal); animation-direction: var(--fa-animation-direction, normal); -webkit-animation-duration: var(--fa-animation-duration, 1s); animation-duration: var(--fa-animation-duration, 1s); -webkit-animation-iteration-count: var(--fa-animation-iteration-count, infinite); animation-iteration-count: var(--fa-animation-iteration-count, infinite); -webkit-animation-timing-function: var(--fa-animation-timing, steps(8)); animation-timing-function: var(--fa-animation-timing, steps(8)); } @media (prefers-reduced-motion: reduce) { .fa-beat, .fa-bounce, .fa-fade, .fa-beat-fade, .fa-flip, .fa-pulse, .fa-shake, .fa-spin, .fa-spin-pulse { -webkit-animation-delay: -1ms; animation-delay: -1ms; -webkit-animation-duration: 1ms; animation-duration: 1ms; -webkit-animation-iteration-count: 1; animation-iteration-count: 1; -webkit-transition-delay: 0s; transition-delay: 0s; -webkit-transition-duration: 0s; transition-duration: 0s; } } @-webkit-keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @keyframes fa-beat { 0%, 90% { -webkit-transform: scale(1); transform: scale(1); } 45% { -webkit-transform: scale(var(--fa-beat-scale, 1.25)); transform: scale(var(--fa-beat-scale, 1.25)); } } @-webkit-keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @keyframes fa-bounce { 0% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 10% { -webkit-transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); transform: scale(var(--fa-bounce-start-scale-x, 1.1), var(--fa-bounce-start-scale-y, 0.9)) translateY(0); } 30% { -webkit-transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); transform: scale(var(--fa-bounce-jump-scale-x, 0.9), var(--fa-bounce-jump-scale-y, 1.1)) translateY(var(--fa-bounce-height, -0.5em)); } 50% { -webkit-transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); transform: scale(var(--fa-bounce-land-scale-x, 1.05), var(--fa-bounce-land-scale-y, 0.95)) translateY(0); } 57% { -webkit-transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); transform: scale(1, 1) translateY(var(--fa-bounce-rebound, -0.125em)); } 64% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } 100% { -webkit-transform: scale(1, 1) translateY(0); transform: scale(1, 1) translateY(0); } } @-webkit-keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @keyframes fa-fade { 50% { opacity: var(--fa-fade-opacity, 0.4); } } @-webkit-keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @keyframes fa-beat-fade { 0%, 100% { opacity: var(--fa-beat-fade-opacity, 0.4); -webkit-transform: scale(1); transform: scale(1); } 50% { opacity: 1; -webkit-transform: scale(var(--fa-beat-fade-scale, 1.125)); transform: scale(var(--fa-beat-fade-scale, 1.125)); } } @-webkit-keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @keyframes fa-flip { 50% { -webkit-transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); transform: rotate3d(var(--fa-flip-x, 0), var(--fa-flip-y, 1), var(--fa-flip-z, 0), var(--fa-flip-angle, -180deg)); } } @-webkit-keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @keyframes fa-shake { 0% { -webkit-transform: rotate(-15deg); transform: rotate(-15deg); } 4% { -webkit-transform: rotate(15deg); transform: rotate(15deg); } 8%, 24% { -webkit-transform: rotate(-18deg); transform: rotate(-18deg); } 12%, 28% { -webkit-transform: rotate(18deg); transform: rotate(18deg); } 16% { -webkit-transform: rotate(-22deg); transform: rotate(-22deg); } 20% { -webkit-transform: rotate(22deg); transform: rotate(22deg); } 32% { -webkit-transform: rotate(-12deg); transform: rotate(-12deg); } 36% { -webkit-transform: rotate(12deg); transform: rotate(12deg); } 40%, 100% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } } @-webkit-keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } @keyframes fa-spin { 0% { -webkit-transform: rotate(0deg); transform: rotate(0deg); } 100% { -webkit-transform: rotate(360deg); transform: rotate(360deg); } } .fa-rotate-90 { -webkit-transform: rotate(90deg); transform: rotate(90deg); } .fa-rotate-180 { -webkit-transform: rotate(180deg); transform: rotate(180deg); } .fa-rotate-270 { -webkit-transform: rotate(270deg); transform: rotate(270deg); } .fa-flip-horizontal { -webkit-transform: scale(-1, 1); transform: scale(-1, 1); } .fa-flip-vertical { -webkit-transform: scale(1, -1); transform: scale(1, -1); } .fa-flip-both, .fa-flip-horizontal.fa-flip-vertical { -webkit-transform: scale(-1, -1); transform: scale(-1, -1); } .fa-rotate-by { -webkit-transform: rotate(var(--fa-rotate-angle, none)); transform: rotate(var(--fa-rotate-angle, none)); } .fa-stack { display: inline-block; vertical-align: middle; height: 2em; position: relative; width: 2.5em; } .fa-stack-1x, .fa-stack-2x { bottom: 0; left: 0; margin: auto; position: absolute; right: 0; top: 0; z-index: var(--fa-stack-z-index, auto); } .svg-inline--fa.fa-stack-1x { height: 1em; width: 1.25em; } .svg-inline--fa.fa-stack-2x { height: 2em; width: 2.5em; } .fa-inverse { color: var(--fa-inverse, #fff); } .sr-only, .fa-sr-only { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .sr-only-focusable:not(:focus), .fa-sr-only-focusable:not(:focus) { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border-width: 0; } .svg-inline--fa .fa-primary { fill: var(--fa-primary-color, currentColor); opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa .fa-secondary { fill: var(--fa-secondary-color, currentColor); opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-primary { opacity: var(--fa-secondary-opacity, 0.4); } .svg-inline--fa.fa-swap-opacity .fa-secondary { opacity: var(--fa-primary-opacity, 1); } .svg-inline--fa mask .fa-primary, .svg-inline--fa mask .fa-secondary { fill: black; } .fad.fa-inverse, .fa-duotone.fa-inverse { color: var(--fa-inverse, #fff); }</style><script type="text/javascript">window.OneSignal = window.OneSignal || [];</script><script id="parsely" type="text/javascript" data-nscript="beforeInteractive">window.PARSELY = window.PARSELY || {}; window.PARSELY.use_localstorage = true;</script><link rel="preload" href="/_next/static/css/133610ba03279ac0.css" as="style"/><link rel="stylesheet" href="/_next/static/css/133610ba03279ac0.css" data-n-g=""/><link rel="preload" href="/_next/static/css/e82ca5eb31e01526.css" as="style"/><link rel="stylesheet" href="/_next/static/css/e82ca5eb31e01526.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-78c92fac7aa8fdd8.js"></script><script src="/_next/static/chunks/webpack-7f2936a10d256c07.js" defer=""></script><script src="/_next/static/chunks/framework-e6b7f5edbdf1e600.js" defer=""></script><script src="/_next/static/chunks/main-a8bae8723e38c3f7.js" defer=""></script><script src="/_next/static/chunks/pages/_app-cac6b44375ca3d63.js" defer=""></script><script src="/_next/static/chunks/93656207-e022531f02d0f1e1.js" defer=""></script><script src="/_next/static/chunks/4c744e84-475c8634f7d1af26.js" defer=""></script><script src="/_next/static/chunks/ad54e6ef-d46e761f1147ca7a.js" defer=""></script><script src="/_next/static/chunks/aeb74aa0-2bdcc805ac1c6490.js" defer=""></script><script src="/_next/static/chunks/8eec4907-3b52a9e94580c3e0.js" defer=""></script><script src="/_next/static/chunks/a981ec11-57883dfa93c2b67f.js" defer=""></script><script src="/_next/static/chunks/69bd6bf3-71dff3b3a37cc29b.js" defer=""></script><script src="/_next/static/chunks/8c469d57-278636cb3035cd4d.js" defer=""></script><script src="/_next/static/chunks/5adc83ef-393b37d1f739f830.js" defer=""></script><script src="/_next/static/chunks/74927-e6eca17cfd52e04d.js" defer=""></script><script src="/_next/static/chunks/25491-a2c0d84c469150a7.js" defer=""></script><script src="/_next/static/chunks/37149-3c57e32bee25fc30.js" defer=""></script><script src="/_next/static/chunks/73737-bc29be1038094f29.js" defer=""></script><script src="/_next/static/chunks/73268-e15b89d697dd4508.js" defer=""></script><script src="/_next/static/chunks/42568-379ea60ff3a1ea4f.js" defer=""></script><script src="/_next/static/chunks/80478-55b510ca744c711f.js" defer=""></script><script src="/_next/static/chunks/97209-33e9c9fa12e49518.js" defer=""></script><script src="/_next/static/chunks/48834-0b3427eb40669fa3.js" defer=""></script><script src="/_next/static/chunks/39097-9e1fd452247607ca.js" defer=""></script><script src="/_next/static/chunks/67326-7eb512377123f4f0.js" defer=""></script><script src="/_next/static/chunks/90162-9baeeb2b96ad8c1c.js" defer=""></script><script src="/_next/static/chunks/6479-3dbc0f000f0bbdc9.js" defer=""></script><script src="/_next/static/chunks/2052-f87ebf4b92a62c84.js" defer=""></script><script src="/_next/static/chunks/67732-a439f69c1a3ec43f.js" defer=""></script><script src="/_next/static/chunks/10960-bbfebdcf6a53f138.js" defer=""></script><script src="/_next/static/chunks/24609-e6c6f256225974e7.js" defer=""></script><script src="/_next/static/chunks/59392-e5eea99f00426be0.js" defer=""></script><script src="/_next/static/chunks/55479-608f5bd0a6221992.js" defer=""></script><script src="/_next/static/chunks/28660-3edc9842a02c1f09.js" defer=""></script><script src="/_next/static/chunks/72876-c2a2c8d76ffa6c75.js" defer=""></script><script src="/_next/static/chunks/50570-4dd11d576c861f08.js" defer=""></script><script src="/_next/static/chunks/62314-9b2028cacd765027.js" defer=""></script><script src="/_next/static/chunks/89859-eebef04218c04174.js" defer=""></script><script src="/_next/static/chunks/71604-6b04bc10138f34c1.js" defer=""></script><script src="/_next/static/chunks/44084-7e8a4c6c6d428863.js" defer=""></script><script src="/_next/static/chunks/60114-164c33ddfb0439bc.js" defer=""></script><script src="/_next/static/chunks/58260-151951153c272be7.js" defer=""></script><script src="/_next/static/chunks/30807-0d49be9d1265d829.js" defer=""></script><script src="/_next/static/chunks/5677-72bcd94f689f2e09.js" defer=""></script><script src="/_next/static/chunks/77039-20e35d04f2791bd6.js" defer=""></script><script src="/_next/static/chunks/13871-fd1d8f152654290b.js" defer=""></script><script src="/_next/static/chunks/28204-d8f20d6a51e15050.js" defer=""></script><script src="/_next/static/chunks/66130-deda31ae92bb0ab5.js" defer=""></script><script src="/_next/static/chunks/81120-bb780fc7a9458199.js" defer=""></script><script src="/_next/static/chunks/61026-5e51b329dfc150c3.js" defer=""></script><script src="/_next/static/chunks/5391-e5b399bb8e5297bb.js" defer=""></script><script src="/_next/static/chunks/74187-d6c5fbcf87b1c173.js" defer=""></script><script src="/_next/static/chunks/89269-4c385d763ad35a63.js" defer=""></script><script src="/_next/static/chunks/28755-f4b6d3dbc6416f3f.js" defer=""></script><script src="/_next/static/chunks/pages/%5B...slug%5D-4cdbc2644b843df5.js" defer=""></script><script src="/_next/static/R05fxUUF7rvKgc3Bg3jzA/_buildManifest.js" defer=""></script><script src="/_next/static/R05fxUUF7rvKgc3Bg3jzA/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="6.1.8">.bz-featured-ad{position:relative;}/*!sc*/ .bz-featured-ad::after{position:absolute;content:'Featured Ad';padding:1px 10px;vertical-align:super;font-size:12px;display:inline-block;background:#f5f5f5;border-radius:16px;margin-left:3px;border:1px solid #cacaca;bottom:5px;left:inherit;}/*!sc*/ data-styled.g37[id="sc-global-jWNYke1"]{content:"sc-global-jWNYke1,"}/*!sc*/ .eJGZYt .layout-above .section-description{margin-bottom:1rem;}/*!sc*/ .eJGZYt .related-info-container{display:inline-flex;margin:0.5rem 0;}/*!sc*/ @media (min-width: 800px){.eJGZYt .has-left-sidebar .layout-sidebar{display:none;}}/*!sc*/ @media (min-width: 1100px){.eJGZYt .has-left-sidebar .layout-sidebar{display:block;}}/*!sc*/ @media (min-width: 800px){.eJGZYt .layout-flex{flex-direction:row;}}/*!sc*/ @media (max-width: 799px){.eJGZYt .layout-flex >div{width:100%;}}/*!sc*/ .eJGZYt .layout-header.full-width{padding:0;}/*!sc*/ .eJGZYt .layout-header.full-width .layout-container{max-width:100%;}/*!sc*/ .eJGZYt .layout-main{overflow-x:auto;width:100%;}/*!sc*/ @media (min-width: 1300px){.eJGZYt .layout-container{max-width:1300px;}}/*!sc*/ @media (max-width: 1300px){.eJGZYt .layout-container,.eJGZYt .layout-header{padding-left:0.25rem;padding-right:0.25rem;}.eJGZYt .layout-container.full-width .layout-container,.eJGZYt .layout-header.full-width .layout-container{padding:0;}}/*!sc*/ data-styled.g45[id="sc-cbDaos"]{content:"eJGZYt,"}/*!sc*/ .iBOlcq{margin-top:1rem;margin-bottom:1.5rem;}/*!sc*/ data-styled.g46[id="sc-iVheDh"]{content:"iBOlcq,"}/*!sc*/ .gsbRr{width:300px;}/*!sc*/ @media (min-width: 800px){.gsbRr{margin-left:1rem;}}/*!sc*/ data-styled.g47[id="sc-iCKXBC"]{content:"gsbRr,"}/*!sc*/ .dNqQyz .block{margin:1rem 0;}/*!sc*/ .dNqQyz .block:first-of-type{margin-top:0;}/*!sc*/ .dNqQyz .block:last-of-type{margin-bottom:0;}/*!sc*/ .dNqQyz .right{float:right;margin-left:0.5rem;}/*!sc*/ .dNqQyz .left{float:left;margin-right:0.5rem;}/*!sc*/ .dNqQyz .center{text-align:center;margin:auto;}/*!sc*/ .dNqQyz .center >figure,.dNqQyz .center >img,.dNqQyz .center >div{margin:auto;}/*!sc*/ .dNqQyz h1.core-block,.dNqQyz h2.core-block{margin-top:2rem;margin-bottom:1rem;}/*!sc*/ .dNqQyz h1.core-block{font-size:36px;}/*!sc*/ .dNqQyz h2.core-block{font-size:30px;color:#395173;}/*!sc*/ .dNqQyz h3.core-block{font-size:24px;margin:1rem 0px 0.5rem 0px;}/*!sc*/ .dNqQyz h4.core-block{margin:1rem 0px 0.5rem 0px;}/*!sc*/ .dNqQyz ul.core-block{list-style:disc;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .dNqQyz ul.core-block ul,.dNqQyz ul.core-block ol{margin-bottom:0;}/*!sc*/ .dNqQyz ol.core-block{list-style:decimal;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .dNqQyz ol.core-block li{margin-bottom:0.2rem;}/*!sc*/ .dNqQyz ol.core-block ul,.dNqQyz ol.core-block ol{margin-bottom:0;}/*!sc*/ .dNqQyz .wp-block-spacer{clear:both;}/*!sc*/ .dNqQyz p.core-block{font-size:1.1rem;}/*!sc*/ .dNqQyz .core-block a{color:#2ca2d1;}/*!sc*/ .dNqQyz .alignright{float:right;margin-left:18px;}/*!sc*/ .dNqQyz .image-wrapper{margin-bottom:1rem;}/*!sc*/ .dNqQyz .wp-block-table{overflow-x:auto;}/*!sc*/ .dNqQyz .wp-element-caption{border-bottom:1px solid #d6d6d6;border-top:1px solid #d6d6d6;background-color:#f4f4f4;font-size:14px;text-align:center;margin-top:-1rem;margin-bottom:1rem;}/*!sc*/ .dNqQyz table.core-block,.dNqQyz figure.core-block table,.dNqQyz figure.wp-block-table table{width:100%;}/*!sc*/ .dNqQyz table.core-block th,.dNqQyz figure.core-block table th,.dNqQyz figure.wp-block-table table th{background-color:#3f83f8;color:#ffffff;padding:4px 8px;font-size:14px;}/*!sc*/ .dNqQyz table.core-block tbody thead tr th,.dNqQyz figure.core-block table tbody thead tr th,.dNqQyz figure.wp-block-table table tbody thead tr th,.dNqQyz table.core-block tbody >tr:first-of-type th,.dNqQyz figure.core-block table tbody >tr:first-of-type th,.dNqQyz figure.wp-block-table table tbody >tr:first-of-type th{padding:4px 8px;font-size:14px;font-weight:600;}/*!sc*/ .dNqQyz table.core-block tbody tr:nth-child(even),.dNqQyz figure.core-block table tbody tr:nth-child(even),.dNqQyz figure.wp-block-table table tbody tr:nth-child(even){background:#f9f9f9;}/*!sc*/ .dNqQyz table.core-block tbody td,.dNqQyz figure.core-block table tbody td,.dNqQyz figure.wp-block-table table tbody td{padding:4px 8px;}/*!sc*/ .dNqQyz .blocks-gallery-grid,.dNqQyz .wp-block-gallery{display:flex;flex-wrap:wrap;list-style-type:none;padding:0;margin:0;}/*!sc*/ .dNqQyz .blocks-gallery-grid .blocks-gallery-item,.dNqQyz .wp-block-gallery .blocks-gallery-item{margin:0 1em 1em 0;display:flex;flex-grow:1;flex-direction:column;justify-content:center;position:relative;width:calc(50% - 1em);}/*!sc*/ .dNqQyz .blocks-gallery-grid .blocks-gallery-item img,.dNqQyz .wp-block-gallery .blocks-gallery-item img{display:block;max-width:100%;}/*!sc*/ .dNqQyz .blocks-gallery-grid .blocks-gallery-item figure,.dNqQyz .wp-block-gallery .blocks-gallery-item figure{display:flex;align-items:flex-end;justify-content:flex-start;}/*!sc*/ @media (min-width: 600px){.dNqQyz .blocks-gallery-grid.columns-3 .blocks-gallery-grid .blocks-gallery-item,.dNqQyz .wp-block-gallery.columns-3 .blocks-gallery-grid .blocks-gallery-item{width:calc(32% - 0.66667em);margin-right:1em;}}/*!sc*/ .dNqQyz .wp-block-quote{padding:0 1em;margin:0px 0px 2rem;line-height:1.6;color:#2d2d2d;border-left:2px solid #1e429f;font-style:italic;}/*!sc*/ .dNqQyz >div >img,.dNqQyz >div >figure{max-width:100%;}/*!sc*/ .dNqQyz >div >table,.dNqQyz >div >figure table,.dNqQyz >div .core-block-table-wrapper table{margin:1rem 0;width:100%;max-width:100%;}/*!sc*/ .dNqQyz >div >table th,.dNqQyz >div >figure table th,.dNqQyz >div .core-block-table-wrapper table th{background-color:#3f83f8;color:#ffffff;padding:4px 8px;text-align:left;}/*!sc*/ .dNqQyz >div >table tbody thead tr th,.dNqQyz >div >figure table tbody thead tr th,.dNqQyz >div .core-block-table-wrapper table tbody thead tr th,.dNqQyz >div >table tbody >tr:first-of-type th,.dNqQyz >div >figure table tbody >tr:first-of-type th,.dNqQyz >div .core-block-table-wrapper table tbody >tr:first-of-type th{padding:4px 8px;font-size:14px;}/*!sc*/ .dNqQyz >div >table tbody tr:nth-child(even),.dNqQyz >div >figure table tbody tr:nth-child(even),.dNqQyz >div .core-block-table-wrapper table tbody tr:nth-child(even){background:#f9f9f9;}/*!sc*/ .dNqQyz >div >table tbody td,.dNqQyz >div >figure table tbody td,.dNqQyz >div .core-block-table-wrapper table tbody td{padding:4px 8px;font-size:14px;}/*!sc*/ .dNqQyz >div >h1,.dNqQyz >div >h2{margin-top:2rem;margin-bottom:1rem;}/*!sc*/ .dNqQyz >div >h1{font-size:36px;}/*!sc*/ .dNqQyz >div >h2{font-size:30px;color:#395173;}/*!sc*/ .dNqQyz >div >h3{font-size:24px;margin:1rem 0px 0.5rem 0px;}/*!sc*/ .dNqQyz >div >h4{margin:1rem 0px 0.5rem 0px;}/*!sc*/ .dNqQyz >div >ul{list-style:disc;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .dNqQyz >div >ol{list-style:decimal;margin-left:2rem;margin-bottom:2rem;}/*!sc*/ .dNqQyz >div >ol li{margin-bottom:0.2rem;}/*!sc*/ .dNqQyz >div >p{font-size:1.1rem;}/*!sc*/ .dNqQyz >div a{color:#2ca2d1;}/*!sc*/ .dNqQyz .bz-campaign hr{background:#5294c1;border:0;height:1px;margin-bottom:26px;padding:0;}/*!sc*/ data-styled.g52[id="sc-bCvmQg"]{content:"dNqQyz,"}/*!sc*/ .iMnyge{font-size:24px;font-weight:bold;margin-bottom:0;text-transform:uppercase;width:100%;}/*!sc*/ .iMnyge >h1,.iMnyge >h2,.iMnyge >h3,.iMnyge >h4,.iMnyge >h5,.iMnyge >h6,.iMnyge >span{font-size:inherit;}/*!sc*/ .iMnyge.bordered{border-bottom:solid 1px #99AECC;border-color:#e1ebfa;font-weight:bold;margin-top:12px;margin-bottom:8px;padding:4px 0;}/*!sc*/ .iMnyge.border-through{margin:12px 0;padding:4px 0;overflow:hidden;text-align:center;}/*!sc*/ .iMnyge.border-through >h1,.iMnyge.border-through >h2,.iMnyge.border-through >h3,.iMnyge.border-through >h4,.iMnyge.border-through >h5,.iMnyge.border-through >h6,.iMnyge.border-through >span{position:relative;display:inline-block;}/*!sc*/ .iMnyge.border-through >h1:before,.iMnyge.border-through >h2:before,.iMnyge.border-through >h3:before,.iMnyge.border-through >h4:before,.iMnyge.border-through >h5:before,.iMnyge.border-through >h6:before,.iMnyge.border-through >span:before,.iMnyge.border-through >h1:after,.iMnyge.border-through >h2:after,.iMnyge.border-through >h3:after,.iMnyge.border-through >h4:after,.iMnyge.border-through >h5:after,.iMnyge.border-through >h6:after,.iMnyge.border-through >span:after{content:'';position:absolute;top:50%;border-bottom:1px solid #99AECC;width:100vw;margin:0 20px;}/*!sc*/ .iMnyge.border-through >h1:before,.iMnyge.border-through >h2:before,.iMnyge.border-through >h3:before,.iMnyge.border-through >h4:before,.iMnyge.border-through >h5:before,.iMnyge.border-through >h6:before,.iMnyge.border-through >span:before{right:100%;}/*!sc*/ .iMnyge.border-through >h1:after,.iMnyge.border-through >h2:after,.iMnyge.border-through >h3:after,.iMnyge.border-through >h4:after,.iMnyge.border-through >h5:after,.iMnyge.border-through >h6:after,.iMnyge.border-through >span:after{left:100%;}/*!sc*/ .iMnyge.contains-right-slot{display:flex;align-items:center;justify-content:space-between;}/*!sc*/ .iMnyge .see-more{font-size:12px;font-weight:600;text-transform:none;color:rgb(44, 162, 209);}/*!sc*/ data-styled.g368[id="sc-fgisPL"]{content:"iMnyge,"}/*!sc*/ .kePTjK{color:#283D59!important;font-size:14px;font-weight:bold;}/*!sc*/ data-styled.g457[id="sc-bIOlYc"]{content:"kePTjK,"}/*!sc*/ .fbdHWX{align-items:center;background:#ffffff;border-color:#E1EBFA!important;border-radius:0.2rem;border-width:1px;color:#283D59;display:inline-flex;margin:0;padding-left:4px;padding-right:4px;overflow:hidden;text-decoration:none;text-align:left;line-height:22px;height:24px;cursor:pointer;white-space:nowrap;}/*!sc*/ .fbdHWX .direction{height:24px;}/*!sc*/ .fbdHWX .direction .anticon{top:2px;position:relative;}/*!sc*/ .fbdHWX .download-report{text-decoration:underline;font-size:14px;padding:0 5px;}/*!sc*/ data-styled.g461[id="sc-dSOwmo"]{content:"fbdHWX,"}/*!sc*/ .fcPNlb{display:flex;position:relative;width:100%;padding-left:unset;}/*!sc*/ .fcPNlb .search-icon{align-items:center;color:#378aff;display:flex;height:44px;justify-content:center;width:44px;}/*!sc*/ .fcPNlb .cancel-button{font-size:1.2rem;padding:0 10px;color:#378aff;}/*!sc*/ .fcPNlb .search-button{border-radius:0;width:50px;}/*!sc*/ .fcPNlb input{background-color:transparent;border-width:0;outline:none;width:100%;font-weight:bold;font-size:16px;}/*!sc*/ data-styled.g464[id="sc-gUDIDV"]{content:"fcPNlb,"}/*!sc*/ .jnspZt.benzinga-logo{display:inline-block;}/*!sc*/ .jnspZt.benzinga-logo.desktop{width:192px;min-width:192px;max-width:192px;}/*!sc*/ .jnspZt.benzinga-logo img,.jnspZt.benzinga-logo svg{width:100%;height:100%;}/*!sc*/ data-styled.g469[id="sc-eRxdlV"]{content:"jnspZt,"}/*!sc*/ @media (max-width: 800px){.itvxwS .layout-sidebar{width:100%;padding:0 0.75rem;}}/*!sc*/ @media screen and (min-width: 1120px){.itvxwS .layout-left-sidebar{display:block;margin-right:1rem;}}/*!sc*/ data-styled.g491[id="sc-mPVAB"]{content:"itvxwS,"}/*!sc*/ .eZXymS{position:relative;width:100%;}/*!sc*/ data-styled.g506[id="sc-vZZzB"]{content:"eZXymS,"}/*!sc*/ .cfstRH.searchbar-wrapper{box-shadow:0px 0px 2px 0 rgb(0 0 0 / 15%);background:#ffffff;padding:4px 12px;padding-right:10px;flex-grow:1;max-width:290px;position:relative;max-width:none;}/*!sc*/ @media screen and (max-width: 800px){.cfstRH.searchbar-wrapper{max-width:none;}}/*!sc*/ .cfstRH.searchbar-wrapper a{text-decoration:none;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box,.cfstRH.searchbar-wrapper.searchbar-inline{padding:0;border:solid 1px #E1EBFA;box-shadow:none;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box .search-results-wrapper,.cfstRH.searchbar-wrapper.searchbar-inline .search-results-wrapper{padding:0;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box .search-result-wrapper,.cfstRH.searchbar-wrapper.searchbar-inline .search-result-wrapper{padding:0;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box .search-icon,.cfstRH.searchbar-wrapper.searchbar-inline .search-icon{height:36px;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-box input ::placeholder,.cfstRH.searchbar-wrapper.searchbar-inline input ::placeholder{color:#99AECC;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-inline{box-shadow:none;}/*!sc*/ .cfstRH.searchbar-wrapper.searchbar-inline .search-dropdown{position:relative;box-shadow:none;border:none;}/*!sc*/ .cfstRH.searchbar-wrapper input:focus{box-shadow:none;}/*!sc*/ .cfstRH.searchbar-wrapper input ::placeholder{color:#395173;}/*!sc*/ data-styled.g518[id="sc-cieYuS"]{content:"cfstRH,"}/*!sc*/ .bRJFnU{width:100%;position:relative;}/*!sc*/ .bRJFnU .content-feed-list{display:flex;flex-direction:column;gap:1rem;}/*!sc*/ .bRJFnU .newsfeed-card{color:#000000;}/*!sc*/ .bRJFnU .newsfeed-card.highlight.fade .post-card-wrapper{animation:fade 5s forwards;}/*!sc*/ @keyframes fade{0%{background-color:#fdf8db;}100%{background-color:transparent;}}/*!sc*/ .bRJFnU .newsfeed-card .post-teaser{color:#7c7c7c;font-weight:400;font-size:12px;}/*!sc*/ .bRJFnU .news-block{border-bottom:solid 1px #CEDDF2;line-height:1.5;padding:12px 0;}/*!sc*/ .bRJFnU .news-block .news-block-headline{color:#000000;}/*!sc*/ .bRJFnU .news-block .article-title{font-size:16px;font-weight:600;}/*!sc*/ data-styled.g570[id="sc-emhixo"]{content:"bRJFnU,"}/*!sc*/ .llnObD.money-page-template.narrow .header-container,.llnObD.money-page-template.narrow .layout-container{max-width:1100px;}/*!sc*/ .llnObD.money-page-template .layout-footer .layout-container{max-width:1100px;}/*!sc*/ .llnObD.money-page-template .layout-footer.primary{padding-top:1rem;background-color:rgb(242, 248, 255);border-top:1px solid rgb(184, 203, 230);}/*!sc*/ .llnObD.money-page-template .tabs-container.lifted-variant .tab-list-wrapper{margin-bottom:unset;border-bottom:unset;display:flex;align-items:flex-end;justify-content:space-between;padding-right:5px;}/*!sc*/ @media screen and (min-width: 1120px){.llnObD.money-page-template .tabs-container.lifted-variant .tab-list-wrapper{padding-right:0;}}/*!sc*/ .llnObD.money-page-template .tabs-container.lifted-variant .tab-list-wrapper .tab-list .tab{padding:10px 40px 9px;font-weight:600;border-top-left-radius:4px;border-top-right-radius:4px;background-color:transparent;border:1px solid #B8CBE6;border-bottom:none;}/*!sc*/ .llnObD.money-page-template .tabs-container.lifted-variant .tab-list-wrapper .tab-list .tab.active{background:#fff;border-color:#f0f0f0;border-bottom-color:#fff;color:#3f83f8;}/*!sc*/ .llnObD.money-page-template .tab-header{background:radial-gradient(1130.97% 126.55% at 78.68% -23.26%, #ffffff 0%, #ecf1f9 80%, #e3eefe 100%);padding-top:1.5rem;}/*!sc*/ .llnObD.money-page-template .money-page-main{position:relative;width:100%;}/*!sc*/ @media (max-width: 1119px){.llnObD.money-page-template .money-page-main{padding:0 0.75rem;}}/*!sc*/ .llnObD.money-page-template .money-page-main .money-post-wrapper{width:100%;}/*!sc*/ .llnObD.money-page-template h1.section-title,.llnObD.money-page-template h2.section-title,.llnObD.money-page-template h3.section-title,.llnObD.money-page-template h4.section-title,.llnObD.money-page-template h5.section-title,.llnObD.money-page-template h6.section-title{margin-top:2rem;margin-bottom:1rem;}/*!sc*/ .llnObD.money-page-template .cornerstone-navigation{display:block;width:100%;border:1px solid #ceddf2;border-radius:4px;padding:0;}/*!sc*/ data-styled.g610[id="sc-fJmXnk"]{content:"llnObD,"}/*!sc*/ .kEwkjg{margin-top:0;padding-top:10px;font-size:12px;line-height:21px;text-decoration:none;}/*!sc*/ data-styled.g760[id="sc-gFYmAs"]{content:"kEwkjg,"}/*!sc*/ .KOtsp{transition:color 0.2s cubic-bezier(0.25, 0.46, 0.45, 0.94),color 0.2s ease;text-decoration:none;}/*!sc*/ data-styled.g761[id="sc-bnRclF"]{content:"KOtsp,"}/*!sc*/ .fgxyIy{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .fgxyIy:hover{color:#3b5998;}/*!sc*/ .fgxyIy svg{fill:#ffffff;}/*!sc*/ .XrAQw{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .XrAQw:hover{color:#e1306c;}/*!sc*/ .XrAQw svg{fill:#ffffff;}/*!sc*/ .cjvdFo{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .cjvdFo:hover{color:#0072b1;}/*!sc*/ .cjvdFo svg{fill:#ffffff;}/*!sc*/ .jlbEXg{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .jlbEXg:hover{color:#fe5000;}/*!sc*/ .jlbEXg svg{fill:#ffffff;}/*!sc*/ .jldMrO{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .jldMrO:hover{color:#000000;}/*!sc*/ .jldMrO svg{fill:#ffffff;}/*!sc*/ .gXlNji{display:flex;justify-content:center;align-items:center;width:40px;height:40px;border-radius:0.25rem;font-size:30px;color:#ffffff;-webkit-transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;transition:color 200ms cubic-bezier(0.25, 0.46, 0.45, 0.94),color 200ms ease;}/*!sc*/ .gXlNji:hover{color:red;}/*!sc*/ .gXlNji svg{fill:#ffffff;}/*!sc*/ data-styled.g762[id="sc-iFEMmm"]{content:"fgxyIy,XrAQw,cjvdFo,jlbEXg,jldMrO,gXlNji,"}/*!sc*/ .brbZLb.button-wrapper{border-radius:6px;overflow:hidden;background-color:#ffffff;display:flex;align-items:center;justify-content:center;padding:5px;min-width:140px;-webkit-transition:all 200ms ease;transition:all 200ms ease;height:50px;box-sizing:border-box;}/*!sc*/ .brbZLb.button-wrapper:hover{background-color:#CEDDF2;}/*!sc*/ data-styled.g763[id="sc-dnxBXz"]{content:"brbZLb,"}/*!sc*/ .bnEqKR.footer-row{display:grid;grid-auto-flow:column;grid-gap:20px;width:100%;padding-top:0.5rem;padding-bottom:2rem;padding-left:1rem;padding-right:1rem;margin-left:auto;margin-right:auto;}/*!sc*/ @media screen and (min-width: 480px){.bnEqKR.footer-row{max-width:480px;}}/*!sc*/ @media screen and (min-width: 768px){.bnEqKR.footer-row{padding-left:4rem;padding-right:4rem;max-width:100%;grid-gap:30px;}}/*!sc*/ @media screen and (max-width: 1000px){.bnEqKR.footer-row{grid-auto-flow:row;grid-template-columns:repeat(auto-fill, minmax(200px, 1fr));}}/*!sc*/ data-styled.g765[id="sc-dxRmzR"]{content:"bnEqKR,"}/*!sc*/ .dfdtYF{display:flex;flex-direction:column;text-align:left;}/*!sc*/ .dfdtYF h3{display:flex;color:#ffffff;font-size:18px;font-weight:600;margin:0;}/*!sc*/ @media screen and (min-width: 480px){.dfdtYF h3{margin-top:0;}}/*!sc*/ @media screen and (min-width: 768px){.dfdtYF h3{font-size:16px;margin-top:2rem;}}/*!sc*/ .dfdtYF ul{list-style:none;padding:0;}/*!sc*/ .dfdtYF ul li{font-size:16px;}/*!sc*/ @media screen and (min-width: 768px){.dfdtYF ul li{font-size:14px;}}/*!sc*/ .dfdtYF ul li >a{color:#CEDDF2;}/*!sc*/ .dfdtYF ul li >a:hover{color:#ffffff;}/*!sc*/ data-styled.g766[id="sc-hPnoVK"]{content:"dfdtYF,"}/*!sc*/ .hqxlow{display:flex;align-items:center;margin:0 4px;padding-right:0px;width:192px;min-width:144px;}/*!sc*/ .hqxlow .benzinga-crypto-logo-wrapper{margin-bottom:-1px;}/*!sc*/ .hqxlow >a{display:inline-flex;}/*!sc*/ data-styled.g771[id="sc-ggVnwW"]{content:"hqxlow,"}/*!sc*/ .jieYJc{align-items:center;display:flex;justify-content:space-between;}/*!sc*/ data-styled.g776[id="sc-fmJrrp"]{content:"jieYJc,"}/*!sc*/ .iqcSMz{color:#CEDDF2;font-weight:600;font-size:14px;line-height:20px;}/*!sc*/ data-styled.g777[id="sc-eYjERw"]{content:"iqcSMz,"}/*!sc*/ .fHqnwx{color:#ffffff;font-size:12px;line-height:16px;}/*!sc*/ data-styled.g778[id="sc-brYdJo"]{content:"fHqnwx,"}/*!sc*/ .gvTojD{color:#99AECC;font-weight:700;display:flex;align-items:center;}/*!sc*/ .gvTojD .quote-icon{margin:0 4px;font-size:12px;}/*!sc*/ data-styled.g779[id="sc-hpmCTx"]{content:"gvTojD,"}/*!sc*/ .kjFNA{display:block;width:100%;max-width:145px;min-width:132px;padding:8px;background:linear-gradient(90deg, #f0525200 0%, #f052520d 100%);}/*!sc*/ .kjFNA .dark{color:#99AECC!important;}/*!sc*/ .kjFNA .light{color:#395173!important;}/*!sc*/ data-styled.g780[id="sc-ehEeqy"]{content:"kjFNA,"}/*!sc*/ .iPnQNb{display:flex;flex-grow:1;height:52px;}/*!sc*/ data-styled.g781[id="sc-keSDAH"]{content:"iPnQNb,"}/*!sc*/ .cLmgSw{position:relative;overflow:hidden;white-space:nowrap;}/*!sc*/ .cLmgSw::before{animation:jBCTCY 5s ease-in-out infinite;content:'';position:absolute;top:0;width:100%;height:100%;background:linear-gradient(120deg, transparent, rgba(255, 255, 255, 0.2), transparent);}/*!sc*/ data-styled.g782[id="sc-dBYnXA"]{content:"cLmgSw,"}/*!sc*/ .fVNyRC{line-height:48px;padding:0 10px;font-family:Manrope,Manrope-fallback,sans-serif;font-weight:bold;font-size:14px;color:#000000;height:100%;display:inline-flex;align-items:center;justify-content:center;}/*!sc*/ .fVNyRC:hover{background-color:#e1effe;color:unset;}/*!sc*/ .fVNyRC.trading-school{color:#298ccd!important;}/*!sc*/ @media screen and (min-width: 1292px){.fVNyRC.trading-school svg{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.fVNyRC{color:white;width:100%;text-align:left;display:inline-flex;justify-content:start;}.fVNyRC:hover{background-color:inherit;}}/*!sc*/ data-styled.g783[id="sc-jzmNhJ"]{content:"fVNyRC,"}/*!sc*/ .hnMSQP{line-height:2em;}/*!sc*/ .hnMSQP a{color:black;}/*!sc*/ .hnMSQP a:hover{color:#1a56db;}/*!sc*/ data-styled.g784[id="sc-grEoEK"]{content:"hnMSQP,"}/*!sc*/ .DsgvI{line-height:2em;}/*!sc*/ .DsgvI a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .DsgvI:hover{color:#1a79ff;}/*!sc*/ .DsgvI.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .DsgvI.highlight a{color:#ffffff;background-color:unset;font-weight:unset;text-align:center;}/*!sc*/ .DsgvI.highlight:hover{color:unset;}/*!sc*/ .cvPhYw{line-height:2em;}/*!sc*/ .cvPhYw a{display:block;padding:6px 12px;line-height:1.4rem;}/*!sc*/ .cvPhYw:hover{color:#1a79ff;}/*!sc*/ .cvPhYw.highlight{padding:0 5px;margin-bottom:5px;}/*!sc*/ .cvPhYw.highlight a{color:#ffffff;background-color:#63bc47;font-weight:600;text-align:center;}/*!sc*/ .cvPhYw.highlight:hover{color:#ffffff;}/*!sc*/ data-styled.g785[id="sc-ZxepX"]{content:"DsgvI,cvPhYw,"}/*!sc*/ .hkDVfA{display:grid;gap:8px;grid-template-columns:repeat(2, minmax(0px, 1fr));}/*!sc*/ data-styled.g786[id="sc-cLGQGY"]{content:"hkDVfA,"}/*!sc*/ .bUPzLk{border-bottom:1px solid #B8CBE6;color:#395173;font-weight:bold;margin-top:4px;margin-bottom:4px;margin-left:16px;margin-right:16px;padding-bottom:4px;}/*!sc*/ data-styled.g787[id="sc-iIVpRh"]{content:"bUPzLk,"}/*!sc*/ .hxeoeN{display:none;position:absolute;width:max-content;top:48px;z-index:2000;background-color:#ffffff;box-shadow:0 4px 6px -1px rgba(0, 0, 0, 0.1),0 2px 4px -1px rgba(0, 0, 0, 0.06);}/*!sc*/ .hxeoeN:hover{display:flex;}/*!sc*/ .hxeoeN .subnav{right:0;}/*!sc*/ .hxeoeN .menu-wrapper a{width:100%;justify-content:left;}/*!sc*/ @media screen and (min-width: 910px){.hxeoeN{min-width:initial;}}/*!sc*/ @media screen and (min-width: 950px){.hxeoeN >div:nth-of-type(1){display:none;}}/*!sc*/ @media screen and (min-width: 1000px){.hxeoeN >div:nth-of-type(2){display:none;}}/*!sc*/ @media screen and (min-width: 1100px){.hxeoeN >div:nth-of-type(3){display:none;}}/*!sc*/ @media screen and (min-width: 1130px){.hxeoeN >div:nth-of-type(4){display:none;}}/*!sc*/ @media screen and (min-width: 1190px){.hxeoeN >div:nth-of-type(5){display:none;}}/*!sc*/ @media screen and (min-width: 1250px){.hxeoeN >div:nth-of-type(6){display:none;}}/*!sc*/ @media screen and (min-width: 1315px){.hxeoeN >div:nth-of-type(7){display:none;}}/*!sc*/ data-styled.g788[id="sc-jNBTOL"]{content:"hxeoeN,"}/*!sc*/ .lcKdMO.sub-group-wrapper{background-color:#ffffff;border-width:1px;border-top-width:1px;border-color:#CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;padding:8px 0;scrollbar-width:thin;max-height:calc(90vh - 100px);}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar{width:6px!important;}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar-track{background:#f1f1f1;}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar-thumb{background:#888;}/*!sc*/ .lcKdMO.sub-group-wrapper ::-webkit-scrollbar-thumb:hover{background:#555;}/*!sc*/ data-styled.g789[id="sc-bXbAQm"]{content:"lcKdMO,"}/*!sc*/ .jBcAho.secondary{position:relative;}/*!sc*/ .jBcAho.secondary .subnav{position:absolute;right:0;top:48px;}/*!sc*/ .jBcAho .subnav{display:none;position:absolute;z-index:2000;}/*!sc*/ .jBcAho .subnav .third-level-menu{display:none;position:absolute;left:100%;background:#ffffff;border:1px solid #CEDDF2;border-bottom-left-radius:2px;border-bottom-right-radius:2px;height:100%;z-index:999999;overflow:auto;top:0;height:auto;min-width:160px;}/*!sc*/ .jBcAho .subnav .more-nav-menu{position:absolute;top:50%;right:0;transform:translateY(-50%);}/*!sc*/ .jBcAho:hover .subnav{display:block;}/*!sc*/ .jBcAho .menu-items{padding:4px;}/*!sc*/ .jBcAho .menu-items .dropdown-menu-item{position:relative;}/*!sc*/ .jBcAho .menu-items .dropdown-menu-item:hover .third-level-menu{display:block;}/*!sc*/ @media screen and (max-width: 800px){.jBcAho .subnav{display:none!important;}}/*!sc*/ data-styled.g790[id="sc-jKJZnd"]{content:"jBcAho,"}/*!sc*/ .ciyAWD{text-align:left;}/*!sc*/ .ciyAWD.has-groups{width:480px;}/*!sc*/ .ciyAWD.has-groups.money-app{max-width:480px;width:auto;min-width:180px;}/*!sc*/ data-styled.g791[id="sc-bUjGoE"]{content:"ciyAWD,"}/*!sc*/ .ievizW{display:flex;align-items:center;justify-content:center;font-size:12px;font-weight:700;white-space:nowrap;}/*!sc*/ .ievizW.others-btn{height:48px;color:#192940;text-transform:capitalize;padding:0 8px;}/*!sc*/ .ievizW.others-btn:hover{color:#1a56db;}/*!sc*/ .ievizW.research-btn{height:34px;color:white;text-transform:uppercase;border-radius:5px;letter-spacing:1px;padding:0 14px;}/*!sc*/ .ievizW.research-btn:hover{opacity:100;color:white;}/*!sc*/ .ievizW.invest-in-art-btn{height:34px;color:#000000;border-radius:5px;letter-spacing:1px;padding:0 10px;margin-right:8px;}/*!sc*/ .ievizW.invest-in-art-btn:hover{background-color:#a4cafe;}/*!sc*/ data-styled.g792[id="sc-cdZxpv"]{content:"ievizW,"}/*!sc*/ .dYSTha.menu-wrapper{background-color:#033251;position:relative;min-width:65px;}/*!sc*/ .dYSTha.menu-wrapper:hover .global-menu-dropdown{display:block;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper{background-color:transparent;}}/*!sc*/ .dYSTha.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .dYSTha.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper .menu-button{padding:0px 6px;}.dYSTha.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;}.dYSTha.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .dYSTha.menu-wrapper .global-menu-dropdown{background-color:#033251;display:none;position:absolute;width:110px;width:max-content;z-index:100;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper .global-menu-dropdown{right:0px;}}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item{color:white;cursor:pointer;font-size:12px;padding:8px 12px;display:block;margin:0;}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item a{color:white;display:flex;align-items:center;}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item span{display:inline-block;vertical-align:middle;line-height:1;margin-right:10px;}/*!sc*/ .dYSTha.menu-wrapper .global-menu-item img{width:30px;display:inline-block;vertical-align:middle;}/*!sc*/ .dYSTha.menu-wrapper .global-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper .global-text{margin-right:0;}}/*!sc*/ @media screen and (max-width: 800px){.dYSTha.menu-wrapper{width:3rem;text-align:center;}}/*!sc*/ data-styled.g793[id="sc-fCUNPS"]{content:"dYSTha,"}/*!sc*/ .kNrvGp.menu-wrapper{background-color:#033251;position:relative;width:140px;white-space:nowrap;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper{background-color:transparent;}}/*!sc*/ @media screen and (min-width: 800px){.kNrvGp.menu-wrapper:hover .account-menu-dropdown{display:block;box-shadow:0 1px 2px 0 rgba(0, 0, 0, 0.05);}}/*!sc*/ .kNrvGp.menu-wrapper .menu-button{align-items:center;color:white;cursor:pointer;display:inline-flex;font-size:12px;height:32px;padding:0px 12px;}/*!sc*/ .kNrvGp.menu-wrapper .menu-button .anticon-user{color:#1a79ff;margin-right:12px;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper .menu-button .anticon-user{color:#a4cafe;font-size:18px;margin-right:0;}.kNrvGp.menu-wrapper .menu-button .anticon-down{display:none;}}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-dropdown{background-color:#ffffff;border:1px solid #E1EBFA;display:none;position:absolute;width:140px;z-index:104;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper .account-menu-dropdown{right:0px;}}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-dropdown.open{display:block;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-dropdown .checkbox-container label{display:flex;font-size:12px;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item{color:#000000;cursor:pointer;font-size:12px;font-weight:700;padding:8px 12px;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item a{color:#000000;display:inline-flex;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item.benzinga-plus a{color:#ff5a1f;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item.benzinga-pro a{color:#1A79FF;}/*!sc*/ .kNrvGp.menu-wrapper .account-menu-item.benzinga-edge a{color:#3f83f8;}/*!sc*/ .kNrvGp.menu-wrapper .divider{margin:0 auto;width:85%;border-color:#CEDDF2;}/*!sc*/ .kNrvGp.menu-wrapper .my-account-text{margin-right:14px;}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper .my-account-text{display:none;}}/*!sc*/ @media screen and (max-width: 800px){.kNrvGp.menu-wrapper{width:3rem;}}/*!sc*/ data-styled.g794[id="sc-cbhCNN"]{content:"kNrvGp,"}/*!sc*/ .iUXfuo{position:fixed;z-index:100;top:0;left:0;right:0;width:100%;transition:all linear 0.12s;}/*!sc*/ .iUXfuo .mobile-header,.iUXfuo .mobile-menu-wrapper,.iUXfuo .mobile-quote-bar{background-color:#08244d;}/*!sc*/ .iUXfuo .mobile-header{border-bottom:1px solid #36537e;}/*!sc*/ .iUXfuo .menu-icon-wrapper{display:flex;align-items:center;justify-content:center;cursor:pointer;flex-shrink:0;width:3rem;height:3rem;color:#CEDDF2;font-size:18px;}/*!sc*/ .iUXfuo.fullscreen .account-menu{pointer-events:none;}/*!sc*/ .iUXfuo .search-wrapper{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);width:100%;z-index:30;}/*!sc*/ .iUXfuo .search-wrapper.fixed{position:fixed;top:181px;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen{position:fixed;background:#242424e0;z-index:999;height:100vh;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .searchbar-wrapper{padding:0;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .searchbar-wrapper .search-input-container{border-bottom:1px solid #a4a4a4;padding:8px 12px;background-color:#1d446a;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .searchbar-wrapper .search-input-wrapper{background-color:white;border-radius:4px;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .search-dropdown{border-radius:unset;border:none;box-shadow:none;position:unset;}/*!sc*/ .iUXfuo .search-wrapper.fullscreen .search-result-wrapper{border-radius:unset;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;line-height:15px;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper input{font-size:14px;height:45px;}/*!sc*/ .iUXfuo .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media screen and (max-width: 800px){.iUXfuo .search-wrapper .searchbar-wrapper input{font-size:16px;}}/*!sc*/ .iUXfuo .mobile-menu-wrapper{z-index:999999;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button{color:white;line-height:40px;padding:4px 10px;position:fixed;height:min-content;bottom:0px;z-index:10000;background-color:#062b4c;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button div{background-color:#ff5a1f;border-radius:10px;padding:0px 10px;width:100%;border-radius:5px;margin:2px 0px;text-align:center;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button svg{font-size:20px;padding-right:5px;}/*!sc*/ .iUXfuo .mobile-menu-wrapper .premium-button:hover div{background-color:#ff8a4c;border-bottom:3px solid #d03801;}/*!sc*/ .iUXfuo .bz-pro-logo{height:60px;background:#062b4c;margin-bottom:60px;}/*!sc*/ .iUXfuo .bz-pro-logo a{border-top:solid 1px #666;padding:1rem;width:100%;}/*!sc*/ .iUXfuo .mobile-logo-wrapper{margin:0;padding:0;width:205px;margin-right:auto;}/*!sc*/ .iUXfuo .mobile-logo-wrapper .benzinga-crypto-logo-wrapper{margin-top:5px;}/*!sc*/ .iUXfuo .mobile-logo-wrapper .benzinga-logo{height:18.2px;width:134.35px;}/*!sc*/ .iUXfuo .mobile-logo-wrapper .benzinga-logo.reactive-holiday-logo{height:30px;}/*!sc*/ data-styled.g798[id="sc-hmzteu"]{content:"iUXfuo,"}/*!sc*/ .hQNIgN{margin-top:242px;width:100%;}/*!sc*/ data-styled.g799[id="sc-bUsiPH"]{content:"hQNIgN,"}/*!sc*/ .WbPfG.top-bar-wrapper{background-color:#072232;height:32px;}/*!sc*/ .WbPfG.top-bar-wrapper .bar-layout-width{max-width:1400px;margin:0 auto;}/*!sc*/ .WbPfG.top-bar-wrapper .top-bar-inner-wrapper{display:flex;justify-content:space-between;}/*!sc*/ .WbPfG.top-bar-wrapper .top-bar-list{list-style:none;display:flex;margin:0;}/*!sc*/ .WbPfG.top-bar-wrapper .auth-buttons{display:flex;height:32px;min-width:234px;}/*!sc*/ .WbPfG.top-bar-wrapper .auth-link-button{color:#ffffff;cursor:pointer;line-height:32px;padding:0 12px;text-transform:uppercase;font-size:14px;font-weight:700;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-pro-btn{display:flex;align-items:center;justify-content:space-between;padding:0 12px;border-radius:3px;height:26px;color:white;font-weight:semi-bold;background-color:#0075cd;margin:3px 3px 0px 0px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item-label{color:white;font-size:12px;line-height:30px;margin:0 8px;white-space:nowrap;}/*!sc*/ .WbPfG.top-bar-wrapper .contributor-link{align-items:center;color:white;display:inline-flex;font-size:12px;height:32px;margin:0 12px;}/*!sc*/ .WbPfG.top-bar-wrapper .contributor-link a{color:white;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item{border-top:2px solid #3f83f8;color:#ffffff;text-transform:uppercase;line-height:28px;font-weight:500;font-size:14px;margin:0;text-align:center;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item.ProLabel{border-top:none;text-transform:none;min-width:140px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(2){border-top-color:#f05252;min-width:84px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(3){border-top-color:#c27803;min-width:66px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(4){border-top-color:#046c4e;min-width:83px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(5){border-top-color:#c81e1e;min-width:93px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(6){border-top-color:#0e9f6e;min-width:59px;}/*!sc*/ .WbPfG.top-bar-wrapper .bz-top-bar-list-item:nth-child(7){min-width:86px;}/*!sc*/ data-styled.g803[id="sc-fAlvPn"]{content:"WbPfG,"}/*!sc*/ .kimWDA.quote-bar-container{background:linear-gradient(180deg, #082132 0%, #1d446a 100%);}/*!sc*/ .kimWDA.quote-bar-container .quote-bar-layout-width{max-width:1400px;margin:0 auto;height:52px;}/*!sc*/ .kimWDA.quote-bar-container .quote-bar-wrapper,.kimWDA.quote-bar-container .quotes-list{display:flex;flex-grow:1;}/*!sc*/ .kimWDA.quote-bar-container .quote-list-container{flex-grow:1;overflow-x:auto;scrollbar-width:none;}/*!sc*/ .kimWDA.quote-bar-container .quote-list-container ::-webkit-scrollbar{display:none;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper{width:100%;max-width:288px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper{padding:8px 12px;background-color:transparent;font-weight:bold;font-size:16px;line-height:15px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:32px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper input{font-size:12px;}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper .searchbar-container{background-color:white;border-radius:2px;}/*!sc*/ @media (min-width: 1300px){.kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper{padding-right:0;}.kimWDA.quote-bar-container .search-wrapper .searchbar-wrapper .search-icon{width:36px;}}/*!sc*/ .kimWDA.quote-bar-container .search-wrapper .search-icon{height:36px;}/*!sc*/ data-styled.g804[id="sc-lcMqGs"]{content:"kimWDA,"}/*!sc*/ .frfjnD.quote-switcher-wrapper{overflow-y:auto;height:52px;width:70px;scrollbar-width:none;flex:none;}/*!sc*/ .frfjnD.quote-switcher-wrapper ::-webkit-scrollbar{display:none;}/*!sc*/ .frfjnD.quote-switcher-wrapper .quote-switcher-container{display:flex;flex-direction:column;}/*!sc*/ data-styled.g805[id="sc-fKFgrF"]{content:"frfjnD,"}/*!sc*/ .hsnbJt.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #99AECC;background:linear-gradient(90deg, #99AECC1a 0%, #99AECC00 100%);text-align:left;color:#99AECC;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .hsnbJt.quote-switcher-button :focus{outline:none;}/*!sc*/ .iQNatV.quote-switcher-button{max-width:73px;width:100%;border-left:1px solid #E1EBFA;background:linear-gradient(90deg, #1c64f21a 0%, #1c64f200 100%);text-align:left;color:#ffffff;font-size:12px;line-height:18px;padding:4px 9px;flex-grow:1;}/*!sc*/ .iQNatV.quote-switcher-button :focus{outline:none;}/*!sc*/ data-styled.g806[id="sc-fCzvdW"]{content:"hsnbJt,iQNatV,"}/*!sc*/ .eLZlCJ{display:flex;overflow-x:scroll;scrollbar-width:none;justify-content:flex-start;}/*!sc*/ .eLZlCJ ::-webkit-scrollbar{display:none;}/*!sc*/ .eLZlCJ li{flex-shrink:0;}/*!sc*/ .eLZlCJ li:nth-of-type(3),.eLZlCJ li:nth-of-type(4),.eLZlCJ li:nth-of-type(5),.eLZlCJ li:nth-of-type(6),.eLZlCJ li:nth-of-type(7),.eLZlCJ li:nth-of-type(8),.eLZlCJ li:nth-of-type(9),.eLZlCJ li:nth-of-type(10),.eLZlCJ li:nth-of-type(11),.eLZlCJ li:nth-of-type(12){display:none;}/*!sc*/ @media screen and (min-width: 850px){.eLZlCJ li:nth-of-type(3){display:initial;}}/*!sc*/ @media screen and (min-width: 900px){.eLZlCJ li:nth-of-type(4){display:initial;}}/*!sc*/ @media screen and (min-width: 950px){.eLZlCJ li:nth-of-type(5){display:initial;}}/*!sc*/ @media screen and (min-width: 1000px){.eLZlCJ li:nth-of-type(6){display:initial;}}/*!sc*/ @media screen and (min-width: 1100px){.eLZlCJ li:nth-of-type(7){display:initial;}}/*!sc*/ @media screen and (min-width: 1130px){.eLZlCJ li:nth-of-type(8){display:initial;}}/*!sc*/ @media screen and (min-width: 1190px){.eLZlCJ li:nth-of-type(9){display:initial;}}/*!sc*/ @media screen and (min-width: 1250px){.eLZlCJ li:nth-of-type(10){display:initial;}}/*!sc*/ @media screen and (min-width: 1315px){.eLZlCJ li:nth-of-type(11){display:initial;}}/*!sc*/ @media screen and (min-width: 1360px){.eLZlCJ li:nth-of-type(12){display:initial;}}/*!sc*/ data-styled.g809[id="sc-bCcCHF"]{content:"eLZlCJ,"}/*!sc*/ .jfzrPN{display:block;position:unset;top:unset;width:unset;z-index:999;box-shadow:unset;}/*!sc*/ @media (max-width: 800px){.jfzrPN{display:none;}}/*!sc*/ .jfzrPN .breaking-news-banner{position:absolute;top:-50px;transition:all ease-in 0.5s;z-index:-1;}/*!sc*/ .jfzrPN .breaking-news-wrapper{position:relative;}/*!sc*/ .jfzrPN .breaking-news-wrapper--visible .breaking-news-banner{position:unset;top:0;}/*!sc*/ .jfzrPN .more-nav-tabs-icon-container{position:relative;display:flex;align-items:center;justify-content:center;margin-left:5px;margin-right:5px;cursor:pointer;}/*!sc*/ .jfzrPN .more-nav-tabs-icon-container:hover >div{display:flex;}/*!sc*/ @media screen and (min-width: 1315px){.jfzrPN .more-nav-tabs-icon-container{display:none!important;}}/*!sc*/ data-styled.g810[id="sc-iGzcki"]{content:"jfzrPN,"}/*!sc*/ .hwhdcM{background-color:#ffffff;border-bottom:0px solid #B8CBE6;width:100%;padding:0;}/*!sc*/ data-styled.g811[id="sc-fPkcnn"]{content:"hwhdcM,"}/*!sc*/ .gigmnn{height:48px;max-width:1400px;margin:0 auto;}/*!sc*/ data-styled.g812[id="sc-dIoOVQ"]{content:"gigmnn,"}/*!sc*/ .bkHEtM{display:flex;position:relative;height:100%;justify-content:center;}/*!sc*/ data-styled.g815[id="sc-fehoED"]{content:"bkHEtM,"}/*!sc*/ .SrdfA{flex-grow:1;margin-left:20px;}/*!sc*/ data-styled.g816[id="sc-izxAxU"]{content:"SrdfA,"}/*!sc*/ .dSjbGr{display:inline-flex;align-items:center;justify-content:flex-end;height:48px;min-width:244px;}/*!sc*/ data-styled.g817[id="sc-fIiAAZ"]{content:"dSjbGr,"}/*!sc*/ .cpYKRp.header-container .navbar-placeholder{height:132px;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar{background-color:#192940;border:none;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .main-menu-wrapper{max-width:1300px;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .main-menu-wrapper .menu-wrapper:hover{background-color:#151f2e;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .logo-wrapper{width:260px;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .menu-item-link{color:#ceddf2;}/*!sc*/ .cpYKRp.header-container.money-app .main-menu-bar .menu-item-link:hover{background-color:transparent;}/*!sc*/ data-styled.g830[id="sc-jHrLvE"]{content:"cpYKRp,"}/*!sc*/ .inqlyg{display:block;margin-bottom:0;}/*!sc*/ @media screen and (min-width: 800px){.inqlyg{display:none;}}/*!sc*/ data-styled.g832[id="sc-kjwMja"]{content:"inqlyg,"}/*!sc*/ @keyframes jBCTCY{0%{left:-100%;transition-property:left;}11.504424778761061%,100%{left:100%;transition-property:left;}}/*!sc*/ data-styled.g833[id="sc-keyframes-jBCTCY"]{content:"jBCTCY,"}/*!sc*/ .fLYDet{padding:0 20px;}/*!sc*/ .fLYDet.highlight{background-color:#fdfdea;}/*!sc*/ data-styled.g1325[id="sc-ehYcQd"]{content:"fLYDet,"}/*!sc*/ .lelLTE.benzinga-brief-block{display:flex;flex-direction:column;padding:20px 0;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-body >*{display:none;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-body ul:first-of-type{display:block;overflow-y:unset;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-body ul:first-of-type li:nth-of-type(1n + 4){display:none;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-main-info iframe{width:100%;max-width:560px;}/*!sc*/ .lelLTE.benzinga-brief-block .benzinga-brief-block-header{margin-bottom:15px;display:flex;flex-direction:column;}/*!sc*/ .lelLTE.benzinga-brief-block .benzinga-brief-block-header a{color:#1e429f;font-size:24px;font-weight:700;}/*!sc*/ .lelLTE.benzinga-brief-block .benzinga-brief-block-header a:hover{color:#76a9fa;}/*!sc*/ .lelLTE.benzinga-brief-block .ticker-list{margin-bottom:10px;display:flex;flex-wrap:wrap;gap:4px;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-sidebar-info{margin-right:20px;display:flex;flex-direction:row;justify-content:space-between;width:100%;}/*!sc*/ .lelLTE.benzinga-brief-block ul{display:flex;flex-direction:column;overflow-y:auto;height:100%;}/*!sc*/ .lelLTE.benzinga-brief-block ul >li{list-style-type:disc;list-style-position:inside;font-size:14px;margin-bottom:10px;}/*!sc*/ .lelLTE.benzinga-brief-block ul >li:last-of-type{margin-bottom:0;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-title{color:#192940;font-weight:600;cursor:pointer;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-datetime{display:flex;font-weight:600;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-time{color:#142133;font-size:12px;margin-right:10px;}/*!sc*/ .lelLTE.benzinga-brief-block .brief-date{color:#142133;font-size:12px;}/*!sc*/ .lelLTE.benzinga-brief-block .read-more{display:block;margin-top:0.4rem;color:#3f83f8;font-weight:700;}/*!sc*/ @media screen and (min-width: 1024px){.lelLTE.benzinga-brief-block{flex-direction:row;}.lelLTE.benzinga-brief-block .brief-sidebar-info{max-width:190px;min-width:180px;flex-direction:column;justify-content:unset;}.lelLTE.benzinga-brief-block .brief-datetime{flex-direction:column;}.lelLTE.benzinga-brief-block .brief-time{margin-right:0;}.lelLTE.benzinga-brief-block .benzinga-brief-block-header{line-height:1.1;}}/*!sc*/ data-styled.g1326[id="sc-iENCyk"]{content:"lelLTE,"}/*!sc*/ .jmpdWl .featured-card{color:#000000;}/*!sc*/ .jmpdWl .featured-card .post-card{margin-bottom:12px;}/*!sc*/ .jmpdWl .feed-more-wrapper{height:100px;}/*!sc*/ .jmpdWl .benzinga-brief-block{padding:20px 0;border-bottom:1px solid #ceddf2;}/*!sc*/ data-styled.g1337[id="sc-eCmNgM"]{content:"jmpdWl,"}/*!sc*/ </style></head><body><div id="__next"><div class="sc-jHrLvE cpYKRp header-container "><div class="sc-kjwMja inqlyg mobile-header-wrapper"><div class="sc-bUsiPH hQNIgN"><div id="navigation-header" class="sc-hmzteu iUXfuo"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="left-0 right-0 top-0 z-[9999999]" id="mobile-main-block"><div class="mobile-header flex items-center justify-between relative" style="transition:all linear 0.3s;z-index:20"><div class="menu-icon-wrapper"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M0 80c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16C7.2 96 0 88.8 0 80zM0 240c0-8.8 7.2-16 16-16H432c8.8 0 16 7.2 16 16s-7.2 16-16 16H16c-8.8 0-16-7.2-16-16zM448 400c0 8.8-7.2 16-16 16H16c-8.8 0-16-7.2-16-16s7.2-16 16-16H432c8.8 0 16 7.2 16 16z" fill="currentColor"></path></svg></div></div><div class="sc-ggVnwW hqxlow logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-eRxdlV jnspZt benzinga-logo light mobile"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span></a></div><div class="flex h-12 items-center text-blue-300"><div class="sc-fCUNPS dYSTha global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><div class="sc-cbhCNN kNrvGp account-menu menu-wrapper"><button class="menu-button"><span role="img" aria-label="user" class="anticon anticon-user"><svg viewBox="64 64 896 896" focusable="false" data-icon="user" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M858.5 763.6a374 374 0 00-80.6-119.5 375.63 375.63 0 00-119.5-80.6c-.4-.2-.8-.3-1.2-.5C719.5 518 760 444.7 760 362c0-137-111-248-248-248S264 225 264 362c0 82.7 40.5 156 102.8 201.1-.4.2-.8.3-1.2.5-44.8 18.9-85 46-119.5 80.6a375.63 375.63 0 00-80.6 119.5A371.7 371.7 0 00136 901.8a8 8 0 008 8.2h60c4.4 0 7.9-3.5 8-7.8 2-77.2 33-149.5 87.8-204.3 56.7-56.7 132-87.9 212.2-87.9s155.5 31.2 212.2 87.9C779 752.7 810 825 812 902.2c.1 4.4 3.6 7.8 8 7.8h60a8 8 0 008-8.2c-1-47.8-10.9-94.3-29.5-138.2zM512 534c-45.9 0-89.1-17.9-121.6-50.4S340 407.9 340 362c0-45.9 17.9-89.1 50.4-121.6S466.1 190 512 190s89.1 17.9 121.6 50.4S684 316.1 684 362c0 45.9-17.9 89.1-50.4 121.6S557.9 534 512 534z"></path></svg></span><span class="my-account-text">My Account</span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></button><div class="account-menu-dropdown"><div class="account-menu-item"><span><a href="/account">My Account</a></span></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=notifications">Notifications</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio">Overview</a></div><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=new_watchlist">+ New Watchlist</a></div><hr class="divider"/><div class="account-menu-item benzinga-edge"><a href="https://www.benzinga.com/profile/portfolio">Benzinga Edge</a></div><div class="account-menu-item benzinga-plus"><a href="https://www.benzinga.com/research">Benzinga Research</a></div><div class="account-menu-item benzinga-pro"><a href="https://pro.benzinga.com">Benzinga Pro</a></div><hr class="divider"/><div class="account-menu-item"><a href="https://www.benzinga.com/profile/portfolio/?action=login">Log In</a></div></div></div></div></div></div><div class="mobile-quote-bar overflow-x-scroll" id="mobile-quote-bar"><div class="sc-keSDAH iPnQNb quote-list-wrapper"><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a></div></div><div class="search-wrapper transition" id="mobile-search-bar" style="transition:all linear 0.3s"><div class="sc-cieYuS cfstRH searchbar-wrapper searchbar-default"><div class="sc-vZZzB eZXymS searchbar-container"><div class="sc-ifVVRW kOhchH search-input-container"><div class="sc-gUDIDV fcPNlb search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div><div class="sc-iGzcki jfzrPN desktop-menu-wrapper" id="navigation-header"><div class="top-banner-fallback h-20 bg-[#0b131d] relative py-4"><div class="animate-pulse h-full relative rounded-full bg-slate-700/50 max-w-[1400px] mx-auto"></div></div><div class="sc-fAlvPn WbPfG top-bar-wrapper"><div class="bar-layout-width"><div class="top-bar-inner-wrapper"><ul class="top-bar-list"><li class="bz-top-bar-list-item ProLabel"><a aria-label="Get Benzinga Pro" class="sc-dBYnXA cLmgSw shine-effect text-white bz-pro-btn" href="https://www.benzinga.com/pro/register?utm_source=homepage-blue-button">Get Benzinga Pro </a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/apis"><div class="bz-top-bar-list-item-label">Data & APIs</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/events"><div class="bz-top-bar-list-item-label">Events</div></a></li><li class="bz-top-bar-list-item"><a href="https://marketfy.com/?__hstc=258999573.1ab86f21505b156c04ee556f3ea4a8de.1617281961141.1623244531459.1623314433592.60&__hssc=258999573.1.1623314433592&__hsfp=58102761"><div class="bz-top-bar-list-item-label">Marketfy</div></a></li><li class="bz-top-bar-list-item"><a href="https://www.benzinga.com/premarket"><div class="bz-top-bar-list-item-label">Premarket</div></a></li><li class="bz-top-bar-list-item"><a href="https://boost.benzinga.com"><div class="bz-top-bar-list-item-label">Boost</div></a></li><li class="bz-top-bar-list-item"><a href="https://advertise.benzinga.com"><div class="bz-top-bar-list-item-label">Advertise</div></a></li></ul><div class="auth-buttons"><div class="contributor-link"><a href="https://contributor.benzinga.com/contributor-onboarding">Contribute</a></div><div class="sc-fCUNPS dYSTha global-menu menu-wrapper"><div aria-label="Global Menu" class="menu-button" role="button"><span class="global-text w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 513 342" title="USA"><path fill="#FFF" d="M0 0h513v342H0z"></path><path fill="#D80027" d="M0 0h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0zm0 76h513v38H0z"></path><path fill="#2E52B2" d="M0 0h256.5v190H0z"></path><path fill="#FFF" d="m47.8 141.9-4-12.8-4.3 12.8H26.3l10.7 7.7-4 12.8 10.8-7.9 10.7 7.9-4.2-12.8 10.9-7.7zm56.4 0-4.1-12.8-4.2 12.8H82.7l10.7 7.7-4.1 12.8 10.8-7.9 10.7 7.9-4-12.8 10.8-7.7zm56.4 0-4.2-12.8-4 12.8h-13.5l10.9 7.7-4.2 12.8 10.8-7.9 10.9 7.9-4.2-12.8 10.8-7.7zm56.3 0-4.1-12.8-4.2 12.8h-13.2l10.7 7.7-4 12.8 10.7-7.9 10.8 7.9-4.2-12.8 10.9-7.7zM100.1 78.3l-4.2 12.8H82.7L93.4 99l-4.1 12.6 10.8-7.8 10.7 7.8-4-12.6 10.8-7.9h-13.4zm-56.3 0-4.3 12.8H26.3L37 99l-4 12.6 10.8-7.8 10.7 7.8L50.3 99l10.9-7.9H47.8zm112.6 0-4 12.8h-13.5l10.9 7.9-4.2 12.6 10.8-7.8 10.9 7.8-4.2-12.6 10.8-7.9h-13.3zm56.4 0-4.2 12.8h-13.2l10.7 7.9-4 12.6 10.7-7.8 10.8 7.8-4.2-12.6 10.9-7.9h-13.4zm-169-50.6-4.3 12.6H26.3L37 48.2l-4 12.7L43.8 53l10.7 7.9-4.2-12.7 10.9-7.9H47.8zm56.3 0-4.2 12.6H82.7l10.7 7.9-4.1 12.7 10.8-7.9 10.7 7.9-4-12.7 10.8-7.9h-13.4zm56.3 0-4 12.6h-13.5l10.9 7.9-4.2 12.7 10.8-7.9 10.9 7.9-4.2-12.7 10.8-7.9h-13.3zm56.4 0-4.2 12.6h-13.2l10.7 7.9-4 12.7 10.7-7.9 10.8 7.9-4.2-12.7 10.9-7.9h-13.4z"></path></svg></span><span role="img" aria-label="down" class="anticon anticon-down"><svg viewBox="64 64 896 896" focusable="false" data-icon="down" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M884 256h-75c-5.1 0-9.9 2.5-12.9 6.6L512 654.2 227.9 262.6c-3-4.1-7.8-6.6-12.9-6.6h-75c-6.5 0-10.3 7.4-6.5 12.7l352.6 486.1c12.8 17.6 39 17.6 51.7 0l352.6-486.1c3.9-5.3.1-12.7-6.4-12.7z"></path></svg></span></div><div class="global-menu-dropdown"><div class="global-menu-item"><a href="https://es.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="España"><path fill="#FFDA44" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M0 85.331h512v113.775H0zm0 227.551h512v113.775H0z"></path></svg></span><span>España</span></a></div><div class="global-menu-item"><a href="https://in.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="India"><path fill="#FFF" d="M0 85.337h512v341.326H0z"></path><path fill="#FF9811" d="M0 85.337h512v113.775H0z"></path><path fill="#6DA544" d="M0 312.888h512v113.775H0z"></path><circle cx="256" cy="256" r="43.896" fill="#0052B4"></circle><circle cx="256" cy="256" r="27.434" fill="#FFF"></circle><path fill="#0052B4" d="m256 222.146 8.464 19.195 20.855-2.268L272.927 256l12.392 16.927-20.855-2.268L256 289.854l-8.464-19.195-20.855 2.268L239.073 256l-12.392-16.927 20.855 2.268z"></path></svg></span><span>India</span></a></div><div class="global-menu-item"><a href="https://it.benzinga.com" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="Italia"><path fill="#FFF" d="M341.334 85.33H0v341.332h512V85.33z"></path><path fill="#6DA544" d="M0 85.333h170.663V426.67H0z"></path><path fill="#D80027" d="M341.337 85.333H512V426.67H341.337z"></path></svg></span><span>Italia</span></a></div><div class="global-menu-item"><a href="https://kr.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="대한민국"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><path fill="#D80027" d="M318.33 255.994c0 15.583-27.906 54.539-62.33 54.539s-62.33-38.957-62.33-54.539c0-34.424 27.906-62.33 62.33-62.33s62.33 27.906 62.33 62.33"></path><path fill="#0052B4" d="M318.33 255.994c0 34.424-27.906 62.33-62.33 62.33s-62.33-27.906-62.33-62.33"></path><path d="m322.114 311.096 16.528-16.528 11.018 11.018-16.528 16.528zm-27.548 27.534 16.528-16.527 11.018 11.018-16.528 16.528zm60.604 5.502 16.527-16.528 11.018 11.018-16.527 16.528zm-27.549 27.557 16.528-16.528 11.018 11.018-16.528 16.528zm11.02-44.075 16.528-16.527 11.018 11.018-16.527 16.527zm-27.547 27.546 16.528-16.528 11.018 11.018-16.528 16.527zm44.083-154.264-44.073-44.073 11.018-11.018 44.073 44.073zm-44.078-11.015-16.528-16.527 11.017-11.018 16.528 16.528zm27.536 27.55-16.528-16.527 11.017-11.018 16.528 16.528zm5.5-60.606-16.528-16.528 11.018-11.018 16.528 16.528zm27.559 27.549-16.528-16.527 11.019-11.019 16.527 16.528zM140.31 327.61l44.073 44.074-11.018 11.018-44.074-44.073zm44.058 11.025 16.527 16.527-11.017 11.018-16.528-16.528zm-27.536-27.548 16.528 16.528-11.019 11.018-16.527-16.528zm16.531-16.523 44.073 44.073-11.018 11.019-44.073-44.074zm11.021-154.277-44.073 44.074-11.018-11.018 44.073-44.074zm16.511 16.536-44.073 44.074-11.018-11.018 44.073-44.074zm16.529 16.528-44.074 44.074-11.017-11.017 44.074-44.074z"></path></svg></span><span>대한민국</span></a></div><div class="global-menu-item"><a href="https://jp.benzinga.com/" rel="noreferrer" tabindex="0" target="_blank"><span class="w-[25px] h-[16px]"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 85.333 512 341.333" title="日本"><path fill="#FFF" d="M0 85.331h512v341.337H0z"></path><circle cx="256" cy="255.994" r="96" fill="#D80027"></circle></svg></span><span>日本</span></a></div></div></div><button class="auth-link-button">Login</button><button class="auth-link-button bg-orange-600">Register</button></div></div></div></div><div class="sc-fPkcnn hwhdcM main-menu-bar"><div class="sc-dIoOVQ gigmnn main-menu-wrapper"><div class="sc-fehoED bkHEtM bar-content-layout"><div class="sc-ggVnwW hqxlow logo-wrapper mobile-logo-wrapper"><a aria-label="Click to go home" href="/"><span class="sc-eRxdlV jnspZt benzinga-logo dark desktop"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#093451"></path></svg></span></a></div><div class="sc-izxAxU SrdfA primary-menu-wrapper"><ul class="sc-bCcCHF eLZlCJ menu-item-container"><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/services" style="min-width:108px" title="Our Services">Our Services </a></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/news" style="min-width:57px" title="News">News </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings">Earnings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance">Guidance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividends">Dividends</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&amp;A">M&A</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/buybacks" title="Buybacks">Buybacks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/legal" title="Legal">Legal</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/interview" title="Interviews">Interviews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/management" title="Management">Management</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/offerings" title="Offerings">Offerings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPOs">IPOs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/insider-trades" title="Insider Trades">Insider Trades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="Biotech/FDA">Biotech/FDA</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/general/politics" title="Politics">Politics</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/healthcare" title="Healthcare">Healthcare</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options </a></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav has-groups"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="sc-cLGQGY hkDVfA group-list"><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Best Stocks & ETFs</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&P 500 ETFs">Best S&P 500 ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto </a></div></li><li><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX cvPhYw highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></li></ul></div><button aria-label="Click to open more navbar items" class="more-nav-tabs-icon-container"><div class="text-2xl text-black"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M432 256a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zm-160 0a48 48 0 1 1 -96 0 48 48 0 1 1 96 0zM64 304a48 48 0 1 1 0-96 48 48 0 1 1 0 96z" fill="currentColor"></path></svg></div><div class="sc-jNBTOL hxeoeN more-menu-items-dropdown-container"><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets" style="min-width:75px" title="Markets">Markets </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/premarket" title="Pre-Market">Pre-Market</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/after-hours-center" title="After Hours">After Hours</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/movers" title="Movers">Movers</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/etfs" title="ETFs">ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis" title="Cannabis">Cannabis</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/commodities" title="Commodities">Commodities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/binary-options" title="Binary Options">Binary Options</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/bonds" title="Bonds">Bonds</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/futures" title="Futures">Futures</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/author/cme-group" title="CME Group">CME Group</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Global Economics">Global Economics</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/mining" title="Mining">Mining</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/previews" title="Previews">Previews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/small-cap" title="Small-Cap">Small-Cap</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/real-estate" title="Real Estate">Real Estate</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Penny Stocks">Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/digital-securities" title="Digital Securities">Digital Securities</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/volatility" title="Volatility">Volatility</a></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/markets/options" style="min-width:75px" title="Options">Options </a></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/analyst-stock-ratings" style="min-width:73px" title="Ratings">Ratings </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/analyst-color" title="Analyst Color">Analyst Color</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/downgrades" title="Downgrades">Downgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/upgrades" title="Upgrades">Upgrades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings/initiations" title="Initiations">Initiations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-ratings/price-target" title="Price Target">Price Target</a></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/trading-ideas" style="min-width:57px" title="Ideas">Ideas </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav has-groups"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="sc-cLGQGY hkDVfA group-list"><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/long-ideas" title="Long Ideas">Long Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/short-ideas" title="Short Ideas">Short Ideas</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas/technicals" title="Technicals">Technicals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/media" title="From The Press">From The Press</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/jim-cramer" title="Jim Cramer">Jim Cramer</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/news/rumors" title="Rumors">Rumors</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-whisper-index" title="Whisper Index">Whisper Index</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/stock-of-the-day" title="Stock of the Day">Stock of the Day</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Best Stocks & ETFs</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-penny-stocks" title="Best Penny Stocks">Best Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-sp-500-etfs" title="Best S&P 500 ETFs">Best S&P 500 ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-swing-trade-stocks" title="Best Swing Trade Stocks">Best Swing Trade Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-blue-chip-stocks" title="Best Blue Chip Stocks">Best Blue Chip Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-high-volume-penny-stocks" title="Best High-Volume Penny Stocks">Best High-Volume Penny Stocks</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-small-cap-etfs" title="Best Small Cap ETFs">Best Small Cap ETFs</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stocks-to-day-trade" title="Best Stocks to Day Trade">Best Stocks to Day Trade</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-reits" title="Best Stocks to Day Trade">Best REITs</a></div></div></div></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/money" style="min-width:66px" title="Money">Money </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/investing" title="Investing">Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/crypto" title="Cryptocurrency">Cryptocurrency</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/mortgage-rates" title="Mortgage">Mortgage</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/insurance" title="Insurance">Insurance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/yield-investments" title="Yield">Yield</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/personal-finance" title="Personal Finance">Personal Finance</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/forex" title="Forex">Forex</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/startups" title="Startup Investing">Startup Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/alternative-investments/real-estate" title="Real Estate Investing">Real Estate Investing</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-prop-trading-firms" title="Prop Trading">Prop Trading</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-credit-cards" title="Credit Cards">Credit Cards</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/money/best-stock-brokers-in-the-us" title="Stock Brokers">Stock Brokers</a></div></div></div></div></div></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/crypto" style="min-width:fit-content" title="Crypto">Crypto </a></div><div class="sc-jKJZnd jBcAho menu-wrapper primary"><a class="sc-jzmNhJ fVNyRC menu-item-link initial" data-action="Navigation Main Menu Click" href="/cannabis" style="min-width:84px" title="Cannabis">Cannabis </a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX cvPhYw highlight dropdown-menu-item"><a data-action="Get Tickets to the Cannabis Conference" href="/events/cannabis-conference/" title="Cannabis Conference">Cannabis Conference</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/earnings" title="Earnings">Earnings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/interviews" title="Interviews">Interviews</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/cannabis/deals" title="Deals">Deals</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/topic/cannabis-regulation" title="Regulations">Regulations</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/markets/psychedelics" title="Psychedelics">Psychedelics</a></div></div></div></div></div></div></div></button><div class="sc-fIiAAZ dSjbGr secondary-menu-wrapper"><div class="sc-jKJZnd jBcAho menu-wrapper secondary"><a aria-label="This opens Research in a new tab" class="sc-cdZxpv ievizW others-btn primary-toolbar-button" href="https://www.benzinga.com/research" style="min-width:110px" target="_blank" title="Research"><div class="text-xl pr-2"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M96 32C60.7 32 32 60.7 32 96V384H96V96l384 0V384h64V96c0-35.3-28.7-64-64-64H96zM224 384v32H32c-17.7 0-32 14.3-32 32s14.3 32 32 32H544c17.7 0 32-14.3 32-32s-14.3-32-32-32H416V384c0-17.7-14.3-32-32-32H256c-17.7 0-32 14.3-32 32z" fill="currentColor"></path></svg></div>Research</a></div><div class="sc-jKJZnd jBcAho menu-wrapper secondary"><a aria-label="This opens My Stocks in a new tab" class="sc-cdZxpv ievizW others-btn primary-toolbar-button" href="https://www.benzinga.com/login?action=register&next=https://www.benzinga.com/profile/portfolio" style="min-width:105px" target="_blank" title="My Stocks"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M500 89c13.8-11 16-31.2 5-45s-31.2-16-45-5L319.4 151.5 211.2 70.4c-11.7-8.8-27.8-8.5-39.2 .6L12 199c-13.8 11-16 31.2-5 45s31.2 16 45 5L192.6 136.5l108.2 81.1c11.7 8.8 27.8 8.5 39.2-.6L500 89zM160 256V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32zM32 352v96c0 17.7 14.3 32 32 32s32-14.3 32-32V352c0-17.7-14.3-32-32-32s-32 14.3-32 32zm288-64c-17.7 0-32 14.3-32 32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V320c0-17.7-14.3-32-32-32zm96-32V448c0 17.7 14.3 32 32 32s32-14.3 32-32V256c0-17.7-14.3-32-32-32s-32 14.3-32 32z" fill="currentColor"></path></svg></div>My Stocks</a></div><div class="sc-jKJZnd jBcAho menu-wrapper secondary"><a aria-label="This opens Tools in a new tab" class="sc-cdZxpv ievizW others-btn primary-toolbar-button" href="https://www.benzinga.com/tools" style="min-width:100px" target="_blank" title="Tools"><div class="text-xl pr-1"><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 512 512" xmlns="http://www.w3.org/2000/svg"><path d="M352 320c88.4 0 160-71.6 160-160c0-15.3-2.2-30.1-6.2-44.2c-3.1-10.8-16.4-13.2-24.3-5.3l-76.8 76.8c-3 3-7.1 4.7-11.3 4.7H336c-8.8 0-16-7.2-16-16V118.6c0-4.2 1.7-8.3 4.7-11.3l76.8-76.8c7.9-7.9 5.4-21.2-5.3-24.3C382.1 2.2 367.3 0 352 0C263.6 0 192 71.6 192 160c0 19.1 3.4 37.5 9.5 54.5L19.9 396.1C7.2 408.8 0 426.1 0 444.1C0 481.6 30.4 512 67.9 512c18 0 35.3-7.2 48-19.9L297.5 310.5c17 6.2 35.4 9.5 54.5 9.5zM80 408a24 24 0 1 1 0 48 24 24 0 1 1 0-48z" fill="currentColor"></path></svg></div>Tools</a><div class="sc-bUjGoE ciyAWD sub-nav-wrapper subnav has-groups"><div class="sc-bXbAQm lcKdMO sub-group-wrapper"><a aria-label="Free Benzinga Pro Trial" class="sc-dBYnXA cLmgSw shine-effect text-white block py-2 rounded-sm bg-bzblue-600 text-center mx-2 md:mx-4 my-2" href="https://pro.benzinga.com/register/?utm_source=tools-bz-pro-free-trial">Free Benzinga Pro Trial </a><div class="sc-cLGQGY hkDVfA group-list"><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Calendars</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings Calendar">Analyst Ratings Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/conference-calls" title="Conference Call Calendar">Conference Call Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/dividends" title="Dividend Calendar">Dividend Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/earnings" title="Earnings Calendar">Earnings Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/economic" title="Economic Calendar">Economic Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/fda-calendar" title="FDA Calendar">FDA Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/guidance" title="Guidance Calendar">Guidance Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/ipos" title="IPO Calendar">IPO Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/m-a" title="M&A Calendar">M&A Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/spac" title="SPAC Calendar">SPAC Calendar</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/stock-splits" title="Stock Split Calendar">Stock Split Calendar</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Trade Ideas</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/reports" title="Free Stock Reports">Free Stock Reports</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/sec/insider-trades/" title="Insider Trades">Insider Trades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/trading-ideas" title="Trade Idea Feed">Trade Idea Feed</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/analyst-stock-ratings" title="Analyst Ratings">Analyst Ratings</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/calendars/unusual-options-activity" title="Unusual Options Activity">Unusual Options Activity</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/heatmap" title="Heatmaps">Heatmaps</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/free-newsletters" title="Free Newsletter">Free Newsletter</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/gov-trades" title="Government Trades">Government Trades</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/perfect-stock-portfolio" title="Perfect Stock Portfolio">Perfect Stock Portfolio</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/portfolio/easy-income-portfolio" title="Easy Income Portfolio">Easy Income Portfolio</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Short Interest</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/most-shorted" title="Most Shorted">Most Shorted</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-increase" title="Largest Increase">Largest Increase</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/short-interest/largest-decrease" title="Largest Decrease">Largest Decrease</a></div></div></div></div></div><div><div class="sc-iIVpRh bUPzLk group-list-item-label">Calculators</div><div><div class="menu-items"><div class="sc-grEoEK hnMSQP menu-item-wrapper"><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/margin-calculator" title="Margin Calculator">Margin Calculator</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/forex-profit-calculator" title="Forex Profit Calculator">Forex Profit Calculator</a></div><div class="sc-ZxepX DsgvI dropdown-menu-item"><a data-action="Navigation Sub-Menu Click" href="/research/tools/100x-options-profit-calculator" title="100x Options Profit Calculator">100x Options Profit Calculator</a></div></div></div></div></div></div></div></div></div></div></div></div></div><div class="sc-lcMqGs kimWDA quote-bar-container"><div class="quote-bar-layout-width"><div class="quote-bar-wrapper"><div class="sc-fKFgrF frfjnD quote-switcher-wrapper"><div class="quote-switcher-container"><button class="sc-fCzvdW hsnbJt quote-switcher-button">Recent</button><button class="sc-fCzvdW iQNatV quote-switcher-button">Markets</button></div></div><div class="quote-list-container"><div class="sc-keSDAH iPnQNb quote-list-wrapper"><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a><a class="sc-ehEeqy kjFNA quote-block " href="/quote/null"><h5 class="sc-eYjERw iqcSMz quotebox-quote-name"></h5><div class="sc-fmJrrp jieYJc quotebox-quote-data"><span class="sc-brYdJo fHqnwx quotebox-quote-price"></span><span class="sc-brYdJo sc-hpmCTx fHqnwx gvTojD quotebox-quote-change "><span></span></span></div></a></div></div><div class="search-wrapper"><div class="sc-cieYuS cfstRH searchbar-wrapper searchbar-default"><div class="sc-vZZzB eZXymS searchbar-container"><div class="sc-ifVVRW kOhchH search-input-container"><div class="sc-gUDIDV fcPNlb search-input-wrapper" style="flex-direction:row"><div class="search-icon" role="presentation"><span role="img" aria-label="search" class="anticon anticon-search"><svg viewBox="64 64 896 896" focusable="false" data-icon="search" width="1em" height="1em" fill="currentColor" aria-hidden="true"><path d="M909.6 854.5L649.9 594.8C690.2 542.7 712 479 712 412c0-80.2-31.3-155.4-87.9-212.1-56.6-56.7-132-87.9-212.1-87.9s-155.5 31.3-212.1 87.9C143.2 256.5 112 331.8 112 412c0 80.1 31.3 155.5 87.9 212.1C256.5 680.8 331.8 712 412 712c67 0 130.6-21.8 182.7-62l259.7 259.6a8.2 8.2 0 0011.6 0l43.6-43.5a8.2 8.2 0 000-11.6zM570.4 570.4C528 612.7 471.8 636 412 636s-116-23.3-158.4-65.6C211.3 528 188 471.8 188 412s23.3-116.1 65.6-158.4C296 211.3 352.2 188 412 188s116.1 23.2 158.4 65.6S636 352.2 636 412s-23.3 116.1-65.6 158.4z"></path></svg></span></div><input aria-label="Search" class="search-input" placeholder="Search Tickers, Companies or News..." role="searchbox" tabindex="0" type="search" value=""/></div></div></div></div></div></div></div></div></div></div><div class="sc-fJmXnk llnObD money-page-template narrow"><div class="sc-mPVAB itvxwS"><div class="sc-cbDaos eJGZYt"><div class="sc-iVheDh iBOlcq layout-content-container lg:px-0 mx-auto px-4 layout-container max-w-7xl"><div class="main-content-container layout-container mx-auto"><div class="layout-flex flex flex-col w-full items-start relative"><div class="layout-main flex flex-grow flex-col justify-between"><main class="money-page-main"><div class="sc-deeVxw cYvaPg money-post-wrapper"><div class="sc-bCvmQg dNqQyz money-blocks-wrapper"><div class="sc-eCmNgM jmpdWl"><div class="sc-emhixo bRJFnU content-feed "><div class="sc-eAGUXh dJeHzD mb-4"><div class="sc-fgisPL iMnyge section-title bordered"><h2>Cannabis Earnings News</h2></div><div class="my-4"></div></div><div class="content-feed-container"><div class="content-feed-list"><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for DB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/db" target="_blank"><span class="sc-bIOlYc kePTjK">DB</span></a></div><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for DBCCF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/dbccf" target="_blank"><span class="sc-bIOlYc kePTjK">DBCCF</span></a></div><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for TSXV:DB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/tsxv:db" target="_blank"><span class="sc-bIOlYc kePTjK">TSXV:DB</span></a></div></div><div class="brief-datetime"><span class="brief-time">01:54pm ET</span><span class="brief-date">11/22/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53">Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%</a></div><div class="brief-teaser">Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. "Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter," CEO Benjamin Sze said. "Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower."</div><a class="read-more" href="https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53">Read More</a></div></div></div><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for INNPF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/innpf" target="_blank"><span class="sc-bIOlYc kePTjK">INNPF</span></a></div></div><div class="brief-datetime"><span class="brief-time">08:49pm ET</span><span class="brief-date">11/21/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth">Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth</a></div><div class="brief-teaser">Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.</div><a class="read-more" href="https://www.benzinga.com/24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth">Read More</a></div></div></div><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for CSE:VEXT" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cse:vext" target="_blank"><span class="sc-bIOlYc kePTjK">CSE:VEXT</span></a></div><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for VEXTF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/vextf" target="_blank"><span class="sc-bIOlYc kePTjK">VEXTF</span></a></div></div><div class="brief-datetime"><span class="brief-time">03:28pm ET</span><span class="brief-date">11/21/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda">Ohio's Weed Enthusiasts Help This Cannabis Company's Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA</a></div><div class="brief-teaser">Cannabis operator with vertical operations in Arizona and Ohio Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Thursday its financial results for the period ended Sept. 30, 2024. "Vext's performance in the third quarter of 2024 was a testament to the team's disciplined execution amid persistent macroeconomic headwinds," Eric Offenberger, CEO of Vext, said. "Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we're pleased to report that our economic unit volumes remain strong."</div><a class="read-more" href="https://www.benzinga.com/24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda">Read More</a></div></div></div><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for ENVB" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/envb" target="_blank"><span class="sc-bIOlYc kePTjK">ENVB</span></a></div></div><div class="brief-datetime"><span class="brief-time">03:06pm ET</span><span class="brief-date">11/18/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders">Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders</a></div><div class="brief-body"><p>Psychedelics biotech company <strong>Enveric Biosciences </strong>(NASDAQ:<a href="https://www.benzinga.com/stock/ENVB#NASDAQ" class="ticker">ENVB</a>) provided a corporate update and reported financial results for the third quarter ended Sept. 30, 2024.</p> <p>"The third quarter of 2024 was highlighted by important progress in the development of EB-003, our neuroplastogenic molecule that is designed to address difficult-to-treat mental health disorders without inducing the hallucinogenic effect common to N,N-Dimethyltryptamine (DMT) and related analogs," stated <strong>Joseph Tucker</strong>, Ph.D., director and CEO of Enveric. "Among the key achievements, data confirmed that EB-003 has the potential <a href="https://www.benzinga.com/markets/cannabis/24/07/39955483/non-hallucinogenic-psychedelic-treatment-for-mental-health-disorders-shows-potential-to-be-dosed">to be delivered via oral administration</a> and penetrate the brain at levels expected to elicit the desired therapeutic effect. Additionally, preclinical safety and pharmacology studies confirmed that EB-003 targets desired serotonergic receptors while minimizing potentially harmful, off-target interactions common to serotonin-like drug compounds. These are clear differentiators for EB-003, which we believe will add to its value potential."</p> <p>Tucker says that "drug technologies that minimize or eliminate the hallucinogenic effect in molecules targeting the 5-HT2A receptor have the potential to become the gold standard in one or more neuropsychiatric indications." The company plans to submit an EB-003 Investigational New Drug (IND) application to the U.S. Food and Drug Administration in the second half of 2025.</p> <p><strong>Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/11/41901157/enveric-biosciences-out-licenses-key-program-to-mycomedica-in-62m-deal">Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal</a></strong></p> <p><em><strong>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a rel="noreferrer noopener" href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you're serious about the business, you can't afford to miss out.</strong></em></p> <h2 class="wp-block-heading"><strong>Q3 Financial Highlights</strong></h2> <p><strong>Net loss attributable to stockholders was $2.1 million</strong>, including $500,000 in net non-cash expense, with a basic and diluted loss per share of $0.24, as compared to a net loss of $2.8 million, including $0.2 million in net non-cash income, with a basic and diluted loss per share of $1.30 for the quarter ended Sept. 30, 2023.</p> <p>Total operating expenses amounted to $2.08 million, compared to $3.45 million in the same period last year.</p> <p>At the end of the reporting period on Sept. 30, 2024, Enveric had cash-on-hand of $3.1 million, and accumulated deficit of $102.92 million.</p> <p><a></a> In the quarterly <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/890821/000149315224045859/form10-q.htm">report</a> filed with the SEC, Enveric noted that "further losses are anticipated in the development of its business. Being a research and development company, since inception, the company has not yet generated revenue and the company has incurred continuing losses from its operations. The company's operations have been funded principally through the issuance of equity. These factors raise substantial doubt about the company's ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements."</p> <p>To continue as a going concern, Enveric needs to raise additional capital.</p> <p>The company had cash-on-hand of $3.1 million for the quarter ended September 30, 2024.</p> <h2 class="wp-block-heading"><strong>Corporate, Product and Business Development Highlights</strong></h2> <ul> <li>Confirmed oral bioavailability and significant brain exposure in preclinical studies of EB-003, supporting expedited development with IND filing and first patient dosed expected in 2025</li> <li>Announced positive results from preclinical safety and pharmacology studies of EB-003, confirming the drug's selective activity with desired serotonergic neuroreceptors and ability to minimize potential adverse cardiovascular and CNS events</li> <li>Presented foundational research involving EB-003 at the 7th Neuropsychiatric Drug Summit and the European Behavioral Pharmacology Society Biennial Workshop</li> <li>Strengthened intellectual property estate for EVM301 portfolio and announced the issuance of five additional U.S. patents</li> <li>Executed licensing agreement with Aries Science & Technology to clinically develop and market Enveric's patented product for radiation dermatitis</li> </ul> <h2 class="wp-block-heading"><strong>Price Action</strong></h2> <p><strong>Enveric Biosciences shares closed Friday market session 8.06% lower at 37 cents per share.</strong></p> <p><strong>Read Next:</strong></p> <ul> <li><a href="https://www.benzinga.com/general/biotech/24/11/41714040/enveric-biosciences-expands-mental-health-patent-portfolio-with-5-new-additions"><strong>Enveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions</strong></a></li> </ul> <p><em>Photo created with AI</em></p></div><a class="read-more" href="https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders">Read More</a></div></div></div><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for GNLN" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/gnln" target="_blank"><span class="sc-bIOlYc kePTjK">GNLN</span></a></div></div><div class="brief-datetime"><span class="brief-time">01:58pm ET</span><span class="brief-date">11/18/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/news/earnings/24/11/42036290/greenlane-cuts-q3-net-loss-despite-66-revenue-drop-shifts-product-strategy">Greenlane Cuts Q3 Net Loss Despite 66% Revenue Drop, Shifts Product Strategy</a></div><div class="brief-body"><p><strong>Greenlane Holdings, Inc. </strong>(NASDAQ:<a href="https://www.benzinga.com/stock/GNLN#NASDAQ" class="ticker">GNLN</a>) reported its financial results for the third quarter ended Sept. 30, 2024, <strong>disclosing revenue of </strong><strong>$4 million compared to $11.8 million in the prior year period.</strong></p> <p>The Florida-based cannabis company noted that beginning with its second quarter 2023 earnings release, it implemented a major restructuring of its industrial product lines, transitioning much of this business from gross sales to a commission structure. This change affects how Greenlane reports revenue and enables it to preserve working capital and improve gross margins.</p> <p>“During the third quarter, we continued to make progress on strengthening our product strategy and roadmap, enhancing our sales team structure and compensation arrangement, and further extracting operating efficiencies across the enterprise,” stated CEO <strong>Barbara Sher</strong> “We continue to see evidence that our efforts to reposition the business over the last six months have been proving successful. As we enter the next phase of our transformation, we are evolving our product portfolio with the addition of health, safety and wellness products that we believe can broaden our market opportunities and grow revenue.”</p> <p><strong>Read Also: <a href="https://www.benzinga.com/24/11/42016079/cannabis-co-grown-rogue-reports-7-increase-in-q3-revenue-focuses-on-new-jersey-and-illinois-expansion">Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion</a></strong></p> <p><em><strong>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a rel="noreferrer noopener" href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you're serious about the business, you can't afford to miss out.</strong></em></p> <h2 class="wp-block-heading"><strong>Q3 Financial Highlights</strong></h2> <ul> <li>Gross margin percentage increased 48.4% to 75%.</li> <li>Gross profit amounted to $3.03 million, compared to $3.13 million in the same period last year.</li> <li>Total operating expenses were $3.6 million, a decrease of 64% compared to $10.0 million in the prior year period.</li> <li>Operating loss improved by approximately $6.3 million to $538,000 compared to an operating loss of approximately $6.9 million in the prior year period.</li> </ul> <ul> <li>Net loss was $3.8 million, which included a $3.2 million one-time non-cash charge for interest expense in connection with various merchant cash advances, compared to a net loss of $10.1 million in the prior year period.</li> <li>As of September 30, 2024, the company had cash and cash equivalents of approximately $2.3 million.</li> </ul> <h2 class="wp-block-heading"><strong>Recent Milestones</strong></h2> <p>In August, Greenlane <strong>entered into a securities purchase agreement with a large institutional investor for gross </strong><strong><a href="https://www.benzinga.com/markets/cannabis/24/08/40346607/greenlane-to-raise-6-5m-through-private-investment-deal-with-large-institutional-investor"><strong>cash proceeds of $6.5 million</strong></a></strong><strong>.</strong> Under the agreement, the vendor of cannabis accessories and vaporization products <strong>issue</strong><strong>d</strong><strong> 3.36 million units.</strong></p> <p>Earlier the same month, the company announced plans to distribute Safety Strips, Inc.'s fentanyl, xylazine and drink spike detection test strips across the U.S. The company's Safety Strips Fentanyl Test Strip (FTS) ISO 13485 validated product can detect potent synthetic opioids, including 3-methyl Fentanyl, Acetyl Fentanyl, Butyryl Fentanyl, Carfentanil, Fentanyl, Furanyl Fentanyl, Ocfentanil, Remifentanil, Sufentanil, Valeryl Fentanyl, and p-Fluoro Fentanyl. The announcement caused Greenlane’s <a href="https://www.benzinga.com/markets/cannabis/24/08/40318873/greenlane-stock-skyrockets-on-plans-to-distribute-high-sensitivity-test-strips-to-tackle-opiate-"><strong>shares t</strong><strong>o jump </strong><strong>244.40%</strong></a><strong>.</strong><strong></strong></p> <h2 class="wp-block-heading"><strong>Price Action</strong></h2> <p><strong>Greenlane shares closed Friday market session 6.70% lower at $1.95 per share.</strong></p> <p><strong>Read Next:</strong></p> <ul> <li><a href="https://www.benzinga.com/news/earnings/24/11/42015700/avicanna-reduces-net-loss-and-improves-gross-profit-focusing-on-international-markets"><strong>Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets</strong></a></li> </ul> <p><em>Photo: Courtesy of SD_FlowerPower via Shutterstock</em></p></div><a class="read-more" href="https://www.benzinga.com/news/earnings/24/11/42036290/greenlane-cuts-q3-net-loss-despite-66-revenue-drop-shifts-product-strategy">Read More</a></div></div></div><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for CSE:GRIN" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/cse:grin" target="_blank"><span class="sc-bIOlYc kePTjK">CSE:GRIN</span></a></div><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for GRIN" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/grin" target="_blank"><span class="sc-bIOlYc kePTjK">GRIN</span></a></div><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for GRUSF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/grusf" target="_blank"><span class="sc-bIOlYc kePTjK">GRUSF</span></a></div><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for VREOF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/vreof" target="_blank"><span class="sc-bIOlYc kePTjK">VREOF</span></a></div></div><div class="brief-datetime"><span class="brief-time">06:33pm ET</span><span class="brief-date">11/15/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/24/11/42016079/cannabis-co-grown-rogue-reports-7-increase-in-q3-revenue-focuses-on-new-jersey-and-illinois-expansion">Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion</a></div><div class="brief-teaser">Cannabis company Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its third quarter 2024 results for the three months ended Sept. 30, 2024. "This was another exciting quarter for Grown Rogue with solid financial metrics showing the continued execution by our team in competitive markets against a backdrop of modest price compression," Obie Strickler, CEO of Grown Rogue, said. "We continue to see strong indoor production yields of craft-quality flower, retail buyer and consumer loyalty, and great initial reception and sell-through with our branded pre-rolls, including our newest brand Yeti".</div><a class="read-more" href="https://www.benzinga.com/24/11/42016079/cannabis-co-grown-rogue-reports-7-increase-in-q3-revenue-focuses-on-new-jersey-and-illinois-expansion">Read More</a></div></div></div><div class="sc-ehYcQd fLYDet benzinga-brief-block-wrapper "><div class="sc-iENCyk lelLTE benzinga-brief-block teaser "><div class="brief-sidebar-info"><div><div class="ticker-list"><div class="sc-dSOwmo fbdHWX ticker-box-wrapper"><a aria-label="Go to Quote Page for AVCNF" rel="dofollow" class="items-end ticker-link-wrapper inline-flex" href="/quote/avcnf" target="_blank"><span class="sc-bIOlYc kePTjK">AVCNF</span></a></div></div><div class="brief-datetime"><span class="brief-time">06:15pm ET</span><span class="brief-date">11/15/2024</span></div></div><div class="brief-sidebar-info-under"></div></div><div class="brief-main-info"><div class="benzinga-brief-block-header"><a href="https://www.benzinga.com/news/earnings/24/11/42015700/avicanna-reduces-net-loss-and-improves-gross-profit-focusing-on-international-markets">Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets</a></div><div class="brief-body"><p><strong>Avicanna Inc. </strong>(OTCQX:<a href="https://www.benzinga.com/stock/AVCNF#OTCQX" class="ticker">AVCNF</a>) announced its financial results Thursday for the third quarter, disclosing<strong> revenue of CA$6.27 million ($4.49 million), compared to CA$6.25 million </strong>in the same period last year. The Toronto-based cannabis company also reported improved consolidated gross margin to 57% from 46% for the same period in 2023.</p> <p>"We are pleased to report the results of another quarter showing progressive improvements across our four business pillars," stated CEO <strong>Aras Azadian</strong>. "Our continuous optimization efforts contributed to improvements in our overall financial performance, consolidated gross margins, and balance sheet. We are now better positioned to turn our attention towards our international growth initiatives and take further steps towards advancing our long-term business model."</p> <p><strong>Read Also: <a href="https://www.benzinga.com/news/earnings/24/11/41998220/agrifys-q3-revenue-drop-18-6m-loss-amid-new-leadership">Agrify’s Q3 Revenue Drop, $18.6M Loss Amid New Leadership</a></strong></p> <p><em><strong>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a rel="noreferrer noopener" href="https://newsletteremail.benzinga.com/subscribe">here</a>. If you're serious about the business, you can't afford to miss out.</strong></em></p> <h2 class="wp-block-heading"><strong>Q3 Financial Highlights</strong></h2> <ul> <li>Gross profit was CA$3.7 million compared to CA$2.9 million in the comparable quarter last year.</li> </ul> <ul> <li>Adjusted EBITDA was a loss of CA$293,931 compared to adjusted EBITDA loss of $473,650 in the corresponding period last year.</li> <li>Net loss amounted to CA$786,388 compared to net loss of CA$1.42 million in the third quarter of 2023.</li> <li>Fully repaid outstanding principle balance of approximately CA$1.3 million owed under non-convertible debenture.</li> </ul> <h2 class="wp-block-heading"><strong>Recent Milestones</strong></h2> <p>In August, the biopharmaceutical company announced  the <a href="https://www.benzinga.com/markets/cannabis/24/08/40403052/avicannas-cbg-products-reach-19-countries-denmark-joins-global-expansion">successful export of its Aureus-branded cannabigerol (CBG) products to Denmark</a>. This marked the 19th international market for Aureus-branded products and the 22nd market overall for Avicanna’s product range. The export was facilitated through Avicanna's majority-owned subsidiary, Santa Marta Golden Hemp SAS.</p> <p>The same month, Avicanna <a href="https://www.benzinga.com/markets/cannabis/24/08/40628172/avicanna-secures-nearly-2m-in-private-placement-deal-amid-us-patent-win-for-cannabinoid-topical-">closed a non-brokered private placement</a> offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross proceeds of $1,986,207.</p> <p>This year also, the company confirmed that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. US 20230025693A1, covering the company’s deep penetrating topical cannabinoid composition and methods for <a rel="noreferrer noopener" href="https://www.benzinga.com/markets/cannabis/24/08/40585810/avicanna-secures-us-patent-for-topical-cannabinoid-technology-to-treat-pain-and-inflammation">treating musculoskeletal inflammation and pain.</a></p> <h2 class="wp-block-heading"><strong>Price Action</strong></h2> <p><strong>Avicanna shares closed Thursday's market session flat at 17 cents a share.</strong></p> <p><strong>Read Next:</strong></p> <ul> <li><a href="https://www.benzinga.com/24/11/41992549/cv-sciences-q3-revenue-stable-amid-new-launches-financing"><strong>CV Sciences Q3: Revenue Stable Amid New Launches, Financing</strong></a></li> </ul> <p><em>Photo: Courtesy of Avicanna </em></p></div><a class="read-more" href="https://www.benzinga.com/news/earnings/24/11/42015700/avicanna-reduces-net-loss-and-improves-gross-profit-focusing-on-international-markets">Read More</a></div></div></div></div></div></div></div></div></div></main></div><div><div class="sc-iCKXBC gsbRr layout-sidebar flex-none justify-between"><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div></div></div></div><div class="lazyload-wrapper "><div class="lazyload-placeholder"></div></div></div></div><div></div></div><div class="footer"><div class="footer-top-section"><div class="benzinga-links-section"><div class="logo-and-socials-wrapper"><span class="sc-eRxdlV jnspZt benzinga-logo light presentation"><svg height="100%" role="img" viewBox="0 0 471.1 63.8" width="100%" xmlns="http://www.w3.org/2000/svg"><path d="M67.7 63.8h45.2V51.9H81.4V37.3h26.1V25.4H81.4V11.9h31.7V0H67.7zm99.6-23.6L137.7 0h-20.4l6.4 8.1V64h13.6V22.1l30.6 41.7H181V0h-13.7zM47.1 31c6-1.1 11-6.7 11-14.6C58.1 7.9 51.9 0 39.6 0H0l6.2 7.9v56H41c12.3 0 18.7-7.7 18.7-17.3-.3-7.9-5.7-14.7-12.6-15.6zM19.8 12h17.1c4.6 0 7.5 2.7 7.5 6.7s-2.9 6.7-7.5 6.7H19.8V12zm17.7 40H19.8V37.3h17.7c5.2 0 8.1 3.3 8.1 7.3 0 4.6-3.1 7.3-8.1 7.4zm343.3-11.8h7.1v7.5c-3.7 3-8.3 4.7-13.1 4.8-11.4 0-19.4-8.7-19.4-20.4s8.1-20.4 19.4-20.4c5.9 0 11.4 3.1 14.6 8.1l10.8-6C395.6 6.5 387.5 0 374.7 0c-18.1 0-33.1 12.5-33.1 31.9s14.8 31.9 33.1 31.9c10 .2 19.5-4.1 26.1-11.5V28.7h-29.2l9.2 11.5zm-61.5 0L289.6 0h-20.3l6.3 8.1V64h13.7V22.1l30.6 41.7h13V0h-13.6zM446 0h-26.3l6.3 8.1-1.1 3.1L404.5 64h15.4l4-10.8h27.5l4 10.8h15.4L446 0zm-18.6 41.2l10-27.5 10 27.5h-20zM247.7 0h13.7v64.1h-13.7zm-10.9 11V0h-48.1v11.9h30.2l-30.2 41v10.9h48.6V51.9h-30.9z" fill="#FFFFFF"></path></svg></span><div class="social-sites-list"><a aria-label="Click to check out Benzinga's facebook" class="sc-iFEMmm fgxyIy facebook" color="#3b5998" href="https://web.facebook.com/Benzinga/?_rdc=1&_rdr" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64h98.2V334.2H109.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H255V480H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's instagram" class="sc-iFEMmm XrAQw instagram" color="#e1306c" href="https://www.instagram.com/benzinga/?hl=en" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M224.1 141c-63.6 0-114.9 51.3-114.9 114.9s51.3 114.9 114.9 114.9S339 319.5 339 255.9 287.7 141 224.1 141zm0 189.6c-41.1 0-74.7-33.5-74.7-74.7s33.5-74.7 74.7-74.7 74.7 33.5 74.7 74.7-33.6 74.7-74.7 74.7zm146.4-194.3c0 14.9-12 26.8-26.8 26.8-14.9 0-26.8-12-26.8-26.8s12-26.8 26.8-26.8 26.8 12 26.8 26.8zm76.1 27.2c-1.7-35.9-9.9-67.7-36.2-93.9-26.2-26.2-58-34.4-93.9-36.2-37-2.1-147.9-2.1-184.9 0-35.8 1.7-67.6 9.9-93.9 36.1s-34.4 58-36.2 93.9c-2.1 37-2.1 147.9 0 184.9 1.7 35.9 9.9 67.7 36.2 93.9s58 34.4 93.9 36.2c37 2.1 147.9 2.1 184.9 0 35.9-1.7 67.7-9.9 93.9-36.2 26.2-26.2 34.4-58 36.2-93.9 2.1-37 2.1-147.8 0-184.8zM398.8 388c-7.8 19.6-22.9 34.7-42.6 42.6-29.5 11.7-99.5 9-132.1 9s-102.7 2.6-132.1-9c-19.6-7.8-34.7-22.9-42.6-42.6-11.7-29.5-9-99.5-9-132.1s-2.6-102.7 9-132.1c7.8-19.6 22.9-34.7 42.6-42.6 29.5-11.7 99.5-9 132.1-9s102.7-2.6 132.1 9c19.6 7.8 34.7 22.9 42.6 42.6 11.7 29.5 9 99.5 9 132.1s2.7 102.7-9 132.1z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's linkedin" class="sc-iFEMmm cjvdFo linkedin" color="#0072b1" href="https://www.linkedin.com/company/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's soundcloud" class="sc-iFEMmm jlbEXg soundcloud" color="#fe5000" href="https://soundcloud.com/bztv" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 640 512" xmlns="http://www.w3.org/2000/svg"><path d="M111.4 256.3l5.8 65-5.8 68.3c-.3 2.5-2.2 4.4-4.4 4.4s-4.2-1.9-4.2-4.4l-5.6-68.3 5.6-65c0-2.2 1.9-4.2 4.2-4.2 2.2 0 4.1 2 4.4 4.2zm21.4-45.6c-2.8 0-4.7 2.2-5 5l-5 105.6 5 68.3c.3 2.8 2.2 5 5 5 2.5 0 4.7-2.2 4.7-5l5.8-68.3-5.8-105.6c0-2.8-2.2-5-4.7-5zm25.5-24.1c-3.1 0-5.3 2.2-5.6 5.3l-4.4 130 4.4 67.8c.3 3.1 2.5 5.3 5.6 5.3 2.8 0 5.3-2.2 5.3-5.3l5.3-67.8-5.3-130c0-3.1-2.5-5.3-5.3-5.3zM7.2 283.2c-1.4 0-2.2 1.1-2.5 2.5L0 321.3l4.7 35c.3 1.4 1.1 2.5 2.5 2.5s2.2-1.1 2.5-2.5l5.6-35-5.6-35.6c-.3-1.4-1.1-2.5-2.5-2.5zm23.6-21.9c-1.4 0-2.5 1.1-2.5 2.5l-6.4 57.5 6.4 56.1c0 1.7 1.1 2.8 2.5 2.8s2.5-1.1 2.8-2.5l7.2-56.4-7.2-57.5c-.3-1.4-1.4-2.5-2.8-2.5zm25.3-11.4c-1.7 0-3.1 1.4-3.3 3.3L47 321.3l5.8 65.8c.3 1.7 1.7 3.1 3.3 3.1 1.7 0 3.1-1.4 3.1-3.1l6.9-65.8-6.9-68.1c0-1.9-1.4-3.3-3.1-3.3zm25.3-2.2c-1.9 0-3.6 1.4-3.6 3.6l-5.8 70 5.8 67.8c0 2.2 1.7 3.6 3.6 3.6s3.6-1.4 3.9-3.6l6.4-67.8-6.4-70c-.3-2.2-2-3.6-3.9-3.6zm241.4-110.9c-1.1-.8-2.8-1.4-4.2-1.4-2.2 0-4.2.8-5.6 1.9-1.9 1.7-3.1 4.2-3.3 6.7v.8l-3.3 176.7 1.7 32.5 1.7 31.7c.3 4.7 4.2 8.6 8.9 8.6s8.6-3.9 8.6-8.6l3.9-64.2-3.9-177.5c-.4-3-2-5.8-4.5-7.2zm-26.7 15.3c-1.4-.8-2.8-1.4-4.4-1.4s-3.1.6-4.4 1.4c-2.2 1.4-3.6 3.9-3.6 6.7l-.3 1.7-2.8 160.8s0 .3 3.1 65.6v.3c0 1.7.6 3.3 1.7 4.7 1.7 1.9 3.9 3.1 6.4 3.1 2.2 0 4.2-1.1 5.6-2.5 1.7-1.4 2.5-3.3 2.5-5.6l.3-6.7 3.1-58.6-3.3-162.8c-.3-2.8-1.7-5.3-3.9-6.7zm-111.4 22.5c-3.1 0-5.8 2.8-5.8 6.1l-4.4 140.6 4.4 67.2c.3 3.3 2.8 5.8 5.8 5.8 3.3 0 5.8-2.5 6.1-5.8l5-67.2-5-140.6c-.2-3.3-2.7-6.1-6.1-6.1zm376.7 62.8c-10.8 0-21.1 2.2-30.6 6.1-6.4-70.8-65.8-126.4-138.3-126.4-17.8 0-35 3.3-50.3 9.4-6.1 2.2-7.8 4.4-7.8 9.2v249.7c0 5 3.9 8.6 8.6 9.2h218.3c43.3 0 78.6-35 78.6-78.3.1-43.6-35.2-78.9-78.5-78.9zm-296.7-60.3c-4.2 0-7.5 3.3-7.8 7.8l-3.3 136.7 3.3 65.6c.3 4.2 3.6 7.5 7.8 7.5 4.2 0 7.5-3.3 7.5-7.5l3.9-65.6-3.9-136.7c-.3-4.5-3.3-7.8-7.5-7.8zm-53.6-7.8c-3.3 0-6.4 3.1-6.4 6.7l-3.9 145.3 3.9 66.9c.3 3.6 3.1 6.4 6.4 6.4 3.6 0 6.4-2.8 6.7-6.4l4.4-66.9-4.4-145.3c-.3-3.6-3.1-6.7-6.7-6.7zm26.7 3.4c-3.9 0-6.9 3.1-6.9 6.9L227 321.3l3.9 66.4c.3 3.9 3.1 6.9 6.9 6.9s6.9-3.1 6.9-6.9l4.2-66.4-4.2-141.7c0-3.9-3-6.9-6.9-6.9z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's twitter" class="sc-iFEMmm jldMrO twitter" color="#000000" href="https://twitter.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 448 512" xmlns="http://www.w3.org/2000/svg"><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zm297.1 84L257.3 234.6 379.4 396H283.8L209 298.1 123.3 396H75.8l111-126.9L69.7 116h98l67.7 89.5L313.6 116h47.5zM323.3 367.6L153.4 142.9H125.1L296.9 367.6h26.3z" fill="currentColor"></path></svg></div></a><a aria-label="Click to check out Benzinga's youtube" class="sc-iFEMmm gXlNji youtube" color="red" href="https://www.youtube.com/benzinga" target="_blank"><div><svg aria-hidden="true" class="leading-none" stroke="currentColor" stroke-width="1" style="height:1em;width:1em" viewBox="0 0 576 512" xmlns="http://www.w3.org/2000/svg"><path d="M549.655 124.083c-6.281-23.65-24.787-42.276-48.284-48.597C458.781 64 288 64 288 64S117.22 64 74.629 75.486c-23.497 6.322-42.003 24.947-48.284 48.597-11.412 42.867-11.412 132.305-11.412 132.305s0 89.438 11.412 132.305c6.281 23.65 24.787 41.5 48.284 47.821C117.22 448 288 448 288 448s170.78 0 213.371-11.486c23.497-6.321 42.003-24.171 48.284-47.821 11.412-42.867 11.412-132.305 11.412-132.305s0-89.438-11.412-132.305zm-317.51 213.508V175.185l142.739 81.205-142.739 81.201z" fill="currentColor"></path></svg></div></a></div></div><div class="app-store-wrapper"><a aria-label="Click to download the Benzinga app" class="sc-dnxBXz brbZLb google-play-store-button-wrapper button-wrapper" data-action="Download on Google Play Store Click" href="https://play.google.com/store/apps/details?id=com.benzinga.app&hl=en_NZ&gl=US"><svg clip-rule="evenodd" fill-rule="evenodd" height="39px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 36" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M2863.6 530.6c-36.3 0-66.9-12.7-91.1-37.7-24-24.3-37.4-57.8-36.8-92 0-36.5 12.4-67.4 36.8-91.9 24.1-25 54.7-37.7 91-37.7 35.9 0 66.5 12.7 91.1 37.7 24.4 25.3 36.8 56.2 36.8 91.9-.4 36.6-12.8 67.5-36.8 91.9-24.1 25.2-54.7 37.8-91 37.8zm-1080.1 0c-35.5 0-66.3-12.5-91.5-37.2-25-24.6-37.7-55.7-37.7-92.4s12.7-67.8 37.7-92.4c24.7-24.7 55.5-37.2 91.5-37.2a127.533 127.533 0 0151.1 10.6c16.1 6.9 29.2 16.3 38.9 27.8l2.4 2.9-27.1 26.6-2.8-3.3c-15.3-18.2-35.8-27.1-62.9-27.1-24.2 0-45.3 8.6-62.7 25.6-17.5 17.1-26.4 39.5-26.4 66.6 0 27.1 8.9 49.5 26.4 66.6 17.4 17 38.5 25.6 62.7 25.6 25.8 0 47.5-8.6 64.4-25.6 10-10 16.2-24 18.4-41.7H1779v-37.4h124.2l.5 3.4c.9 6.3 1.8 12.8 1.8 18.8 0 34.5-10.4 62.4-31 83-23.4 24.4-54 36.8-91 36.8zm1436.1-5.3h-38.3L3064 337.6l1 33.8v153.8h-38.3V276.7h43.7l1.2 1.9 110.3 176.8-1-33.7v-145h38.7v248.6zm-643.8 0H2537V314.1h-67.3v-37.4H2643v37.4h-67.3v211.2h.1zm-137.7 0h-38.7V276.7h38.7v248.6zm-217.5 0h-38.7V314.1h-67.3v-37.4h173.3v37.4h-67.3v211.2zm-130.5-.4h-148.4V276.7h148.4v37.4h-109.6v68.2h98.9v37h-98.9v68.2h109.6v37.4zm710.8-57.7c17.3 17.3 38.3 26 62.7 26 25.1 0 45.6-8.5 62.7-26 17-17 25.6-39.3 25.6-66.2 0-26.9-8.6-49.3-25.5-66.2-17.3-17.3-38.4-26-62.7-26-25.1 0-45.6 8.5-62.6 26-17 17-25.6 39.3-25.6 66.2 0 26.9 8.5 49.3 25.4 66.2zM2732.1 872.4c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.6-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4.1 61-44.5 103.4-96.2 103.4zm-373.3-273.6c-94.5 0-171.1 71.7-171.1 170.6 0 98 77.1 170.6 171.1 170.6 94.5 0 171.1-72.2 171.1-170.6 0-98.9-76.7-170.6-171.1-170.6zm0 273.6c-51.7 0-96.2-42.8-96.2-103.4 0-61.5 44.6-103.4 96.2-103.4 51.7 0 96.2 41.9 96.2 103.4 0 61-44.5 103.4-96.2 103.4zm-444.2-221.5v72.2h173.3c-5.3 40.5-18.7 70.4-39.2 90.9-25.4 25.4-64.6 53-133.7 53-106.5 0-189.8-86-189.8-192.5s83.3-192.5 189.8-192.5c57.5 0 99.4 22.7 130.5 51.7l51.2-51.2c-43.2-41.4-100.7-73.1-181.3-73.1-146.1 0-268.7 119-268.7 264.7 0 146.1 122.5 264.7 268.7 264.7 78.9 0 138.1-25.8 184.9-74.4 47.7-47.7 62.8-115 62.8-169.3 0-16.9-1.3-32.1-4-45h-244.6c.1-.1.1.8.1.8zm1816.9 56.2C3717.2 942.4 3674 872 3585.4 872c-87.8 0-160.8 69.1-160.8 170.6 0 95.8 72.2 170.6 169.3 170.6 78 0 123.4-47.7 142.1-75.7l-57.9-38.8c-19.2 28.5-45.9 47.2-83.8 47.2-38.3 0-65.1-17.4-82.9-51.7l228.1-94.5c0 .1-8-19-8-19zm-232.6 57c-1.8-65.9 51.2-99.4 89.1-99.4 29.9 0 54.8 14.7 63.3 36.1l-152.4 63.3zM3313.6 1203h74.9V701.8h-74.9V1203zm-123-292.7h-2.7c-16.9-20.1-49-38.3-90-38.3-85.1 0-163.5 74.9-163.5 171.1 0 95.8 78 169.8 163.5 169.8 40.5 0 73.1-18.3 90-38.8h2.7v24.5c0 65.1-34.8 100.2-90.9 100.2-45.9 0-74.4-33-86-60.6l-65.1 27.2c18.7 45 68.6 100.7 151 100.7 87.8 0 162.2-51.7 162.2-177.8V882.2H3191v28.1h-.4zm-86 235.7c-51.7 0-94.9-43.2-94.9-102.9 0-60.2 43.2-103.8 94.9-103.8 51.2 0 90.9 44.1 90.9 103.8.5 59.7-39.6 102.9-90.9 102.9zm977.6-444.2h-179.1V1203h74.9v-189.8h104.3c82.9 0 164.4-60.1 164.4-155.5s-81.2-155.9-164.5-155.9zm2.2 241.4h-106.5v-172h106.5c56.1 0 87.8 46.3 87.8 86 0 39.3-32.1 86-87.8 86zm462.5-71.7c-54.4 0-110.5 24.1-133.7 76.6l66.4 27.6c14.3-27.6 40.5-37 68.2-37 38.8 0 78 23.2 78.9 64.6v5.3c-13.4-7.6-42.8-19.2-78-19.2-71.7 0-144.4 39.2-144.4 112.7 0 67.3 58.8 110.5 124.3 110.5 50.3 0 78-22.7 95.3-49h2.7v38.8h72.2v-192c0-89.4-66.4-138.9-151.9-138.9zm-9.4 274.5c-24.5 0-58.8-12-58.8-42.8 0-38.8 42.8-53.5 79.3-53.5 33 0 48.6 7.1 68.2 16.9-5.4 45-43.4 79-88.7 79.4zm424.7-263.8l-86 217.4h-2.7l-89.1-217.4h-80.6l133.7 303.9-76.2 168.9h78L5045 882.2h-82.8zM4288 1203h74.9V701.8H4288V1203zM418.4 302.1c-11.6 12.5-18.3 31.6-18.3 56.6v886.7c0 25 6.7 44.1 18.7 56.1l3.1 2.7 496.8-496.8v-11.1L421.5 299.4l-3.1 2.7z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1084 973.5L918.3 807.8v-11.6L1084 630.5l3.6 2.2 196 111.4c56.1 31.6 56.1 83.8 0 115.8l-196 111.4-3.6 2.2z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path><path d="M1087.6 971.3L918.3 802l-499.9 499.9c18.3 19.6 49 21.8 83.3 2.7l585.9-333.3M1087.6 632.7L501.7 299.9c-34.3-19.6-65.1-16.9-83.3 2.7L918.3 802l169.3-169.3z" fill="#0C2140" fill-rule="nonzero" transform="scale(.02208)"></path></svg></a><a aria-label="Click to download the Benzinga app" class="sc-dnxBXz brbZLb apple-app-store-button-wrapper button-wrapper" data-action="Download on Apple App Store Click" href="https://apps.apple.com/us/app/benzinga-stock-news-tracker/id688949481"><svg fill="#0c2140" height="43.3px" stroke-linejoin="round" stroke-miterlimit="2" viewBox="0 0 120 40" width="130px" xmlns="http://www.w3.org/2000/svg"><path d="M24.997 19.889a5.15 5.15 0 012.45-4.317 5.27 5.27 0 00-4.15-2.244c-1.746-.183-3.439 1.045-4.329 1.045-.907 0-2.277-1.027-3.753-.997a5.534 5.534 0 00-4.651 2.837c-2.011 3.482-.511 8.6 1.416 11.414.963 1.378 2.09 2.918 3.564 2.863 1.442-.06 1.981-.919 3.722-.919 1.725 0 2.231.919 3.734.885 1.548-.026 2.523-1.385 3.453-2.776a11.366 11.366 0 001.579-3.216 4.98 4.98 0 01-3.035-4.575zm-2.841-8.412a5.066 5.066 0 001.159-3.63 5.153 5.153 0 00-3.335 1.726 4.82 4.82 0 00-1.19 3.495 4.265 4.265 0 003.366-1.591zM42.302 27.14h-4.734l-1.136 3.356h-2.005l4.483-12.418h2.083l4.484 12.418h-2.039l-1.136-3.356zm-4.243-1.549h3.752l-1.85-5.447h-.052l-1.85 5.447zm17.1.379c0 2.813-1.506 4.621-3.778 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.298 0 3.812 1.816 3.812 4.622zm-1.91 0c0-1.833-.947-3.038-2.393-3.038-1.419 0-2.375 1.23-2.375 3.038 0 1.824.956 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm11.876 0c0 2.813-1.507 4.621-3.779 4.621a3.076 3.076 0 01-2.849-1.584h-.043v4.484h-1.858V21.442h1.799v1.506h.034a3.216 3.216 0 012.883-1.6c2.297 0 3.813 1.816 3.813 4.622zm-1.911 0c0-1.833-.947-3.038-2.393-3.038-1.42 0-2.375 1.23-2.375 3.038 0 1.824.955 3.046 2.375 3.046 1.446 0 2.393-1.197 2.393-3.046zm8.495 1.066c.138 1.232 1.334 2.04 2.969 2.04 1.567 0 2.694-.808 2.694-1.919 0-.964-.68-1.541-2.289-1.936l-1.61-.388c-2.28-.551-3.339-1.617-3.339-3.348 0-2.142 1.867-3.614 4.518-3.614 2.625 0 4.424 1.472 4.484 3.614H77.26c-.112-1.239-1.136-1.987-2.634-1.987s-2.521.757-2.521 1.858c0 .878.654 1.395 2.255 1.79l1.368.336c2.548.603 3.605 1.626 3.605 3.443 0 2.323-1.849 3.778-4.793 3.778-2.753 0-4.613-1.421-4.733-3.667h1.902zM83.346 19.3v2.142h1.722v1.472h-1.722v4.991c0 .776.345 1.137 1.102 1.137.204-.004.408-.018.611-.043v1.463c-.34.063-.686.092-1.032.086-1.833 0-2.548-.689-2.548-2.445v-5.189h-1.316v-1.472h1.316V19.3h1.867zm2.718 6.67c0-2.849 1.678-4.639 4.294-4.639 2.625 0 4.295 1.79 4.295 4.639 0 2.856-1.661 4.638-4.295 4.638s-4.294-1.782-4.294-4.638zm6.695 0c0-1.954-.895-3.108-2.401-3.108s-2.401 1.162-2.401 3.108c0 1.962.895 3.106 2.401 3.106s2.401-1.144 2.401-3.106zm3.426-4.528h1.773v1.541h.043a2.164 2.164 0 012.177-1.635c.214-.001.428.022.637.069v1.738a2.62 2.62 0 00-.835-.112l-.076-.002a1.883 1.883 0 00-1.873 1.873 1.87 1.87 0 00.012.212v5.37h-1.858v-9.054zm13.198 6.395c-.25 1.643-1.85 2.771-3.898 2.771-2.634 0-4.269-1.764-4.269-4.595 0-2.84 1.644-4.682 4.191-4.682 2.505 0 4.08 1.721 4.08 4.466v.637h-6.395v.112l-.009.208a2.37 2.37 0 002.358 2.358l.087-.002a2.05 2.05 0 002.091-1.273h1.764zm-6.282-2.702h4.526l.004-.121a2.19 2.19 0 00-2.177-2.178l-.047.001a2.306 2.306 0 00-2.306 2.292v.006zM37.826 8.731l.189-.007a2.653 2.653 0 012.64 2.64 2.63 2.63 0 01-.021.332c0 1.906-1.03 3.002-2.808 3.002h-2.155V8.731h2.155zm-1.228 5.123h1.125l.112.003a1.884 1.884 0 001.875-1.876 1.79 1.79 0 00-.02-.273c.012-.085.018-.17.018-.256a1.89 1.89 0 00-1.881-1.881l-.104.003h-1.125v4.28zm5.083-1.41a2.143 2.143 0 012.123-2.336c1.17 0 2.133.963 2.133 2.133l-.009.203.01.207c0 1.171-.963 2.134-2.134 2.134s-2.133-.963-2.133-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm6.559 2.254h-.922l-.93-3.317h-.071l-.926 3.317h-.913l-1.242-4.503h.902l.806 3.436h.067l.926-3.436h.852l.926 3.436h.07l.803-3.436h.889l-1.237 4.503zm2.281-4.503h.855v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.472 1.472 0 011.449 1.679v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.888v-4.503zm5.24-1.758h.889v6.261h-.889zm2.124 4.007a2.144 2.144 0 012.124-2.336c1.171 0 2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.17-.963 2.134-2.133 2.134s-2.134-.964-2.134-2.134l.01-.207zm3.333 0c0-.976-.439-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.434 1.551 1.207 1.551s1.208-.571 1.208-1.551zm1.85.98c0-.81.603-1.278 1.675-1.344l1.219-.07v-.389c0-.475-.314-.744-.921-.744-.497 0-.84.182-.939.5h-.86c.091-.773.818-1.269 1.84-1.269 1.128 0 1.765.562 1.765 1.513v3.077h-.855v-.633h-.071a1.52 1.52 0 01-1.352.707 1.33 1.33 0 01-.141.007c-.744 0-1.357-.61-1.36-1.355zm2.894-.384v-.377l-1.099.07c-.62.042-.902.253-.902.65 0 .405.352.641.835.641a.97.97 0 00.107.005c.556 0 1.022-.435 1.059-.989zm2.053-.596c0-1.423.732-2.324 1.869-2.324a1.486 1.486 0 011.381.79h.067V8.437h.888v6.261h-.851v-.712h-.071a1.565 1.565 0 01-1.414.786c-1.145 0-1.869-.901-1.869-2.328zm.918 0c0 .955.45 1.53 1.203 1.53s1.212-.583 1.212-1.526-.468-1.53-1.212-1.53-1.203.579-1.203 1.526zm6.964 0l-.01-.203c0-1.17.963-2.133 2.134-2.133s2.133.963 2.133 2.133l-.01.203a2.05 2.05 0 01.01.207c0 1.171-.963 2.134-2.133 2.134s-2.134-.963-2.134-2.134l.01-.207zm3.333 0c0-.976-.438-1.547-1.208-1.547s-1.207.571-1.207 1.547c0 .984.435 1.551 1.207 1.551s1.208-.571 1.208-1.551zm2.106-2.249h.856v.715h.066a1.35 1.35 0 011.344-.802l.11-.004a1.47 1.47 0 011.464 1.464c0 .072-.005.144-.015.215v2.915h-.889v-2.692c0-.724-.314-1.084-.972-1.084l-.048-.001a1.04 1.04 0 00-1.033 1.033.98.98 0 00.006.109v2.635h-.889v-4.503zm8.846-1.121v1.141h.976v.749h-.976v2.315c0 .472.194.679.637.679.113-.001.226-.008.339-.021v.74c-.16.029-.322.044-.484.046-.988 0-1.381-.348-1.381-1.216v-2.543h-.715v-.749h.715V9.074h.889zm2.19-.637h.88v2.481h.071c.241-.53.792-.853 1.373-.806l.08-.002a1.49 1.49 0 011.484 1.483c0 .066-.005.132-.013.198v2.907h-.89V12.01c0-.719-.335-1.084-.963-1.084l-.086-.003a1.06 1.06 0 00-1.052 1.052l.004.093v2.63h-.888V8.437zm9.056 5.045a1.833 1.833 0 01-1.951 1.303h-.054a2.055 2.055 0 01-2.026-2.325 2.086 2.086 0 012.058-2.352c1.271 0 2.027.856 2.027 2.27v.31h-3.18v.05a1.1 1.1 0 00-.004.1c0 .653.537 1.19 1.19 1.19a1.09 1.09 0 001.085-.546h.855zm-3.126-1.451h2.275l.003-.081c0-.596-.491-1.086-1.087-1.086h-.025a1.16 1.16 0 00-1.166 1.152v.015z"></path></svg></a></div></div><div class="sc-dxRmzR bnEqKR footer-row"><div class="sc-hPnoVK dfdtYF"><h3>Popular Channels</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/premarket-prep/" class="sc-bnRclF KOtsp">PreMarket Prep</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/pressreleases" class="sc-bnRclF KOtsp">Press Releases</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/analyst-stock-ratings" class="sc-bnRclF KOtsp">Analyst Ratings</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/news" class="sc-bnRclF KOtsp">News</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/markets/options" class="sc-bnRclF KOtsp">Options</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/etfs" class="sc-bnRclF KOtsp">ETFs</a></li></ul></div><div class="sc-hPnoVK dfdtYF"><h3>Tools & Features</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://pro.benzinga.com/" class="sc-bnRclF KOtsp">Real Time Feed</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/feeds/list" class="sc-bnRclF KOtsp">Public RSS Feeds</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/contact" class="sc-bnRclF KOtsp">Submit News Tips</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://pro.benzinga.com/blog/" class="sc-bnRclF KOtsp">Blog</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/widgets" class="sc-bnRclF KOtsp">Embeddable Finance Widgets & Tools</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/catalyst" class="sc-bnRclF KOtsp">Benzinga Catalyst</a></li></ul></div><div class="sc-hPnoVK dfdtYF"><h3>Partners & Contributors</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://app.impact.com/campaign-promo-signup/Benzinga1659111587301.brand?execution=e1s1" class="sc-bnRclF KOtsp">Affiliate Program</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://contributor.benzinga.com/contributor-onboarding" class="sc-bnRclF KOtsp">Contributor Portal</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/apis/" class="sc-bnRclF KOtsp">Licensing & Syndication</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/reach/" class="sc-bnRclF KOtsp">Sponsored Content</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://advertise.benzinga.com/" class="sc-bnRclF KOtsp">Advertise With Us</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/contact/" class="sc-bnRclF KOtsp">Lead Generation & SEO</a></li></ul></div><div class="sc-hPnoVK dfdtYF"><h3>About Benzinga</h3><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/about" class="sc-bnRclF KOtsp">About Us</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://jobs.benzinga.com/" class="sc-bnRclF KOtsp">Careers</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/inthenews" class="sc-bnRclF KOtsp">In The News</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/events/" class="sc-bnRclF KOtsp">Events</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/contact" class="sc-bnRclF KOtsp">Contact Us</a></li></ul></div></div></div><div class="footer-bottom-section"><ul><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/terms-and-conditions" class="sc-bnRclF KOtsp">Terms & Conditions </a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/page/privacy" class="sc-bnRclF KOtsp"> Do Not Sell My Personal Data/Privacy Policy</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/disclaimer" class="sc-bnRclF KOtsp">Disclaimer </a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="http://www.benzingastatus.com" class="sc-bnRclF KOtsp">Service Status</a></li><li class="sc-gFYmAs kEwkjg footer-link"><a href="https://www.benzinga.com/sitemap" class="sc-bnRclF KOtsp">Sitemap</a></li></ul><div class="copyright-section text-center w-full whitespace-nowrap mt-2">© 2024 Benzinga | All Rights Reserved</div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"brokerWidget":null,"headerProps":{"hideBanner":true,"hideFooter":false,"hideNavigationBar":false,"hideQuoteBar":false,"hideSearchBar":true,"isMainDrawerVisible":true},"metaProps":{"author":"Benzinga","canonical":"https://www.benzinga.com/cannabis/earnings","dateCreated":"2019-04-18T13:04:28.000-04:00","dateUpdated":"2023-02-22T13:02:15.000-05:00","description":"","dimensions":{"authorName":"Benzinga","contentType":"evergreen"},"hrefLanguage":"en","image":null,"ogImage":null,"ogType":"article","robots":"","structuredData":{"pageType":"Article"},"title":"Cannabis Earnings News","vertical":["Cannabis"]},"pageTargeting":{"BZ_AUTHOR":"Benzinga","BZ_CHANNEL":[],"BZ_PTYPE":"page","BZ_TAG":["Cannabis"]},"post":{"id":35276,"title":"Cannabis Earnings News","post_type":"page","robots":"","intro":null,"slug":"earnings","template":"page","canonical_link":"https://www.benzinga.com/cannabis/earnings","image":null,"taxonomies":[{"term_taxonomy_id":192,"term_id":192,"taxonomy":"verticals","description":"","parent":0,"count":183,"term":{"term_id":192,"name":"Cannabis","slug":"cannabis"}}],"parent":[],"meta":{"title":"Cannabis Earnings News","description":"","image":null,"author":"Benzinga","authorSlug":"benzinga","postId":35276,"publishedDate":"2019-04-18T17:04:28.000000Z","modifiedDate":"2023-02-22T18:02:15.000000Z","verifiedUserSlug":null,"verifiedBy":null,"editedUserSlug":null,"editedBy":null,"hrefLanguage":"en"},"breadcrumbs":[{"id":232396,"href":"/cannabis","name":"Latest Cannabis News"},{"id":35276,"href":"/cannabis/earnings","name":"Cannabis Earnings News"}],"blocks":[{"blockName":"acf/content-feed","attrs":{"id":"block_63f312c82c71e","name":"acf/content-feed","data":{"contentFeedProps":{"title":"Cannabis Earnings News","contentId":"","link":"","limit":7,"channelAndTagQueryOperator":"and","poolLatest":true,"loadMore":true,"loadMoreButton":false,"loadMoreDevice":false,"showCommentCount":false,"isInfinite":true,"raptiveAdPlacementIndex":null,"query":{"displayOutput":"full","limit":7,"excludeAutomated":true,"excludeSponsored":true,"primaryChannel":"123430","channels":[16888],"channelAndTagQueryOperator":"and"},"nodes":[{"assets":[{"type":"image","title":"pexels-kindelmedia-7668049(1)","alt":"Cannabis earnings","source":"Photo: Courtesy of Kindel Media","mime":"","primary":true,"attributes":{"fid":"901001","filename":"pexels-kindelmedia-76680491.jpeg","filepath":"files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003e\u003cstrong\u003eDecibel Cannabis Company Inc.\u003c/strong\u003e (TSXV:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DB#TSXV\"\u003eDB\u003c/a\u003e) (OTCQB:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/DBCCF#OTCQB\"\u003eDBCCF\u003c/a\u003e) announced its unaudited interim financial results on Thursday for the third quarter ending Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,\" CEO \u003cstrong\u003eBenjamin Sze\u003c/strong\u003e said.\u0026nbsp;\"Maintaining discipline over time will result in a stronger balance sheet.\u0026nbsp; This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40369534/decibel-cannabis-reports-22-yoy-decrease-in-q2-net-revenue-plans-to-benefit-with-new-product-lau\"\u003eDecibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eQ3 Financial Highlights\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eNet revenue totaled CA$24.1 million ($17.2 million), representing a 9% increase sequentially, but a 12% decrease year-over-year.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit before fair value adjustments was CA$12.7 million, compared to roughly CA$12 million in the prior year's period.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross margin before fair value adjustments reached 53% in the third quarter, up from 44% in the prior year's period, reflecting improved operational efficiency.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA was positive at CA$5.1 million, representing a 31% increase from the previous quarter but a 21% decrease year over year.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet loss and comprehensive loss amounted to CA$585 000, compared to a net income and comprehensive income of CA$413 000.\u003c/li\u003e\n\n\n\n\u003cli\u003eGenerated positive free cash flow of $1.8 million, up 75% year-over-year.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003eThe company said that it's seeing significant demand for its flower internationally as it continues to integrate\u003cstrong\u003e \u003c/strong\u003eAgMedica.\u003c/p\u003e\n\n\n\n\u003cp\u003eDecibel \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41600492/decibel-acquires-agmedica-announces-private-placement-and-third-quarter-guidance\"\u003eclosed the acquisition\u003c/a\u003e of \u003cstrong\u003eAgMedica Bioscience Ltd\u003c/strong\u003e. in October. The transaction was arranged through an agreement with Callisto Capital Corp. and was made in exchange for a $6.3 million unsecured convertible debenture.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40577591/decibels-10m-strategy-how-it-could-enhance-your-canadian-cannabis-portfolio\"\u003e\u003cstrong\u003eDecibel\u0026#8217;s $10M Strategy: How It Could Enhance Your Canadian Cannabis Portfolio\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eDBCCF Price Action\u003c/h3\u003e\n\n\n\n\u003cp\u003eDecibel's shares traded 5.54% higher at $0.0495 per share after the market close on Thursday afternoon.\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-22T13:54:23Z","createdAt":"2024-11-22T13:54:23Z","id":42137701,"image":"https://www.benzinga.com/files/images/story/2024/11/22/pexels-kindelmedia-76680491.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":10320020,"Industry":"Banks—Regional","IndustryGroupCode":10320,"IndustryGroup":"Banks","SectorCode":103,"Sector":"Financial Services","SuperSectorCode":1,"SuperSector":"Cyclical"},{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":660753,"post_path":"24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53","post_type":"post"}},"nodeId":42137701,"stocks":[{"tid":14243,"vid":2,"name":"DB","description":"Deutsche Bank Ag"},{"tid":769655,"vid":2,"name":"DBCCF","description":"Decibel Cannabis Co"},{"tid":769656,"vid":2,"name":"TSXV:DB"}],"storyId":"67408d03b6cb720001aa1066","tags":[{"tid":945494,"vid":3,"name":"AgMedica"},{"tid":927015,"vid":3,"name":"Benjamin Sze"},{"tid":712759,"vid":3,"name":"Canada Cannabis"},{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":20107,"vid":3,"name":"earnings report"},{"tid":914018,"vid":3,"name":"third quarter financial results"}],"teaser":"Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. \u0026#34;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,\u0026#34; CEO Benjamin Sze said. \u0026#34;Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.\u0026#34;","teaserText":"Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. \u0026#34;Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter,\u0026#34; CEO Benjamin Sze said. \u0026#34;Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower.\u0026#34;","tickers":[{"tid":14243,"vid":2,"name":"DB","description":"Deutsche Bank Ag"},{"tid":769655,"vid":2,"name":"DBCCF","description":"Decibel Cannabis Co"},{"tid":769656,"vid":2,"name":"TSXV:DB"}],"title":"Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%","updated":"2024-11-22T13:54:23Z","updatedAt":"2024-11-22T13:54:23Z","url":"https://www.benzinga.com/24/11/42137701/canadian-cannabis-co-decibel-reports-12-yoy-drop-in-q3-revenue-but-increases-gross-margin-to-53"},{"assets":[{"type":"image","title":"cannabis, stock market, trading, earnings Business,Cannabis,Leaves,Marijuana,Stock,Exchange,Market,Or,Trading,Analysis","alt":"cannabis, stock market, trading, earnings Business,Cannabis,Leaves,Marijuana,Stock,Exchange,Market,Or,Trading,Analysis","source":"Photo: Courtesy of C.Aphirak via Shutterstock","mime":"","primary":true,"attributes":{"fid":"900867","filename":"cannabis--stock-market--trading--earning.jpeg","filepath":"files/images/story/2024/11/21/cannabis--stock-market--trading--earning.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Patricio Liddle","body":"\u003cp\u003e\u003cstrong\u003eInnocan Pharma Corporation \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/INNPF#OTC\"\u003eINNPF\u003c/a\u003e), an Israel-based \u003ca href=\"http://benzinga.com/cannabis\"\u003ecannabinoids-focused\u003c/a\u003e pharmaceutical company, reported a 174% year-over-year revenue growth, reaching $24 million for the first nine months of 2024. Quarterly revenues rose 111% YoY to $8.6 million, driven by robust sales from its subsidiary, \u003cstrong\u003eBI Sky Global Ltd.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch4 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 2024 Financial Highlights\u003c/strong\u003e\u003c/h4\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eRevenue was $8.6 million for the third quarter\u003c/strong\u003e, up 111% year-over-year, and $24 million for the nine-month period, up 174% year-over-year.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eNet income was $0.3 million\u003c/strong\u003e, an increase of $2.1 million compared to a net loss of $1.8 million in Q3 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eAdjusted EBITDA \u003c/strong\u003ewas not stated in the press release.\u003c/li\u003e\n\n\n\n\u003cli\u003e\u003cstrong\u003eGross profit was $7.8 million for the third quarter\u003c/strong\u003e, up 112% year-over-year.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eGross profit surged 183% YoY for the nine-month period\u003c/strong\u003e, totaling $21.8 million, while Q3 gross profit grew 112% to $7.8 million. Operating profit turned positive, reaching $0.4 million, reversing a $1.2 million loss in Q3 2023.\u0026nbsp;\u003c/p\u003e\n\n\n\n\u003cp\u003eNet profit also improved significantly, increasing by $2.1 million to $0.3 million for the quarter.\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga\u0026#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003c/em\u003e\u003c/strong\u003e\u003ca href=\"https://newsletteremail.benzinga.com/subscribe\"\u003e\u003cstrong\u003e\u003cem\u003ehere\u003c/em\u003e\u003c/strong\u003e\u003c/a\u003e\u003cstrong\u003e\u003cem\u003e. If you\u0026#8217;re serious about the business, you can\u0026#8217;t afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eManagement Commentary\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eIris Bincovich\u003c/strong\u003e, Innocan's CEO, attributed the strong performance to the company's dual focus on pharmaceutical innovation and wellness. She highlighted the company's progress in developing LPT-CBD, a proprietary non-opioid chronic pain management solution targeting both human and animal care. \"Innocan is bringing strong value for shareholders,\" Bincovich \u003ca href=\"https://www.newswire.ca/news-releases/innocan-pharma-reports-third-quarter-2024-financial-results-849241974.html\"\u003esaid\u003c/a\u003e, emphasizing the company's commitment to addressing chronic pain.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003c/strong\u003e\u003ca href=\"https://www.benzinga.com/general/market-summary/24/11/42049450/can-trumps-return-save-the-cannabis-sector-debt-mounts-as-giants-face-post-election-reckoning\"\u003e\u003cstrong\u003eCan Trump\u0026#8217;s Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning\u003c/strong\u003e\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRoni Kamhi\u003c/strong\u003e, of BI Sky Global and COO of Innocan Pharma, highlighted the company\u0026#8217;s consistent growth. \u0026#8220;We are pleased to report nine consecutive quarters of continuous revenue growth,\u0026#8221; he stated. He credited new product launches and enhanced brand awareness for the success.\u003c/p\u003e\n\n\n\n\u003cp\u003eInnocan's financial gains underscore its strategic focus on innovation and market expansion, positioning the company as a rising player in the pharmaceutical sector. The company's results signal ongoing growth potential amid increasing demand for non-opioid pain management solutions.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders\"\u003e\u003cstrong\u003eEnveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-21T20:49:09Z","createdAt":"2024-11-21T20:49:09Z","id":42122829,"image":"https://www.benzinga.com/files/images/story/2024/11/21/cannabis--stock-market--trading--earning.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":659381,"post_path":"24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth","post_type":"post"}},"nodeId":42122829,"stocks":[{"tid":737819,"vid":2,"name":"INNPF","primary":true}],"storyId":"673f9cc13f4e8b0001bb2330","tags":[{"tid":893158,"vid":3,"name":"BI Sky Global"},{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":725960,"vid":3,"name":"Israel Cannabis"}],"teaser":"Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.","teaserText":"Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd.","tickers":[{"tid":737819,"vid":2,"name":"INNPF","primary":true}],"title":"Cannabinoid Leader Innocan Pharma\u0026#39;s Q3: 174% YoY Revenue Growth","updated":"2024-11-21T20:49:09Z","updatedAt":"2024-11-21T20:49:09Z","url":"https://www.benzinga.com/24/11/42122829/cannabinoid-leader-innocan-pharma-reports-174-yoy-revenue-growth"},{"assets":[{"type":"image","title":"elsa-olofsson-ZYEk3w9q2DM-unsplash(3)","alt":"Cannabis earnings","source":"Photo: Courtesy of Elsa Olofsson on Unsplash","mime":"","primary":true,"attributes":{"fid":"900715","filename":"elsa-olofsson-ZYEk3w9q2DM-unsplash3.jpeg","filepath":"files/images/story/2024/11/21/elsa-olofsson-ZYEk3w9q2DM-unsplash3.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003eCannabis operator with vertical operations in Arizona and Ohio \u003cstrong\u003eVext Science, Inc\u003c/strong\u003e. (CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VEXT#CSE\"\u003eVEXT\u003c/a\u003e) (OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VEXTF#OTCQX\"\u003eVEXTF\u003c/a\u003e) reported on its financial results Thursday for the period ended Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;Vext\u0026#8217;s performance in the third quarter of 2024 was a testament to the team\u0026#8217;s disciplined execution amid persistent macroeconomic headwinds,\"\u003cstrong\u003e Eric Offenberger, \u003c/strong\u003eCEO of Vext, said. \"Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we\u0026#8217;re pleased to report that our economic unit volumes remain strong.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40463152/vext-cannabis-co-s-q2-revenue-drops-over-8-yoy-but-top-cannabis-analyst-sees-ohio-market-as-majo\"\u003eVext Cannabis Co.\u0026#8217;s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eQ3 2024 Financial Highlights\u003c/h3\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eRevenue totaled roughly $9 million, up from $8 million in the prior year's period.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit was $3.9 million, up from $2.8 million in the third quarter of last year.\u003c/li\u003e\n\n\n\n\u003cli\u003eTotal operating expenses amounted to $5.2 million, up from $4.5 million in the corresponding quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA amounted to approximately $2.9 million, up from $1 million in the third quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet loss was $2.5 million, up from $1.8 million in the prior year's period.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003eOutlook\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe company noted that it's well-positioned to increase its Ohio footprint with an integrated approach.\u003c/p\u003e\n\n\n\n\u003cp\u003eVext aims to open more dispensaries in Ohio by 2025–2026, anticipating reaching the state's dispensary cap of 8.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003ePablo Zuanic,\u003c/strong\u003e senior analyst at Zuanic \u0026amp; Associates initiated coverage of Vext Science with an Overweight rating earlier this year, highlighting the company\u0026#8217;s significant growth potential.\u003c/p\u003e\n\n\n\n\u003cp\u003eZuanic calculated that Vext has the most EBITDA torque among the twelve public multi-state operators (MSOs) in Ohio, projecting Vext\u0026#8217;s EBITDA could grow six-fold by calendar 2026, taking calendar 2023 as the base year. Recreational marijuana sales launched across Ohio on \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40172821/its-official-ohio-begins-recreational-cannabis-sales-on-tuesday-heres-where-and-how-you-know-the\"\u003eTuesday, Aug. 6.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/09/40761882/1b-in-26-days-this-marijuana-company-is-capitalizing-on-ohios-cannabis-surge\"\u003e\u003cstrong\u003e$1B In 26 Days: This Marijuana Company Is Capitalizing On Ohio's Cannabis Surge\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"},{"tid":30777,"vid":1,"name":"Retail Sales"}],"created":"2024-11-21T15:28:36Z","createdAt":"2024-11-21T15:28:36Z","id":42115532,"image":"https://www.benzinga.com/files/images/story/2024/11/21/elsa-olofsson-ZYEk3w9q2DM-unsplash3.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":658799,"post_path":"24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda","post_type":"post"}},"nodeId":42115532,"stocks":[{"tid":761042,"vid":2,"name":"CSE:VEXT","primary":true},{"tid":761043,"vid":2,"name":"VEXTF","primary":true}],"storyId":"673f51a13f4e8b0001bb05ed","tags":[{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":20107,"vid":3,"name":"earnings report"},{"tid":804604,"vid":3,"name":"Eric Offenberger"},{"tid":154491,"vid":3,"name":"Pablo Zuanic"},{"tid":914018,"vid":3,"name":"third quarter financial results"}],"teaser":"Cannabis operator with vertical operations in Arizona and Ohio Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Thursday its financial results for the period ended Sept. 30, 2024. \u0026#34;Vext\u0026#39;s performance in the third quarter of 2024 was a testament to the team\u0026#39;s disciplined execution amid persistent macroeconomic headwinds,\u0026#34; Eric Offenberger, CEO of Vext, said. \u0026#34;Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we\u0026#39;re pleased to report that our economic unit volumes remain strong.\u0026#34;","teaserText":"Cannabis operator with vertical operations in Arizona and Ohio Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported on Thursday its financial results for the period ended Sept. 30, 2024. \u0026#34;Vext\u0026#39;s performance in the third quarter of 2024 was a testament to the team\u0026#39;s disciplined execution amid persistent macroeconomic headwinds,\u0026#34; Eric Offenberger, CEO of Vext, said. \u0026#34;Our solid Adjusted EBITDA results reflect both the transition to adult-use sales in Ohio, as well as our focus on maintaining strict cost control. Despite a challenging economic climate and typical third-quarter seasonality and pricing pressures in the Arizona market with the ongoing supply-demand imbalance, we\u0026#39;re pleased to report that our economic unit volumes remain strong.\u0026#34;","tickers":[{"tid":761042,"vid":2,"name":"CSE:VEXT","primary":true},{"tid":761043,"vid":2,"name":"VEXTF","primary":true}],"title":"Ohio\u0026#39;s Weed Enthusiasts Help This Cannabis Company\u0026#39;s Bottom Line: 165% YoY Increase In Q3 Adjusted EBITDA","updated":"2024-11-21T15:28:37Z","updatedAt":"2024-11-21T15:28:37Z","url":"https://www.benzinga.com/24/11/42115532/this-cannabis-co-is-capitalizing-on-ohios-recreational-sales-reports-165-yoy-increase-in-q3-adjusted-ebitda"},{"assets":[{"type":"image","title":"Enveric drug for mental health disorders","alt":"Enveric drug for mental health disorders","source":"","mime":"","primary":true,"attributes":{"fid":"899739","filename":"Enveric-drug-for-mental-health-disorders.jpeg","filepath":"files/images/story/2024/11/18/Enveric-drug-for-mental-health-disorders.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","body":"\u003cp\u003ePsychedelics biotech company \u003cstrong\u003eEnveric Biosciences \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/ENVB#NASDAQ\"\u003eENVB\u003c/a\u003e) provided a corporate update and reported financial results for the third quarter ended Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"The third quarter of 2024 was highlighted by important progress in the development of EB-003, our neuroplastogenic molecule that is designed to address difficult-to-treat mental health disorders without inducing the hallucinogenic effect common to N,N-Dimethyltryptamine (DMT) and related analogs,\" stated \u003cstrong\u003eJoseph Tucker\u003c/strong\u003e, Ph.D., director and CEO of Enveric. \"Among the key achievements, data confirmed that EB-003 has the potential \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/07/39955483/non-hallucinogenic-psychedelic-treatment-for-mental-health-disorders-shows-potential-to-be-dosed\"\u003eto be delivered via oral administration\u003c/a\u003e and penetrate the brain at levels expected to elicit the desired therapeutic effect. Additionally, preclinical safety and pharmacology studies confirmed that EB-003 targets desired serotonergic receptors while minimizing potentially harmful, off-target interactions common to serotonin-like drug compounds. These are clear differentiators for EB-003, which we believe will add to its value potential.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eTucker says that \"drug technologies that minimize or eliminate the hallucinogenic effect in molecules targeting the 5-HT2A receptor have the potential to become the gold standard in one or more neuropsychiatric indications.\" The company plans to submit an EB-003 Investigational New Drug (IND) application to the U.S. Food and Drug Administration in the second half of 2025.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also:\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/11/41901157/enveric-biosciences-out-licenses-key-program-to-mycomedica-in-62m-deal\"\u003eEnveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 Financial Highlights\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eNet loss attributable to stockholders was $2.1 million\u003c/strong\u003e, including $500,000 in net non-cash expense, with a basic and diluted loss per share of $0.24, as compared to a net loss of $2.8 million, including $0.2 million in net non-cash income, with a basic and diluted loss per share of $1.30 for the quarter ended Sept. 30, 2023.\u003c/p\u003e\n\n\n\n\u003cp\u003eTotal operating expenses amounted to $2.08 million, compared to $3.45 million in the same period last year.\u003c/p\u003e\n\n\n\n\u003cp\u003eAt the end of the reporting period on Sept. 30, 2024, Enveric had cash-on-hand of $3.1 million, and accumulated deficit of $102.92 million.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003ca\u003e\u003c/a\u003e In the quarterly \u003ca href=\"https://www.sec.gov/ix?doc=/Archives/edgar/data/890821/000149315224045859/form10-q.htm\"\u003ereport\u003c/a\u003e filed with the SEC, Enveric noted that \"further losses are anticipated in the development of its business. Being a research and development company, since inception, the company has not yet generated revenue and the company has incurred continuing losses from its operations. The company's operations have been funded principally through the issuance of equity. These factors raise substantial doubt about the company's ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.\"\u003c/p\u003e\n\n\n\n\u003cp\u003eTo continue as a going concern, Enveric needs to raise additional capital.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe company had cash-on-hand of $3.1 million for the quarter ended September 30, 2024.\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eCorporate, Product and Business Development Highlights\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eConfirmed oral bioavailability and significant brain exposure in preclinical studies of EB-003, supporting expedited development with IND filing and first patient dosed expected in 2025\u003c/li\u003e\n\n\n\n\u003cli\u003eAnnounced positive results from preclinical safety and pharmacology studies of EB-003, confirming the drug's selective activity with desired serotonergic neuroreceptors and ability to minimize potential adverse cardiovascular and CNS events\u003c/li\u003e\n\n\n\n\u003cli\u003ePresented foundational research involving EB-003 at the 7th Neuropsychiatric Drug Summit and the European Behavioral Pharmacology Society Biennial Workshop\u003c/li\u003e\n\n\n\n\u003cli\u003eStrengthened intellectual property estate for EVM301 portfolio and announced the issuance of five additional U.S. patents\u003c/li\u003e\n\n\n\n\u003cli\u003eExecuted licensing agreement with Aries Science \u0026amp; Technology to clinically develop and market Enveric's patented product for radiation dermatitis\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eEnveric Biosciences shares closed Friday market session 8.06% lower at 37 cents per share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/general/biotech/24/11/41714040/enveric-biosciences-expands-mental-health-patent-portfolio-with-5-new-additions\"\u003e\u003cstrong\u003eEnveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto created with AI\u003c/em\u003e\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"},{"tid":748887,"vid":1,"name":"Psychedelics","description":"Coverage of Psychedelics."}],"created":"2024-11-18T15:06:29Z","createdAt":"2024-11-18T15:06:29Z","id":42039385,"image":"https://www.benzinga.com/files/images/story/2024/11/18/Enveric-drug-for-mental-health-disorders.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":2834,"Industry":"Pharmaceutical Preparations","IndustryGroup":283,"MajorGroup":28,"Division":""}],"NAICS":[{"NationalIndustryCode":541714,"NationalIndustry":"Research and Development in Biotechnology (except Nanobiotechnology)","IndustryCode":54171,"Industry":"Research and Development in the Physical, Engineering, and Life Sciences","IndustryGroupCode":5417,"IndustryGroup":"Scientific Research and Development Services","SubSectorCode":541,"SubSector":"Professional, Scientific, and Technical Services","SectorCode":54,"Sector":"Professional, Scientific, and Technical Services"}],"Morningstar":[{"IndustryCode":20610010,"Industry":"Biotechnology","IndustryGroupCode":20610,"IndustryGroup":"Biotechnology","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":652349,"post_path":"news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders","post_type":"post"}},"nodeId":42039385,"stocks":[{"tid":788535,"vid":2,"name":"ENVB","description":"Enveric Biosciences, Inc. - Common Stock","primary":true}],"storyId":"673b57f1d149ec00010e8434","tags":[{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":794954,"vid":3,"name":"Joseph Tucker"},{"tid":28340,"vid":3,"name":"premium"},{"tid":827425,"vid":3,"name":"Psychedelics earnings"}],"teaser":" ","teaserText":" ","tickers":[{"tid":788535,"vid":2,"name":"ENVB","description":"Enveric Biosciences, Inc. - Common Stock","primary":true}],"title":"Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders","updated":"2024-11-18T15:06:29Z","updatedAt":"2024-11-18T15:06:29Z","url":"https://www.benzinga.com/news/earnings/24/11/42039385/enveric-biosciences-trims-losses-eyes-key-drug-approval-for-difficult-to-treat-mental-health-disorders"},{"assets":[{"type":"image","title":"cannabis money, cannabis earnings, marijuana money, buds, money","alt":"cannabis money, cannabis earnings, marijuana money, buds, money","source":"Photo: Courtesy of SD_FlowerPower via Shutterstock ","mime":"","primary":true,"attributes":{"fid":"899709","filename":"cannabis-money--cannabis-earnings--marij.jpeg","filepath":"files/images/story/2024/11/18/cannabis-money--cannabis-earnings--marij.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","body":"\u003cp\u003e\u003cstrong\u003eGreenlane Holdings, Inc. \u003c/strong\u003e(NASDAQ:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GNLN#NASDAQ\"\u003eGNLN\u003c/a\u003e) reported its financial results for the third quarter ended Sept. 30, 2024, \u003cstrong\u003edisclosing revenue of \u003c/strong\u003e\u003cstrong\u003e$4 million compared to $11.8 million in the prior year period.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eThe Florida-based cannabis company noted that beginning with its second quarter 2023 earnings release, it implemented a major restructuring of its industrial product lines, transitioning much of this business from gross sales to a commission structure. This change affects how Greenlane reports revenue and enables it to preserve working capital and improve gross margins.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u0026#8220;During the third quarter, we continued to make progress on strengthening our product strategy and roadmap, enhancing our sales team structure and compensation arrangement, and further extracting operating efficiencies across the enterprise,\u0026#8221; stated CEO \u003cstrong\u003eBarbara Sher\u003c/strong\u003e \u0026#8220;We continue to see evidence that our efforts to reposition the business over the last six months have been proving successful. As we enter the next phase of our transformation, we are evolving our product portfolio with the addition of health, safety and wellness products that we believe can broaden our market opportunities and grow revenue.\u0026#8221;\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/24/11/42016079/cannabis-co-grown-rogue-reports-7-increase-in-q3-revenue-focuses-on-new-jersey-and-illinois-expansion\"\u003eCannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 Financial Highlights\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eGross margin percentage increased 48.4% to 75%.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit amounted to $3.03 million, compared to $3.13 million in the same period last year.\u003c/li\u003e\n\n\n\n\u003cli\u003eTotal operating expenses were $3.6 million, a decrease of 64% compared to $10.0 million in the prior year period.\u003c/li\u003e\n\n\n\n\u003cli\u003eOperating loss improved by approximately $6.3 million to $538,000 compared to an operating loss of approximately $6.9 million in the prior year period.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eNet loss was $3.8 million, which included a $3.2 million one-time non-cash charge for interest expense in connection with various merchant cash advances, compared to a net loss of $10.1 million in the prior year period.\u003c/li\u003e\n\n\n\n\u003cli\u003eAs of September 30, 2024, the company had cash and cash equivalents of approximately $2.3 million.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRecent Milestones\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eIn August, Greenlane \u003cstrong\u003eentered into a securities purchase agreement with a large institutional investor for gross \u003c/strong\u003e\u003cstrong\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40346607/greenlane-to-raise-6-5m-through-private-investment-deal-with-large-institutional-investor\"\u003e\u003cstrong\u003ecash proceeds of $6.5 million\u003c/strong\u003e\u003c/a\u003e\u003c/strong\u003e\u003cstrong\u003e.\u003c/strong\u003e Under the agreement, the vendor of cannabis accessories and vaporization products \u003cstrong\u003eissue\u003c/strong\u003e\u003cstrong\u003ed\u003c/strong\u003e\u003cstrong\u003e 3.36 million units.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003eEarlier the same month, the company announced plans to distribute Safety Strips, Inc.'s fentanyl, xylazine and drink spike detection test strips across the U.S. The company's Safety Strips Fentanyl Test Strip (FTS) ISO 13485 validated product can detect potent synthetic opioids, including 3-methyl Fentanyl, Acetyl Fentanyl, Butyryl Fentanyl, Carfentanil, Fentanyl, Furanyl Fentanyl, Ocfentanil, Remifentanil, Sufentanil, Valeryl Fentanyl, and p-Fluoro Fentanyl. The announcement caused Greenlane\u0026#8217;s \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40318873/greenlane-stock-skyrockets-on-plans-to-distribute-high-sensitivity-test-strips-to-tackle-opiate-\"\u003e\u003cstrong\u003eshares t\u003c/strong\u003e\u003cstrong\u003eo jump \u003c/strong\u003e\u003cstrong\u003e244.40%\u003c/strong\u003e\u003c/a\u003e\u003cstrong\u003e.\u003c/strong\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eGreenlane shares closed Friday market session 6.70% lower at $1.95 per share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/news/earnings/24/11/42015700/avicanna-reduces-net-loss-and-improves-gross-profit-focusing-on-international-markets\"\u003e\u003cstrong\u003eAvicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of SD_FlowerPower via Shutterstock\u003c/em\u003e\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-18T13:58:20Z","createdAt":"2024-11-18T13:58:20Z","id":42036290,"image":"https://www.benzinga.com/files/images/story/2024/11/18/cannabis-money--cannabis-earnings--marij.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":132,"Industry":"Tobacco","IndustryGroup":132,"MajorGroup":13,"Division":""}],"NAICS":[{"NationalIndustryCode":111910,"NationalIndustry":"Tobacco Farming","IndustryCode":11191,"Industry":"Tobacco Farming","IndustryGroupCode":1119,"IndustryGroup":"Other Crop Farming","SubSectorCode":111,"SubSector":"Crop Production","SectorCode":11,"Sector":"Agriculture, Forestry, Fishing and Hunting"}],"Morningstar":[{"IndustryCode":20560010,"Industry":"Tobacco","IndustryGroupCode":20560,"IndustryGroup":"Tobacco Products","SectorCode":205,"Sector":"Consumer Defensive","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":652327,"post_path":"news/earnings/24/11/42036290/greenlane-cuts-q3-net-loss-despite-66-revenue-drop-shifts-product-strategy","post_type":"post"}},"nodeId":42036290,"stocks":[{"tid":741912,"vid":2,"name":"GNLN","primary":true}],"storyId":"673b47f4d149ec00010e780a","tags":[{"tid":934130,"vid":3,"name":"Barbara Sher"},{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":28340,"vid":3,"name":"premium"}],"teaser":" ","teaserText":" ","tickers":[{"tid":741912,"vid":2,"name":"GNLN","primary":true}],"title":"Greenlane Cuts Q3 Net Loss Despite 66% Revenue Drop, Shifts Product Strategy","updated":"2024-11-18T13:58:20Z","updatedAt":"2024-11-18T13:58:20Z","url":"https://www.benzinga.com/news/earnings/24/11/42036290/greenlane-cuts-q3-net-loss-despite-66-revenue-drop-shifts-product-strategy"},{"assets":[{"type":"image","title":"finance and marijuana (Kindel Media by Pexels)(4)","alt":"Cannabis earnings","source":"Photo: Courtesy of Kindel Media by Pexels","mime":"","primary":true,"attributes":{"fid":"899455","filename":"finance-and-marijuana-Kindel-Media-by-Pe.jpeg","filepath":"files/images/story/2024/11/15/finance-and-marijuana-Kindel-Media-by-Pe.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Jelena Martinovic","body":"\u003cp\u003e\u003cstrong\u003eGrown Rogue International Inc. \u003c/strong\u003e(CSE:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GRIN#CSE\"\u003eGRIN\u003c/a\u003e) (OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/GRUSF#OTC\"\u003eGRUSF\u003c/a\u003e) reported its third quarter 2024 results on Thursday for the three months ended Sept. 30, 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"This was another exciting quarter for Grown Rogue with solid financial metrics showing the continued execution by our team in competitive markets against a backdrop of modest price compression,\" CEO \u003cstrong\u003eObie Strickler\u003c/strong\u003e said. \"We continue to see strong indoor production yields of craft-quality flower, retail buyer and consumer loyalty, and great initial reception and sell-through with our branded pre-rolls, including our newest brand Yeti.\"\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 2024 Financial Highlights\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eThe comparison period for 2023 is the three months ended Oct. 31, 2023, due to the fiscal year-end change from Oct. 31 to Dec. 31. \u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eRevenue totaled $7 million, up 7% compared to $6.5 million in the fourth quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eGross profit amounted to $3.9 million, a decrease from $4.4 million in Q4 2023, primarily due to lower margins in Oregon and pricing pressures.\u003c/li\u003e\n\n\n\n\u003cli\u003eAdjusted EBITDA was positive at $2.1 million, unchanged from the previous quarter. Its margin was 30%, down 210 basis points from the fourth quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eOperating cash flow was $1.21 million, down 24% from $1.5 million in the fourth quarter of 2023. The decrease was attributed to increased spending on the New Jersey market launch.\u003c/li\u003e\n\n\n\n\u003cli\u003eOperating expenses increased by 35% to $2.95 million due to higher selling, general and administrative expenses.\u003c/li\u003e\n\n\n\n\u003cli\u003eThe net loss was $667,240, an improvement from the $2.01 million recorded in the same period last year.\u003c/li\u003e\n\n\n\n\u003cli\u003eCash and cash equivalents totaled $5.6 million, down from $6.8 million as of Dec. 31, 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003ePositive cash flow of $5.01 million for the quarter.\u003c/li\u003e\n\n\n\n\u003cli\u003eTotal assets grew to $41.3 million, up from $29.6 million at year-end 2023.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40576446/grown-rogue-cannabis-reports-record-q2-revenue-and-adjusted-ebitda-nj-and-illinois-major-growth-\"\u003eGrown Rogue Cannabis Reports Record Q2 Revenue And Adjusted EBITDA, NJ And Illinois Major Growth Drivers\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e\u003cem\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/em\u003e\u003c/strong\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eOther Business Highlights\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eIn New Jersey, Grown Rogue announced competition of the company's first harvest in the state, with product drops expected in Dec. 2024. The company is optimistic about generating significant cash flow from this market.\u003c/p\u003e\n\n\n\n\u003cp\u003eIt also announced the commencement of phase I operations in the Garden State, which includes roughly 8,000 square feet of flowering canopy that will produce 500-600 pounds of whole flower per month with sales anticipated in the fourth quarter of 2024.\u003c/p\u003e\n\n\n\n\u003cp\u003eIn Illinois, phase II construction is progressing, with a target of 1,100 pounds of whole flower production per month once completed in mid-2025.\u003c/p\u003e\n\n\n\n\u003cp\u003eSubsequent to quarter-end, the company announced the termination of an advisory agreement with \u003cstrong\u003eVireo Growth Inc. \u003c/strong\u003e(OTC:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/VREOF#OTC\"\u003eVREOF\u003c/a\u003e).\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eOutlook\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eGrown Rogue said it will focus on its New Jersey and Illinois expansions as primary growth drivers for 2025.\u003c/p\u003e\n\n\n\n\u003cp\u003eAdditionally, Phase II of the New Jersey operation is expected to be completed by mid-2025, with the Illinois project following later in the year.\u003c/p\u003e\n\n\n\n\u003ch3 class=\"wp-block-heading\"\u003e\u003cstrong\u003eGRUSF Price Action\u003c/strong\u003e\u003c/h3\u003e\n\n\n\n\u003cp\u003eGrown Rogue's shares traded 2.94% higher at 7 cents per share after the market close on Thursday afternoon.\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/markets/cannabis/24/10/41284994/grown-rogue-secures-800k-vireo-forfeits-4-5m-warrants-in-cannabis-shakeup-whats-next-for-both\"\u003e\u003cstrong\u003eGrown Rogue Secures $800K, Vireo Forfeits 4.5M Warrants In Cannabis Shakeup—What\u0026#8217;s Next For Both?\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-15T18:33:39Z","createdAt":"2024-11-15T18:33:39Z","id":42016079,"image":"https://www.benzinga.com/files/images/story/2024/11/15/finance-and-marijuana-Kindel-Media-by-Pe.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325412,"NationalIndustry":"Pharmaceutical Preparation Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":false},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":649901,"post_path":"24/11/42016079/cannabis-co-grown-rogue-reports-7-increase-in-q3-revenue-focuses-on-new-jersey-and-illinois-expansion","post_type":"post"}},"nodeId":42016079,"stocks":[{"tid":740215,"vid":2,"name":"CSE:GRIN"},{"tid":723515,"vid":2,"name":"GRIN","description":"Grindrod Shipping Holdings Ltd Ordinary Shares"},{"tid":745779,"vid":2,"name":"GRUSF"},{"tid":744818,"vid":2,"name":"VREOF"}],"storyId":"673793ffd149ec00010e2989","tags":[{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":20107,"vid":3,"name":"earnings report"},{"tid":726937,"vid":3,"name":"New Jersey Cannabis"},{"tid":745130,"vid":3,"name":"Obie Strickler"},{"tid":914018,"vid":3,"name":"third quarter financial results"}],"teaser":"Cannabis company Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its third quarter 2024 results for the three months ended Sept. 30, 2024. \u0026#34;This was another exciting quarter for Grown Rogue with solid financial metrics showing the continued execution by our team in competitive markets against a backdrop of modest price compression,\u0026#34; Obie Strickler, CEO of Grown Rogue, said. \u0026#34;We continue to see strong indoor production yields of craft-quality flower, retail buyer and consumer loyalty, and great initial reception and sell-through with our branded pre-rolls, including our newest brand Yeti\u0026#34;.","teaserText":"Cannabis company Grown Rogue International Inc. (CSE: GRIN) (OTC: GRUSF) reported on Thursday its third quarter 2024 results for the three months ended Sept. 30, 2024. \u0026#34;This was another exciting quarter for Grown Rogue with solid financial metrics showing the continued execution by our team in competitive markets against a backdrop of modest price compression,\u0026#34; Obie Strickler, CEO of Grown Rogue, said. \u0026#34;We continue to see strong indoor production yields of craft-quality flower, retail buyer and consumer loyalty, and great initial reception and sell-through with our branded pre-rolls, including our newest brand Yeti\u0026#34;.","tickers":[{"tid":740215,"vid":2,"name":"CSE:GRIN"},{"tid":723515,"vid":2,"name":"GRIN","description":"Grindrod Shipping Holdings Ltd Ordinary Shares"},{"tid":745779,"vid":2,"name":"GRUSF"},{"tid":744818,"vid":2,"name":"VREOF"}],"title":"Cannabis Co. Grown Rogue Reports 7% Increase In Q3 Revenue, Focuses On New Jersey And Illinois Expansion","updated":"2024-11-15T18:33:39Z","updatedAt":"2024-11-15T18:33:39Z","url":"https://www.benzinga.com/24/11/42016079/cannabis-co-grown-rogue-reports-7-increase-in-q3-revenue-focuses-on-new-jersey-and-illinois-expansion"},{"assets":[{"type":"image","title":"avcn-pr-q3-rsults-2024-linkedin-x-q3-2024nov14","alt":"avcn-pr-q3-rsults-2024-linkedin-x-q3-2024nov14","source":"","mime":"","primary":true,"attributes":{"fid":"899446","filename":"avcn-pr-q3-rsults-2024-linkedin-x-q3-202.jpeg","filepath":"files/images/story/2024/11/15/avcn-pr-q3-rsults-2024-linkedin-x-q3-202.jpeg","filesize":0,"image_attributes":{"resolution":{"height":0,"width":0,"dpi":0}}}}],"author":"Nina Zdinjak","body":"\u003cp\u003e\u003cstrong\u003eAvicanna Inc. \u003c/strong\u003e(OTCQX:\u003ca class=\"ticker\" href=\"https://www.benzinga.com/stock/AVCNF#OTCQX\"\u003eAVCNF\u003c/a\u003e) announced its financial results Thursday for the third quarter, disclosing\u003cstrong\u003e revenue of CA$6.27 million ($4.49 million), compared to CA$6.25 million \u003c/strong\u003ein the same period last year. The Toronto-based cannabis company also reported improved consolidated gross margin to 57% from 46% for the same period in 2023.\u003c/p\u003e\n\n\n\n\u003cp\u003e\"We are pleased to report the results of another quarter showing progressive improvements across our four business pillars,\" stated CEO \u003cstrong\u003eAras Azadian\u003c/strong\u003e. \"Our continuous optimization efforts contributed to improvements in our overall financial performance, consolidated gross margins, and balance sheet. We are now better positioned to turn our attention towards our international growth initiatives and take further steps towards advancing our long-term business model.\"\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Also: \u003ca href=\"https://www.benzinga.com/news/earnings/24/11/41998220/agrifys-q3-revenue-drop-18-6m-loss-amid-new-leadership\"\u003eAgrify\u0026#8217;s Q3 Revenue Drop, $18.6M Loss Amid New Leadership\u003c/a\u003e\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eGet Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter \u003ca href=\"https://newsletteremail.benzinga.com/subscribe\" target=\"_blank\" rel=\"noreferrer noopener\"\u003ehere\u003c/a\u003e. If you're serious about the business, you can't afford to miss out.\u003c/strong\u003e\u003c/em\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eQ3 Financial Highlights\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eGross profit was CA$3.7 million compared to CA$2.9 million in the comparable quarter last year.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003eAdjusted EBITDA was a loss of CA$293,931 compared to adjusted EBITDA loss of $473,650 in the corresponding period last year.\u003c/li\u003e\n\n\n\n\u003cli\u003eNet loss amounted to CA$786,388 compared to net loss of CA$1.42 million in the third quarter of 2023.\u003c/li\u003e\n\n\n\n\u003cli\u003eFully repaid outstanding principle balance of approximately CA$1.3 million owed under non-convertible debenture.\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003eRecent Milestones\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003eIn August, the biopharmaceutical company\u0026nbsp;announced \u0026nbsp;the \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40403052/avicannas-cbg-products-reach-19-countries-denmark-joins-global-expansion\"\u003esuccessful export of its Aureus-branded cannabigerol (CBG) products to Denmark\u003c/a\u003e. This marked the 19th international market for Aureus-branded products and the 22nd market overall for Avicanna\u0026#8217;s product range. The export was facilitated through Avicanna's majority-owned subsidiary, Santa Marta Golden Hemp SAS.\u003c/p\u003e\n\n\n\n\u003cp\u003eThe same month, Avicanna \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40628172/avicanna-secures-nearly-2m-in-private-placement-deal-amid-us-patent-win-for-cannabinoid-topical-\"\u003eclosed a non-brokered private placement\u003c/a\u003e offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross proceeds of $1,986,207.\u003c/p\u003e\n\n\n\n\u003cp\u003eThis year also, the company confirmed that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. US 20230025693A1, covering the company\u0026#8217;s deep penetrating topical cannabinoid composition and methods for \u003ca href=\"https://www.benzinga.com/markets/cannabis/24/08/40585810/avicanna-secures-us-patent-for-topical-cannabinoid-technology-to-treat-pain-and-inflammation\" target=\"_blank\" rel=\"noreferrer noopener\"\u003etreating musculoskeletal inflammation and pain.\u003c/a\u003e\u003c/p\u003e\n\n\n\n\u003ch2 class=\"wp-block-heading\"\u003e\u003cstrong\u003ePrice Action\u003c/strong\u003e\u003c/h2\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eAvicanna shares closed Thursday's market session flat at 17 cents a share.\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cp\u003e\u003cstrong\u003eRead Next:\u003c/strong\u003e\u003c/p\u003e\n\n\n\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https://www.benzinga.com/24/11/41992549/cv-sciences-q3-revenue-stable-amid-new-launches-financing\"\u003e\u003cstrong\u003eCV Sciences Q3: Revenue Stable Amid New Launches, Financing\u003c/strong\u003e\u003c/a\u003e\u003c/li\u003e\n\u003c/ul\u003e\n\n\n\n\u003cp\u003e\u003cem\u003ePhoto: Courtesy of Avicanna \u003c/em\u003e\u003c/p\u003e","channels":[{"tid":123430,"vid":1,"name":"Cannabis"},{"tid":16888,"vid":1,"name":"Earnings"},{"tid":57,"vid":1,"name":"News"}],"created":"2024-11-15T18:15:23Z","createdAt":"2024-11-15T18:15:23Z","id":42015700,"image":"https://www.benzinga.com/files/images/story/2024/11/15/avcn-pr-q3-rsults-2024-linkedin-x-q3-202.jpeg","isBzPost":true,"isBzProPost":true,"meta":{"SectorV2":{"SIC":[{"IndustryCode":3741,"Industry":"Pharmaceutical and Medicine Industry","IndustryGroup":374,"MajorGroup":37,"Division":""}],"NAICS":[{"NationalIndustryCode":325411,"NationalIndustry":"Medicinal and Botanical Manufacturing ","IndustryCode":32541,"Industry":"Pharmaceutical and Medicine Manufacturing","IndustryGroupCode":3254,"IndustryGroup":"Pharmaceutical and Medicine Manufacturing","SubSectorCode":325,"SubSector":"Chemical Manufacturing","SectorCode":32,"Sector":"Manufacturing"}],"Morningstar":[{"IndustryCode":20620020,"Industry":"Drug Manufacturers—Specialty \u0026 Generic","IndustryGroupCode":20620,"IndustryGroup":"Drug Manufacturers","SectorCode":206,"Sector":"Healthcare","SuperSectorCode":2,"SuperSector":"Defensive"}]},"Partner":null,"PartnerTaxonomy":null,"SEC":null,"Author":null,"Authors":[{"uid":"0","name":""}],"Flags":{"ShowCopyrightNotice":true,"EvergreenContent":false,"ShowAdvertiserDisclosure":false,"ContributedContent":false,"AddGoogleStandoutMetaTag":false,"MediaSiteDNDOverride":false,"SendToYahooFinance":false,"SendToRobinhood":true,"SendToMSN":true},"Reach":{"Disclosure":{}},"Reference":null,"Ext":null,"wp_post_meta":{"campaign_strategy":"Default","post_id":649963,"post_path":"news/earnings/24/11/42015700/avicanna-reduces-net-loss-and-improves-gross-profit-focusing-on-international-markets","post_type":"post"}},"nodeId":42015700,"stocks":[{"tid":758850,"vid":2,"name":"AVCNF","primary":true}],"storyId":"67378fb7d149ec00010e27fe","tags":[{"tid":691480,"vid":3,"name":"Aras Azadian"},{"tid":734058,"vid":3,"name":"Cannabis Earnings"},{"tid":28340,"vid":3,"name":"premium"}],"teaser":" ","teaserText":" ","tickers":[{"tid":758850,"vid":2,"name":"AVCNF","primary":true}],"title":"Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets","updated":"2024-11-15T18:15:23Z","updatedAt":"2024-11-15T18:15:23Z","url":"https://www.benzinga.com/news/earnings/24/11/42015700/avicanna-reduces-net-loss-and-improves-gross-profit-focusing-on-international-markets"}]},"layout":"default","briefs_type":"briefs","mobileOnly":false,"newsItemElement":"briefs_element","newsContainer":"none","reachContent":null},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36","type":"default"}],"campaigns":{"primary":{"has_targeting":true,"placements":[{"id":316091,"type":"campaign","devices":"all-devices","geo_target":"GLOBAL","multiplier":"2"},{"id":226605,"type":"campaign","devices":"all-devices","geo_target":"GLOBAL","multiplier":"1"}],"campaigns":{"226605":{"cta_title":"Cannabis Coverage Simplified","cta_description":"Budding protection for your cannabis operation.","cta_text":"Get a Quote – Fast!","cta_btn_type":"button","cta_btn_position":"below_image","impression_tag":"","customize_modal_popup":false,"customize_floating_popup":false,"disclosure":"","link_type":"internal","placement_slug":"226605","bzgo_link_id":325097,"bzpartner_id":0,"url":"https://www.benzinga.com/go/carma-cannabis-insurance","go_link_dofollow":0,"utm_action":"::AdvancedCampaign:: `Cannabis/CBD` ::Campaign:: `Carma Cannabis Insurance` ::Title:: `Cannabis Coverage Simplified`","href":"https://www.benzinga.com/go/carma-cannabis-insurance","image_url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/01/02162705/Carma-365.png","product_id":228451},"316091":{"cta_title":"Don't Get Lost in the Weeds","cta_description":"AlphaRoot's cannabis insurance expertise keeps you covered, seed to sale.\r\n","cta_text":"Get a Quote","cta_btn_type":"button","cta_btn_position":"below_image","impression_tag":"","customize_modal_popup":false,"customize_floating_popup":false,"disclosure":"","link_type":"internal","placement_slug":"alpharoot","bzgo_link_id":315757,"bzpartner_id":315732,"url":"https://www.benzinga.com/go/alpharoot","go_link_dofollow":0,"partner":"AlphaRoot","utm_action":"::AdvancedCampaign:: `Cannabis/CBD` ::Campaign:: `Alpharoot` ::Partner:: `AlphaRoot` ::Title:: `Don't Get Lost in the Weeds`","href":"https://www.benzinga.com/go/alpharoot","image_url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/05/24162423/alpharoot-1-Barry-Galvin.png","product_id":315759}},"placeholder_type":"primary"},"secondary":{"has_targeting":true,"placements":[{"id":316091,"type":"campaign","devices":"all-devices","geo_target":"GLOBAL","multiplier":"2"},{"id":226605,"type":"campaign","devices":"all-devices","geo_target":"GLOBAL","multiplier":"1"}],"campaigns":{"226605":{"cta_title":"Cannabis Coverage Simplified","cta_description":"Budding protection for your cannabis operation.","cta_text":"Get a Quote – Fast!","cta_btn_type":"button","cta_btn_position":"below_image","impression_tag":"","customize_modal_popup":false,"customize_floating_popup":false,"disclosure":"","link_type":"internal","placement_slug":"226605","bzgo_link_id":325097,"bzpartner_id":0,"url":"https://www.benzinga.com/go/carma-cannabis-insurance","go_link_dofollow":0,"utm_action":"::AdvancedCampaign:: `Cannabis/CBD` ::Campaign:: `Carma Cannabis Insurance` ::Title:: `Cannabis Coverage Simplified`","href":"https://www.benzinga.com/go/carma-cannabis-insurance","image_url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2023/01/02162705/Carma-365.png","product_id":228451},"316091":{"cta_title":"Don't Get Lost in the Weeds","cta_description":"AlphaRoot's cannabis insurance expertise keeps you covered, seed to sale.\r\n","cta_text":"Get a Quote","cta_btn_type":"button","cta_btn_position":"below_image","impression_tag":"","customize_modal_popup":false,"customize_floating_popup":false,"disclosure":"","link_type":"internal","placement_slug":"alpharoot","bzgo_link_id":315757,"bzpartner_id":315732,"url":"https://www.benzinga.com/go/alpharoot","go_link_dofollow":0,"partner":"AlphaRoot","utm_action":"::AdvancedCampaign:: `Cannabis/CBD` ::Campaign:: `Alpharoot` ::Partner:: `AlphaRoot` ::Title:: `Don't Get Lost in the Weeds`","href":"https://www.benzinga.com/go/alpharoot","image_url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/05/24162423/alpharoot-1-Barry-Galvin.png","product_id":315759}},"placeholder_type":"secondary"},"floating":null,"popup":null,"compare_partners":{"widget":null}},"cornerstone":[],"header":null,"content_header":null,"in_content":null,"in_article_content":null,"sidebar":{"id":54194,"title":"Cannabis Sidebar","type":"sidebar","blocks":[{"blockName":"acf/widget-container","attrs":{"name":"acf/widget-container","data":{"widget":{"ID":233532,"post_author":"27","post_date":"2023-02-22 12:00:39","post_date_gmt":"2023-02-22 17:00:39","post_content":"\u003c!-- wp:acf/newsletter-subscription-box {\"name\":\"acf/newsletter-subscription-box\",\"data\":{\"title\":\"Benzinga Cannabis Daily Newsletter\",\"_title\":\"field_title\",\"form_id\":\"5e65f50d-e5c4-407b-a8e6-c6a1f2cd3858\",\"_form_id\":\"field_form_id\",\"style\":\"solid-box\",\"_style\":\"field_style\",\"mobile_only\":\"0\",\"_mobile_only\":\"field_mobile_only\",\"description\":\"\\u003cdiv class=\\u0022c-message_kit__gutter\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022c-message_kit__gutter__right\\u0022 role=\\u0022presentation\\u0022 data-qa=\\u0022message_content\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022c-message_kit__blocks c-message_kit__blocks\\u002d\\u002drich_text\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022c-message__message_blocks c-message__message_blocks\\u002d\\u002drich_text\\u0022 data-qa=\\u0022message-text\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-block_kit_renderer\\u0022 data-qa=\\u0022block-kit-renderer\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-block_kit_renderer__block_wrapper p-block_kit_renderer__block_wrapper\\u002d\\u002dfirst\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-rich_text_block\\u0022 dir=\\u0022auto\\u0022\\u003e\\r\\n\\u003cdiv class=\\u0022p-rich_text_section\\u0022\\u003e\\r\\n\\u003cp data-pm-slice=\\u00221 1 []\\u0022\\u003eSubscribe to \\u003cstrong\\u003eBenzinga's free daily cannabis newsletter\\u003c/strong\\u003e to get policy and market updates directly in your inbox!\\u003c/p\\u003e\\r\\n\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\\r\\n\\u003c/div\\u003e\",\"_description\":\"field_description\",\"redirect_url\":\"\",\"_redirect_url\":\"redirect_url\",\"utm_label\":\"\",\"_utm_label\":\"field_utm_label\"},\"align\":\"\",\"mode\":\"edit\"} /--\u003e","post_title":"Cannabis Newsletter Subscription Box","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"cannabis-newsletter-subscription-box","to_ping":"","pinged":"","post_modified":"2024-07-26 15:37:26","post_modified_gmt":"2024-07-26 19:37:26","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=233532","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","dynamic":false,"blocks":[{"blockName":"acf/newsletter-subscription-box","attrs":{"name":"acf/newsletter-subscription-box","data":{"title":"Benzinga Cannabis Daily Newsletter","form_id":"5e65f50d-e5c4-407b-a8e6-c6a1f2cd3858","description":"\u003cdiv class=\"c-message_kit__gutter\"\u003e\n\u003cdiv class=\"c-message_kit__gutter__right\" role=\"presentation\" data-qa=\"message_content\"\u003e\n\u003cdiv class=\"c-message_kit__blocks c-message_kit__blocks--rich_text\"\u003e\n\u003cdiv class=\"c-message__message_blocks c-message__message_blocks--rich_text\" data-qa=\"message-text\"\u003e\n\u003cdiv class=\"p-block_kit_renderer\" data-qa=\"block-kit-renderer\"\u003e\n\u003cdiv class=\"p-block_kit_renderer__block_wrapper p-block_kit_renderer__block_wrapper--first\"\u003e\n\u003cdiv class=\"p-rich_text_block\" dir=\"auto\"\u003e\n\u003cdiv class=\"p-rich_text_section\"\u003e\n\u003cp data-pm-slice=\"1 1 []\"\u003eSubscribe to \u003cstrong\u003eBenzinga\u0026#8217;s free daily cannabis newsletter\u003c/strong\u003e to get policy and market updates directly in your inbox!\u003c/p\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n\u003c/div\u003e\n","mobileOnly":false,"style":"solid-box","utm_label":"","redirect_url":""},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"}],"deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"},{"blockName":"acf/advertisement-card","attrs":{"name":"acf/advertisement-card","data":{"title":"Cannabis is evolving – don’t get left behind!","description":"\u003cp\u003e\u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eCurious about what’s next for the industry and how to leverage California’s unique market?\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e \u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003eJoin top executives, policymakers, and investors at the \u003cstrong\u003e\u003ca href=\"https://cannabismarketspotlight.com/california/anaheim-november-12/\"\u003eBenzinga Cannabis Market Spotlight\u003c/a\u003e\u003c/strong\u003e in Anaheim, CA, at the House of Blues on \u003cstrong\u003eNovember 12\u003c/strong\u003e. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!\u003c/p\u003e\n\u003cp\u003e\u003c!-- /wp:paragraph --\u003e \u003c!-- wp:paragraph --\u003e\u003c/p\u003e\n\u003cp\u003e\u003ca href=\"https://cannabismarketspotlight.com/california/anaheim-november-12/\"\u003eGet your tickets now\u003c/a\u003e to secure your spot and avoid last-minute price hikes.\u003c!-- /wp:paragraph --\u003e\u003c/p\u003e\n","image":false,"height":0,"link":"","button_text":"Get tickets now","align":"left"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"},{"blockName":"acf/link-group","attrs":{"name":"acf/link-group","data":{"title":"Cannabis Investor Resources","style":"box","action":"Click","links":[{"title":"Benzinga Cannabis Insider - Our Bi-Weekly Show \u0026 Podcast","url":"https://www.benzinga.com/money/podcast-show/cannabisinsider","list_icon":"fa-file-alt"},{"title":"How to Invest in Marijuana Stocks","url":"https://www.benzinga.com/money/marijuana-stocks/","list_icon":"fa-file-alt"},{"title":"What Brokerages can I use to Purchase Cannabis Stocks?","url":"https://www.benzinga.com/money/best-online-stock-broker-for-beginners/","list_icon":"fa-file-alt"}],"open_in_new_tab":false,"query":null},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"\u003cdiv class=\"bz3-solid-box\"\u003e\u003cdiv class=\"bz3-solid-box-container\"\u003e\u003ch6 class=\"bz3-solid-box-title accent\"\u003eCannabis Investor Resources\u003c/h6\u003e\u003cdiv class=\"bz3-solid-box-link-wrapper\"\u003e\u003cdiv class=\"bz3-solid-box-item\"\u003e\u003ca href=\"https://www.benzinga.com/money/podcast-show/cannabisinsider\" \u003e Benzinga Cannabis Insider - Our Bi-Weekly Show \u0026amp; Podcast \u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"bz3-solid-box-item\"\u003e\u003ca href=\"https://www.benzinga.com/money/marijuana-stocks/\" \u003e How to Invest in Marijuana Stocks \u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"bz3-solid-box-item\"\u003e\u003ca href=\"https://www.benzinga.com/money/best-online-stock-broker-for-beginners/\" \u003e What Brokerages can I use to Purchase Cannabis Stocks? \u003c/a\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cstyle\u003e .bz3-solid-box { color: #fff; margin: 1em auto; border-radius: 2px; border-width: 1px;\n}\n.bz3-solid-box-link-wrapper { font-size: 16px; font-weight: bold;\n}\n.bz3-solid-box .bz3-solid-box-container { background-color: #fff; color: #002d45; border-radius: 4px; border: solid 1px #002d45;\n}\n.bz3-solid-box .bz3-solid-box-container .bz3-solid-box-title { font-size: 1em; background-color: #2d425f; border-bottom: 1px solid #E1EBFA; font-weight: 700; padding: 0.4em 0.6em; text-transform: uppercase; margin: 0;\n}\n.bz3-solid-box .bz3-solid-box-title { text-transform: uppercase; font-weight: 800; font-family: \"Open Sans\",sans-serif; margin-bottom: 0.6em; line-height: 1.2em; font-size: 1.1em;\n}\n.bz3-solid-box .accent { color: white;\n}\n.bz3-solid-box .bz3-solid-box-item { line-height: 1.2em; padding: 0.4em 0.6em; font-weight: 700; font-size: .95em; overflow: hidden; text-overflow: ellipsis;\n}\n.bz3-solid-box .bz3-solid-box-container a { color: #002d45;\n}\n.bz3-solid-box a { color: #fff;\n}\n@media screen and (min-width: 40em) { .bz3-solid-box .bz3-solid-box-item { font-size: .8em; }\n}\n\u003c/style\u003e","deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"},{"blockName":"acf/stock-movers-compact","attrs":{"name":"acf/stock-movers-compact","data":{"title":"Cannabis Movers","title_link":"","tickers":["HMLSF","MJ","MJNE","YOLO","MJUS","ACRZF","APHA","ACB","CTST","CGC","CRON","CURLF","TGODF","GTBIF","GWPH","HEXO","HRVSF","ITHUF","MRMD","MMNFF","OGI","SMG","TLRY","YCBD","GNLN","IIPR","PYX","GMVP","IVITF","TBPMF","BBRRF","CNPOF","XXII","EVVLF","GSRX","CWBHF","CVSI","ACCA","CNBX","FLOOF","CBMJ","GABLF","NABIF","BGRDF","CURR","CPTRF","HERTF","CHOOF","CWWBF","ADVT","IMLFF","KSHB","VREOF","LRSNF","RMHB","HHPHF","IILBF","BHHKF","CLSH","QILFF","MDCL","ALYI","LDSYF","INSY","HZEMF","TRSSF","CADMF","VGWCF","AGEEF","APPB","HSTRF","CANN","VIVO","MMJFF","NOBDF","ACNNF","KALTF","MTEC","NWVCF","ALEAF","EMOR","ISOLF","RGI","CANX","LBUY","SVVTF","AUSAF","NTEC","KBEVF","FUAPF","CAPD","CNGGF","KAYS","RHNMF","RSSFF","GRWG","NCNNF","GEATF","EMHTF","LXRP","SUGR","GGTTF","BLEVF","WDEXF","GLDFF","BLOZF","ACRGF","ALGWF","RIV","PUFXF","JWCAF","VVCIF","EEVVF","HLIX","PKPH","CRLBF","ZYNE","DYMEF","TRPX","ORHOF","MGWFF","LVCNF","ZBISF","CBDY","CNXXF","GENE","BMMJ","NXGWF","CXXIF","CNVCF","CPHRF","HMPPF","ATTBF","KALY","HEMP","PHGRF","KHRNF","FFRMF","MBII","LQSIF","INSHF","SOLCF","BLGVF","SOL","CNTMF","INLB","MGCLF","HRVOF","GBHPF","CBWTF","OILFF","VFF","DRVD","WIZP","RLLRF","SARSF","AHGIF","CBIIF","CANVF","LIBFF","TGIFF","EVIO","ARNA","WRLD","HBOSF","ICNAF","ELLXF","GRNH","HITIF","CVHIF","FNNZF","BUGVF","MPXOF","LVRLF","CBIS","FSDDF","LNLHF","LGGCF","ZLDAF","LXLLF","LHSIF","PMD","NDVAF","LFCOF","LMLLF","VRNDF","PHOT","MXC","FLWPF","BOSQF","FFNTF","UGRO","CANN","CNBS","SNDL","ZDPY","TCNNF","PSDN","AYRWF","LIFD","AAWH","LFLY","MAPS","TLLTF","XTXXF","ayrwf","FFLWF","FFNTF","INCR","FLGC","SSIC","GRAMF","GLASF","GHBWF","AVTBF","LOVFF","CLVR",""],"see_all_link":"/cannabis/stocks/","see_all_text":"See all cannabis stocks","style":"light"},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","symbols":["HMLSF","MJ","MJNE","YOLO","MJUS","ACRZF","APHA","ACB","CTST","CGC","CRON","CURLF","TGODF","GTBIF","GWPH","HEXO","HRVSF","ITHUF","MRMD","MMNFF","OGI","SMG","TLRY","YCBD","GNLN","IIPR","PYX","GMVP","IVITF","TBPMF","BBRRF","CNPOF","XXII","EVVLF","GSRX","CWBHF","CVSI","ACCA","CNBX","FLOOF","CBMJ","GABLF","NABIF","BGRDF","CURR","CPTRF","HERTF","CHOOF","CWWBF","ADVT","IMLFF","KSHB","VREOF","LRSNF","RMHB","HHPHF","IILBF","BHHKF","CLSH","QILFF","MDCL","ALYI","LDSYF","INSY","HZEMF","TRSSF","CADMF","VGWCF","AGEEF","APPB","HSTRF","CANN","VIVO","MMJFF","NOBDF","ACNNF","KALTF","MTEC","NWVCF","ALEAF","EMOR","ISOLF","RGI","CANX","LBUY","SVVTF","AUSAF","NTEC","KBEVF","FUAPF","CAPD","CNGGF","KAYS","RHNMF","RSSFF","GRWG","NCNNF","GEATF","EMHTF","LXRP","SUGR","GGTTF","BLEVF","WDEXF","GLDFF","BLOZF","ACRGF","ALGWF","RIV","PUFXF","JWCAF","VVCIF","EEVVF","HLIX","PKPH","CRLBF","ZYNE","DYMEF","TRPX","ORHOF","MGWFF","LVCNF","ZBISF","CBDY","CNXXF","GENE","BMMJ","NXGWF","CXXIF","CNVCF","CPHRF","HMPPF","ATTBF","KALY","HEMP","PHGRF","KHRNF","FFRMF","MBII","LQSIF","INSHF","SOLCF","BLGVF","SOL","CNTMF","INLB","MGCLF","HRVOF","GBHPF","CBWTF","OILFF","VFF","DRVD","WIZP","RLLRF","SARSF","AHGIF","CBIIF","CANVF","LIBFF","TGIFF","EVIO","ARNA","WRLD","HBOSF","ICNAF","ELLXF","GRNH","HITIF","CVHIF","FNNZF","BUGVF","MPXOF","LVRLF","CBIS","FSDDF","LNLHF","LGGCF","ZLDAF","LXLLF","LHSIF","PMD","NDVAF","LFCOF","LMLLF","VRNDF","PHOT","MXC","FLWPF","BOSQF","FFNTF","UGRO","CANN","CNBS","SNDL","ZDPY","TCNNF","PSDN","AYRWF","LIFD","AAWH","LFLY","MAPS","TLLTF","XTXXF","ayrwf","FFLWF","FFNTF","INCR","FLGC","SSIC","GRAMF","GLASF","GHBWF","AVTBF","LOVFF","CLVR",""],"deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"},{"blockName":"acf/widget-container","attrs":{"name":"acf/widget-container","data":{"widget":{"ID":168314,"post_author":"27","post_date":"2022-02-03 13:08:08","post_date_gmt":"2022-02-03 18:08:08","post_content":"\u003c!-- wp:heading {\"textAlign\":\"center\"} --\u003e\n\u003ch2 class=\"has-text-align-center\"\u003e\u003cstrong\u003eViridian Chart Of The Week\u003c/strong\u003e\u003c/h2\u003e\n\u003c!-- /wp:heading --\u003e\n\n\u003c!-- wp:paragraph --\u003e\n\u003cp\u003e\u003cstrong\u003eThis week's Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance.\u003c/strong\u003e\u003c/p\u003e\n\u003c!-- /wp:paragraph --\u003e\n\n\u003c!-- wp:image {\"id\":320076,\"sizeSlug\":\"full\",\"linkDestination\":\"none\"} --\u003e\n\u003cfigure class=\"wp-block-image size-full\"\u003e\u003cimg src=\"https://www.benzinga.com/wp-content/uploads/2024/06/unnamed20.png\" alt=\"\" class=\"wp-image-320076\"/\u003e\u003c/figure\u003e\n\u003c!-- /wp:image --\u003e","post_title":"Viridian Capital Chart of the Week","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"viridian-capital-chart-of-the-week","to_ping":"","pinged":"","post_modified":"2024-06-24 11:30:16","post_modified_gmt":"2024-06-24 15:30:16","post_content_filtered":"","post_parent":0,"guid":"https://www.benzinga.com/?post_type=widget\u0026#038;p=168314","menu_order":0,"post_type":"widget","post_mime_type":"","comment_count":"0","filter":"raw"}},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":"","dynamic":false,"blocks":[{"blockName":"core/heading","attrs":{"textAlign":"center","data":[]},"innerBlocks":[],"innerHTML":"\n\u003ch2 class=\"has-text-align-center\"\u003e\u003cstrong\u003eViridian Chart Of The Week\u003c/strong\u003e\u003c/h2\u003e\n","tag":"h2","id":"viridian-chart-of-the-week","html":"\u003cstrong\u003eViridian Chart Of The Week\u003c/strong\u003e","deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"},{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003cstrong\u003eThis week's Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance.\u003c/strong\u003e\u003c/p\u003e\n","html":"\u003cstrong\u003eThis week's Viridian Chart of the Week explores the relationship between financial strength and YTD stock performance.\u003c/strong\u003e","tag":"p","deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"},{"blockName":"core/image","attrs":{"id":320076,"sizeSlug":"full","linkDestination":"none","data":[]},"innerBlocks":[],"innerHTML":"\n\u003cfigure class=\"wp-block-image size-full\"\u003e\u003cimg src=\"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20.png\" alt=\"\" class=\"wp-image-320076\"/\u003e\u003c/figure\u003e\n","image":{"image_id":320076,"attachment_id":320076,"title":"unnamed20","caption":null,"sizes":{"original":{"height":714,"width":658,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20.png"},"medium":{"height":300,"width":276,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-276x300.png"},"thumbnail":{"height":150,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-150x150.png"},"Multi Rating Pro Thumbnail":{"height":100,"width":100,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-100x100.png"},"slideshow-img":{"height":600,"width":658,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-658x600.png"},"web-stories-poster-portrait":{"height":714,"width":640,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-640x714.png"},"web-stories-publisher-logo":{"height":96,"width":96,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-96x96.png"},"web-stories-thumbnail":{"height":163,"width":150,"url":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2024/06/24112936/unnamed20-150x163.png"}}},"deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"}],"deviceType":"desktop","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/77.0.3865.90 Safari/537.36"}]},"unmonetized_interstitial":null,"sidebar_placement":null,"left_sidebar":null,"global_footer":{"id":160497,"title":"Advertise With Us","type":"footer","blocks":[{"blockName":"core/paragraph","attrs":{"data":[]},"innerBlocks":[],"innerHTML":"\n\u003cp\u003e\u003cstrong\u003eWant to advertise with us? \u003ca href=\"https://www.benzinga.com/money/advertise-with-us/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eSend us a message\u003c/a\u003e. \u003c/strong\u003e\u003c/p\u003e\n","html":"\u003cstrong\u003eWant to advertise with us? \u003ca href=\"https://www.benzinga.com/money/advertise-with-us/\" target=\"_blank\" rel=\"noreferrer noopener\"\u003eSend us a message\u003c/a\u003e. \u003c/strong\u003e","tag":"p"}]},"content_footer":null,"footer":{"id":62772,"title":"Cannabis Footer","type":"footer","blocks":[{"blockName":"acf/featured-articles","attrs":{"id":"block_5e714fca34d4c","name":"acf/featured-articles","data":{"grid_width":"3 Wide Grid","title":"Check out Weedstock, Benzinga's Free Cannabis Education Academy","header_style":"","title_align":"center","articles":[{"id":11793,"title":"Best Marijuana Penny Stocks Right Now","url":"https://www.benzinga.com/money/marijuana-penny-stocks","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2018/02/02035924/esteban-lopez-346908-1024x683.jpg","description":"Investing in marijuana doesn't have to be expensive. Check out Benzinga's best marijuana penny stocks for 2024: updated daily.","author":{"image":"https://secure.gravatar.com/avatar/0ee0ae4e24a27480d1481bbdd16750a6?s=96\u0026d=mm\u0026r=g","name":"Jacinta Sherris"}},{"id":40031,"title":"How to Invest in Cannabis Stocks","url":"https://www.benzinga.com/money/marijuana-stocks","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/03/10161028/qccpihhdgtw-791x1024.jpg","description":"Learn how to invest in marijuana stocks now. Compare our top recommendations for brokers and find your match to start trading today.","author":{"image":"https://secure.gravatar.com/avatar/9fcc314d33e458d1d57ef6972ca1e52f?s=96\u0026d=mm\u0026r=g","name":"Sarah Horvath"}},{"id":46455,"title":"Does Insurance Cover Medical Marijuana?","url":"https://www.benzinga.com/money/does-insurance-cover-medical-marijuana","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2019/09/17120638/photo-1556928045-16f7f50be0f3.jpeg","description":"With all the laws regarding medical marijuana, it can be hard to be sure whether or not yours is covered. Find medical coverage and alternatives here.","author":{"image":"https://secure.gravatar.com/avatar/09011404b3cfabf3eb535dcf10d88e32?s=96\u0026d=mm\u0026r=g","name":"Kimberly Hayes Taylor"}},{"id":68212,"title":"Best CBD Softgels","url":"https://www.benzinga.com/money/best-cbd-softgels","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/04/30125232/wixvlhw9etw.jpg","description":"CBD softgels are flavorless, convenient and widely available online. Check out the best CBD softgels online in 2024 and try one for yourself!","author":{"image":"https://secure.gravatar.com/avatar/5f4d2946d1382d63630980ba2c61cade?s=96\u0026d=mm\u0026r=g","name":"Besty Kuecker"}},{"id":45890,"title":"Cannabis Business Insurance","url":"https://www.benzinga.com/money/cannabis-business-insurance","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/05/02024604/h3pwuqxpp_0.jpg","description":"Learn how to insure your cannabis business with our top rated cannabis insurance companies. Keep your business operation safe and protected.","author":{"image":"https://secure.gravatar.com/avatar/a496a3873b473820b9572a9deed716cf?s=96\u0026d=mm\u0026r=g","name":"Dena Landon"}},{"id":36375,"title":"Best Marijuana ETFs","url":"https://www.benzinga.com/money/marijuana-etf","image":"https://cdnwp-s3.benzinga.com/wp-content/uploads/2020/05/02024413/hrrm_v-v0sm.jpg","description":"Interested in investing in cannabis? Discover the best marijuana ETFs traded in American and Canadian exchanges and where and how to buy them.","author":{"image":"https://secure.gravatar.com/avatar/a7a3e4487e9cc2c28d57bae0a878c1f2?s=96\u0026d=mm\u0026r=g","name":"Luke Jacobi"}}],"layout":"","action":"none","action_text":null,"action_link":null,"custom_link":null},"align":"","mode":"edit"},"innerBlocks":[],"innerHTML":""}]},"layout":{"settings":{"cache_max_age":0,"display_y_position":0,"show_author_credentials":false,"floating_cta_hide":true,"footer_hide":false,"hide_article_footer":false,"hide_article_header":false,"hide_navigation_bar":false,"hide_menu_bar_items":false,"simple_article_title":false,"hide_quotes_searchbar":false,"hide_sidebar_placement":false,"hide_sidebar":false,"hide_site_footer":false,"ignore_compare_products_popup":false,"is_root_path":false,"no_direct_partnership":false,"popup_delay":0,"popup_hide":true,"post_alternative_title":"","post_exclusive_partner":"","post_update_frequency":"","post_verified_by_user":null,"banner_text":"","banner_link":"","menu_location":null}},"surrogate_keys":"campaign:316091 campaign:226605 campaign:316091 campaign:226605 verticals:cannabis post-id:35276","author":{"wordpress_id":5860,"slug":"benzinga","avatar":"//secure.gravatar.com/avatar/d34e67a3708a958bb67f0ec0d657580c?d=mm","display_name":"Benzinga"}},"template":"page"},"__N_SSP":true},"page":"/[...slug]","query":{"slug":["cannabis","earnings"]},"buildId":"R05fxUUF7rvKgc3Bg3jzA","isFallback":false,"isExperimentalCompile":false,"gssp":true,"scriptLoader":[]}</script></body></html>